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Abstract 
 
A novel strategy for the construction of macrocyclic resorcylate natural products is 
currently under investigation. Our strategy, to construct the aromatic resorcylate units 
from poly-β-carbonyl precursors with late aromatisation, constitutes a biomimetic 
approach towards these targets, as consistent with the polyketide pathway1 
(Scheme I). 
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Scheme I.  Late-Stage Aromatisation Strategy for Resorcylate Construction. 
 
 
This thesis will discuss our first attempts to apply the late-stage aromatisation strategy 
to the construction of a macrocyclic resorcylate natural product target.  
 
(S)-Zearalenone (iii) is potent anabolic and estrogenic mycotoxin which was first 
isolated in 1962 from the microfungus Fusarium graminearum.2 (S)-Zearalenone (iii) 
belongs to the resorcylic acid lactone (RAL) family of natural products and was our 
initial target chosen to demonstrate the strategy.  
 
The first two results and discussion chapters will outline our initial attempts to 
synthesise (S)-zearalenone (iii) from protected β-triketo ester, diketone iv, firstly via a 
RCEYM strategy followed by selective oxidative scission of the exocyclic double 
bond of  the product diene, and secondly via a RCM reaction (Scheme II).  
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Scheme II.  Strategy for (S)-Zearalenone Synthesis. 
 
 
Difficulties encountered in these investigations prompted the search for a more 
general and selective method for resorcylate and poly-β-carbonyl synthesis, in order 
to introduce an element of control into the aromatisation step. The final chapter of the 
results and discussion section will summarise our revised strategy, employing 
dioxinone analogues v as masked β-triketo ester equivalents and hence resorcylate 
precursors. General methods for their construction, their use in the total synthesis of 
(S)-zearalenone (iii) and in addition, their potential use in the synthesis of other 
resorcylate natural products will be examined (Scheme III). 
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Scheme III.  Strategy for Resorcylate Construction from Dioxinone Analogues v. 
 
 
 
1) Birch, A. J., Proc. Chem. Soc. 1962, 3. 
2) Stob, M.; Baldwin, R. S.; Tuite, J.; Andrews, F. N.; Gillette, K. G., Nature 
(London) 1962, 196, 1318. 
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Abbreviations 
 
[α]D optical rotation 
Ac acetyl 
AIBN 2,2’-azobisisobutyronitrile 
Alloc allyloxycarbonyl 
Anal. analysis 
app. apparent 
aq. aqueous 
Ar aryl 
atm. atmosphere (pressure) 
Bn benzyl 
b.p. boiling point 
br.  broad  
Bt benzotriazole 
Bu butyl 
BuLi butyllithium 
Bz benzoyl 
c. concentrated 
°C degrees Celsius  
ca. circa 
CAL-B Candida antarctica lipase B 
CAN ceric ammonium nitrate 
cat. Catalytic 
Cbz benzyloxycarbonyl 
CDCl3 chloroform 
CDI carbonyldiimidazole 
CI chemical ionisation 
CM cross metathesis 
COD cyclooctadienyl 
cp cyclopentadienyl 
δ chemical shift 
d doublet 
DBU 1,8-diazabicycloundec-7-ene 
 9 
dd doublet of doublets 
DDQ dichlorodicyanoquinine 
DHP 3,4-dihydro-2H-pyran 
DIAD diisopropyl azodicarboxylate  
DIPA diisopropylamine 
DIPEA diisopropylethylamine 
DMAP 4-dimethylaminopyridine 
DMDO dimethyldioxirane  
DMF N,N-dimethylformamide 
DMP Dess-Martin periodinane 
DMSO dimethylsulfoxide     
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ee enantiomeric excess                                         
EI electron ionisation 
eq. equivalent 
ES electrospray 
Et  ethyl 
Et3N triethylamine 
Et2O diethyl ether 
EtOAc ethyl acetate 
Fur 2-furyl 
GCMS gas chromatography mass spectrometry 
h hour 
HMDS hexamethyldisilazane 
HRMS high-resolution mass spectrometry 
Hz Hertz 
i iso 
IBX o-iodylbenzoic acid 
Imid. imadazole 
IR infrared spectroscopy 
J coupling constant 
L litre 
LDA lithium diisopropylamine 
Ln ligand 
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M molar 
m multiplet 
m meta 
MAP kinase mitogen activated protein kinase 
Me methyl 
MeOH methanol 
MIC minimum inhibitory concentration 
min minute(s) 
mL millilitre(s) 
mol mole(s) 
MOM methoxymethyl 
mmol millimole(s) 
m.p. melting point 
MS mass spectrometry 
m.s. molecular sieves 
m/z mass to charge ratio 
n normal 
N3 azide 
NaH sodium hydride 
NCS N-chlorosuccinimide 
NHPI N-hydroxyphthalimide 
NMO N-methylmorpholine N-oxide 
NMR nuclear magnetic resonance spectroscopy 
o ortho 
p para 
P general protecting group 
PCC pyridinium chlorochromate 
PDC pyridinium dichromate 
Ph phenyl 
PhH benzene 
PhMe toluene 
Ph3PO triphenylphosphine oxide 
PPh3 triphenylphosphine 
PKS polyketide synthase 
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ppm parts per million 
PPTS pyridinium para-toluene sulfonate 
Pr propyl 
pTSA para-toluenesulfonic acid 
pyr. pyridine 
q quartet 
quint. quintet 
R general substituent 
RAL resorcylic acid lactone 
RCEYM ring-closing enyne metathesis 
RCM ring-closing metathesis 
Rf retention factor 
s singlet 
sat. saturated 
S.M. starting material 
t tertiary 
t triplet 
TBADH Thermoanaerobium brokii alcohol dehydrogenase 
TBAF tetrabutylammonium fluoride 
TBS tert-butyldimethylsilyl 
TDS thexyldimethylsilyl 
TES triethylsilyl 
Tf trifluoromethanesulfonyl (triflic) 
THF tetrahydrofuran 
THP tetrahydropyran 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMS trimethylsilyl 
TPAP tetrapropylammonium perruthenate 
Ts para-toluenesulfonyl (tosyl) 
µL microlitre(s) 
µM micromole(s) 
UV Ultra-violet
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1.1  Examples of Macrocyclic Resorcylate Natural Products 
 
The 6-alkyl-2,4-dihydroxybenzoic acid or β-resorcylate unit (1) can be found as part 
of macrocyclic lactone ring systems in a number of biologically active natural 
products. The biosynthesis of these compounds arises from the polyketide pathway 
(see Section 1.2), hence they are included in the rare macrolide polyketide natural 
product class. Examples include lasiodiplodin (2),3 zearalenone (3),2 
monocillin I (4a),4 radicicol (4b),5 15G256-α (5a) and 15G256-β (5b)6 (Figure 1).  
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Figure 1.  Examples of  Bioactive Resorcylate Natural Products  
 
The biosyntheses of macrocyclic resorcylate natural products are catalysed by 
polyketide synthases (PKSs), which are prevalent in fungi. This has resulted in the 
re-isolation of the same macrolide resorcylates from different fungal strains. For 
example, radicicol (4b) was first isolated from the fungus Monocillium nordinii and 
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accordingly named monorden.7 The same compound was later independently isolated 
from the fungus Nectria radicicola and given the name radicicol,5 which has 
prevailed. 
 
1.1.1   β-Resorcylic Acid Lactones (RALs) 
 
Zearalenone (3) is a potent anabolic and estrogenic mycotoxin8, 9 isolated in 1962 
from the microfungus Fusarium graminearum which colonises maize, barley, wheat 
and oats. Urry et al. confirmed the structure and the natural (S)-configuration of 
(S)-zearalenone (3) by mass spectrometric and NMR studies10 and it is considered the 
primary member of a biologically important naturally occurring class of 12- and 14-
membered macrolides called the β-resorcylic acid lactones (RALs). In addition to 
(S)-zearalenone (3), monocillin I (4a) and radicicol (4b) (Figure 1), other examples of 
RALs include agialomycin D (6),11 pochinon D (7)12 and hypothemycin (8).13 These 
examples reflect the diversity of functionality exhibited around the macrocycle as 
well as the differing biological activities (Figure 2).14  
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Figure 2.  Examples of β-Resorcylic Acid Lactones 
 
 
Today, (S)-zearalenone (3) is manufactured industrially via fermentation and is thence 
utilised in the synthesis of its derivatives zearalanone (9), zearalenol (10) and 
zeranol (11), the latter of which is marketed as Ralgro®, an anabolic growth stimulant 
for cattle (Figure 3).9 
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Figure 3.  Further Derivatives of (S)-Zearalenone (3) 
 
 
1.1.2   Antifungal Macrolides from LL-15G256 
 
A novel class of macrocyclic polyesters, including 15G256-α (5a) and 
15G256-β (5b), were isolated by Abbanat and co-workers in 1998 during the 
screening of fermentation extracts of Hypoxylon oceanicium (LL-15G256) for chitin 
biosynthesis inhibitors (Figure 4).6, 15, 16  
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Figure 4.  Macrolides Isolated from LL-15G256 
 
These antifungal macrolides were shown to be identical to some natural products 
previously isolated from different fungal cultures by Breinholt and co-workers, named 
BK223-A and BK223-C.17 The absolute stereochemistry was assigned by degradation 
and shown to be (9R, 12R, 21R, 24S, 27R) for 15G256-α (5a), and (9R, 12R, 21R, 
24R, 27R) for 15G256-β (5b) and in turn it was found that the same compounds had 
previously been isolated by Ito et al.,18, 19 and Kondo et al.20  
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These macrolides are of interest due to their potent, broad spectrum activity against a 
number of pathogenic fungi. They act by inhibiting fungi cell wall (formed mainly of 
chitin) biosynthesis and hence fungal growth. 15G256-β (5b) is the most active of the 
family, having an MIC (minimum inhibitory concentration) of 0.5 µg/mL against 
Neurospora crassa (OS-1) for example. 17 
 
To date there are no reported chemical syntheses of either 15G256-α (5a) or 
15G256-β (5b). 
 
1.2   Biosynthesis of Polyketides 
 
Biomimetic synthesis has long been of interest within the field of organic chemistry, 
not only to probe in detail the biosynthetic pathway of natural products but also to 
provide alternative solutions to conventional synthetic problems.  
 
The biosynthesis of many aromatic units found in nature involves the condensation of 
acetate and malonate units. This concept was pioneered by Collie at the start of the 
20th century,21 however, lack of available technology at this time meant there was 
little supporting evidence for his theories. He first coined the phrase ‘polyketide’ 
which was used to loosely describe a molecule or structure made up of repeating 
“CH2CO” units. These included derivatives such as lactones, pyrones, benzenoids and 
other aromatic or non-aromatic compounds built from acetate via the ‘polyketide 
route’.21-27  
 
Interest in the biosynthesis of polyketide compounds was revived in the late 1940’s 
and early 1950’s firstly by Robinson28, 29 and then Birch.1, 30, 31 This resulted in a 
revision of the hypothesis, culminating in the theory still believed today: polyketide 
chains are constructed by the condensations of coenzyme A esters 12 with malonyl 
coenzyme A ester (13) which, following decarboxylation, produce β-keto thiol 
esters 14. These can then undergo further Claisen-type condensations with malonyl 
coenzyme A ester (13) to give thiol esters of 3,5-diketo acids 15, then thiol esters of 
3,5,7-triketo acids 16 and so on, thus building poly-β-carbonyl chains (Scheme 1).  
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Scheme 1. Biosynthesis of Poly-β-carbonyl Chains 
 
 
An array of further biocatalysed transformations, such as reductions, deoxygenations, 
halogenations or alkylations, can then be undertaken to create a diverse set of  natural 
products. Intramolecular condensations to give non-aromatic or aromatic systems may 
also occur. For example, β-triketo acid derivatives 17 can undergo four possible 
condensations: aldol condensation-dehydration to generate resorcylates 18, Claisen 
(Dieckmann) cyclisations to produce acylphloroglucinols 19, or two different 
O-cyclisations to give 4-pyrones 20 or 4-hydroxy-2-pyrones 21 (Scheme 2).   
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Scheme 2.  Possible Intramolecular Condensations of β-Triketo acid Derivatives 17 
 
As well as resorcylates 18, 4-hydroxy-2-pyrones 21 (sometimes called polyketide 
lactones)32 and Claisen-type products 19 can also occur naturally, but the natural 
occurrence of 4-pyrones 20 have not as yet been reported. 
 
Birch et al. provided evidence for the polyketide hypothesis primarily by 
demonstrating that 14C-labelled 6-methyl salicylic acid (25) could be produced 
biosynthetically from Penicillium griseofulvum fed 1-14C-acetic acid (22). The 
product acid 25 was shown to have four alternating 14C labelled sites, as predicted by 
the polyketide route from intermediates 23 and 24 (Scheme 3).1, 33 
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Scheme 3. Biosynthesis of 6-Methyl Salicylic Acid (25), * indicates 14C labelling 
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At least 3000 polyketide compounds have been identified, often using similar 
14C tracer techniques. Indeed, the distribution of 14C in zearalenone isolated from 
Fusarium roseum cultures fed 1-14C-enriched acetate has been examined and the 
alternating labelling of the carbon skeleton provided evidence for condensation of 
nine acetate units.34-36 The upper limit of the polyketide pathway is thought to be 
poly-β-carbonyl compounds containing approximately ten carbonyl groups, which is 
sufficient to produce tetracyclic systems.37  
 
1.3  Brief Review of the Biomimetic Synthesis of Polyketides 
 
Following Birch’s revival of the polyketide hypothesis, in the early 1960’s and late 
1970’s several research groups became interested in developing ways to mimic this 
pathway in the laboratory. It was demonstrated that poly-β-carbonyl chains could be 
synthesised and would undergo many cyclisation reactions analogous to those carried 
out in nature, without enzyme catalysis.38-44 This led the way for an extensive study of 
biomimetic synthesis of polyketides and, in 1979, Harris and Harris published a 
review of the synthesis and cyclisation products of poly-β-carbonyl compounds from 
dicarbonyls to nonacarbonyls.37, 44 
 
One of the simplest aromatisations demonstrated by Harris et al. was that of methyl 
3,5,7-trioxooctanoate (27), the self-condensation product of methyl acetoacetate (26). 
Treatment of ester 27 over a pH range from 4 to 12 resulted in rapid aldol 
condensation-dehydration to give methyl orsellinate (28), a resorcylate. This 
procedure was later optimised by Barrett et al. to give resorcylate 28 in 78% yield, 
utilising pH 9.2 buffer (Scheme 4).45 
 
OMe OMe
O O O O O O
OH
HO
OMe
O
26 27 28
base acid or base
 
 
Scheme 4. Self-condensation and Aromatisation  of Methyl Acetoacetate (26) 
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Evidence from the work of Harris et al. suggests that of the four possible cyclisations 
which can occur from β-triketo acid derivatives 17 (Scheme 2), the aldol 
condensation-dehydration pathway is predominant under the majority of laboratory 
reaction conditions. It is, however, possible to control which cyclisation product is 
obtained by careful selection of solvent and pH. 
 
From methyl 3,5,7-trioxooctanoate (27), the Claisen product 29 could also be 
obtained simply by switching to an aqueous reaction medium. The corresponding 
carboxylic acid, 3,5,7-trioxooctanoic acid (30), will undergo O-cyclisation to give 
4-pyrone 31 in strongly acidic conditions.  In the presence of acetic anhydride 
however, 4-hydroxy-2-pyrone 32 is the product (Scheme 5).37  
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Scheme 5.  Condensations of β-Triketo acid Derivatives  
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At the same time as Harris’ work, several research groups were carrying out 
investigations into complex 2-pyrone derivatives and their lactone-opening reactions. 
It was recognised that the use of a base could initiate lactone cleavage to give acyclic 
intermediates, which would undergo rearrangement into aromatic polyketide 
compounds.38, 44, 46-49 Scott et al. developed this approach whilst attempting to 
introduce control into the base-catalysed intramolecular condensations. It was found 
that when 2-pyrone 33 was treated with potassium hydroxide in methanol, only 
aromatic compound 34 and its decarboxylation product, resorcylate 35, were observed  
(Scheme 6).44  
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Scheme 6. Douglas and Money’s 2-Pyrone Opening. 
 
This transformation constituted a rearrangement from one aromatic form to another, 
presumably occurring via open chain polycarbonyl 36 (Scheme 7). 
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Scheme 7. Mechanism of Transformation of 2-Pyrone 33 to Resorcylate 34. 
 
In addition to the use of basic conditions for resorcylate synthesis, several masked 
β-triketo ester compounds were synthesised in the late 1960’s and shown to undergo 
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spontaneous aromatisation under acidic deprotection conditions.50-52 Examples 
include symmetrical 2,8-bisketal 3753 and 2,8-bisenamine 39,54 both of which were 
shown to reveal resorcylate 38 (Scheme 8).  
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Scheme 8. Cyclisation of Protected β-Triketo Esters 
 
Up until this point, the lack of control in the condensation step had usually resulted in 
poor isolated product yields and complex product mixtures. A key strategy to control 
selectivity was discovered in 1975 by Griffin and Staunton,55 who recognised that 
internal constraints were needed in the poly-β-carbonyl chains in order to control the 
aromatisation. They successfully achieved the synthesis of resorcylate 44 from 2-
pyrone 40, in 65% isolated yield from the key aromatisation step. They attributed this 
to the directing effect of the phosphonate group which increases the acidity of the 
adjacent protons, thus favouring aldol-condensation pathways. The β-triketo ester 
derivative 43 is generated by opening of intermediate pyrillium ion 41 with 
phosphonate ester 42 (Scheme 9). 
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Scheme 9. Griffin and Staunton’s Use of A Directing Phosponate Group 
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In the 1980’s, Chan et al. developed intermolecular condensations to form 
resorcylates from two fragments which represented a second major breakthrough in 
polyketide synthesis. Chan utilised silyl enol ethers 45 and 46 (Figure 5) as 
β-keto ester and β-diketo ester equivalents respectively. Condensation of these silyl 
ethers with activated acid equivalents, under Lewis acid catalysis, generated 
resorcylates or more complex polyketides.  
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Figure 5. Chan et al’s Polyketide Synthons (R=TMS). 
 
This strategy was employed in the synthesis of Sclerin (52).56 Condensation of 
bis(trimethylsilyl)enol ether 49 with methyl orthoacetate (50) led to polyketide 51 in 
53% yield, which was further elaborated to the natural product by methylation and 
hydrolysis (Scheme 10).  
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Scheme 10. Chan et al’s Synthesis of Sclerin (52) (R=TMS). 
 
A postulated mechanism for the key step in this sequence is illustrated in Scheme 11. 
Condensation of bis-silyl ether 49 with methyl orthoacetate (50) generates 
intermediate 53, which undergoes a second condensation with another molecule of 
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bis-silyl ether 49 to provide the resorcylate 51, presumably through intermediates 54 
and 55. 
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Scheme 11. Mechanism of Key Aromatisation Step in Studies Towards Sclerin (52) (R=TMS). 
 
The condensation of a bis-silyl ether such as 45 or 49 with more complex β-keto acid 
derivatives has also led to formation of resorcylates in high yields. For example, 
β-ketal acid chloride 56 can be employed as the condensation partner, yielding 
resorcylate 57 in 55% yield after spontaneous ketal deprotection (Scheme 12). Chan 
notes that the high regioselectivity observed is due to the order of reactivity 
acid chloride > ketal > ester.57 
CH3(CH2)4
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Scheme 12. Chan et al’s Synthesis of Resorcylate 57 (R=TMS). 
 
Chan and co-workers further developed their condensations to allow the use of 
tris(trimethylsilyl)enol ether 46 in resorcylate synthesis. Commercially available  
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dehydroacetic acid (58) was converted to methyl triacetate 59,58 which was thus 
converted to silyl ether 46, a β-diketo ester trianion equivalent, via ester 60.59 
Reaction with activated acid derivatives, such as acyl imidazole 61, afforded 
resorcylates, such as resorcylate 62. This approach was successfully employed in the 
formal synthesis of (±)-lasiodiplodin (2), the key aromatisation step proceeding in 
excellent yield (75%) (Scheme 13).60 
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Scheme 13. Chan et al’s Synthesis of (±)-Lasiodiplodin (2) (R=TMS). 
  
At the end of the 1980’s, Yamaguchi et al. revisited poly-β-carbonyl condensations. 
They developed an improved protocol for poly-β-carbonyl synthesis involving the 
condensation of β-ketal dimethylamides 64 with the dianion of methylacetoacetate 65 
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under BF3-catalysis. The spontaneous aromatisation of the produced ketal protected 
β-triketo esters 66 in acetic acid with sodium perchlorate formed resorcylates 67 
(Scheme 14).61, 62 Unfortunately however, increasing complexity of side chains ‘R’ 
led to a lowering of yields for both of the two steps and functional groups were not 
well tolerated. 
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Scheme 14. Yamaguchi et al.’s Resorcylate Synthesis:  
R = n-C9H19; Ph(CH2)2; C2H5(CH3)CHCH2; CH2=CH(CH2)2. 
 
In more recent times, several biomimetic syntheses of complex polyketide natural 
products have been carried out via intramolecular poly-β-carbonyl condensations. For 
example, semivioxanthin (70) has been synthesised from ketone 69, which was 
generated by the aromatisation of polyketide lactone 68b (which predominantly exists 
as the bis-enol 68a in solution) (Scheme 15).63, 64 Also, a biomimetic aromatisation 
has been utilised as the key step in the synthesis of benzo[a]naphthacenequinone 72, 
from poly-β-carbonyl compound 71 (Scheme 16).65 
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Scheme 15.  Biomimetic Synthesis of Semivioxanthin (70) 
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Scheme 16.  Biomimetic Synthesis of Benzo[a]naphthacenequinone 72 
 
In spite of progress in the latter half of the 20th century, biomimetic strategies for the 
syntheses of simple resorcylate natural products have failed to develop into methods 
widely used today. Although several potential strategies have been examined, these 
have either been shown to have limited substrate compatibility, due partly to harsh 
basic or acidic conditions required for the aromatisation reaction, or to result in side 
products and moderate yields as a consequence of alternative aromatisation pathways. 
 
In summary, a mild and selective method for the formation and aromatisation of 
β-triketo acid derivatives remains elusive. 
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1.4 Initial Project Objectives 
 
Traditionally, syntheses of resorcylate derivatives have begun with aromatic building 
blocks such as resorcylic acid (73), orsellinic acid (28) or their derivatives (Figure 6) 
and the focus is on formation of the macrocycle. 
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O OH
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Figure 6.  Conventional Starting Materials for Resorcylate Synthesis 
 
Syntheses from such aromatic starting materials have proven fraught with unexpected 
difficulties, not least of which are manipulations of the necessary protecting groups on 
the two phenols and in particular their removal as the ultimate step.  
 
Indeed, previous work within the Barrett Group66 had attempted the total synthesis of 
polyketide macrolide 15G256-β (5b) and failed by conventional means. The 
resorcylate benzoic ester is hindered and also particularly deactivated to nucleophilic 
attack by the electron-donating power of the two hydroxy groups, even if these are 
protected as ethers. This can make macrolactonisation or esterification difficult. In the 
case of 15G256-β (5b), an additional problem was the tendency for elimination under 
the esterification conditions to form stable lactone 74 (Figure 7).  
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Figure 7.  Encountered Difficulties in 15G256-β (5b) Synthesis. 
 
Whilst examining alternative synthetic approaches, the idea of employing a 
biomimetic strategy to construct the two aromatic units in 15G256-β (5b) from 
poly-β-carbonyl precursor 75 was developed. It was thought that masking the 
aromatic unit, or late-aromatisation, could potentially avoid some traditionally 
encountered synthetic problems in resorcylate chemistry (Scheme 17). 
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Scheme 17. Proposed New Retrosynthetic Analysis of 15G256-β (5b). 
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This idea prompted research into general biomimetic resorcylate syntheses, which 
proved to be an area with the potential for development. It was deemed appropriate to 
first carry out the total synthesis of a simpler natural product by the same strategy and 
RAL synthesis was an obvious choice.  
 
Interest in RALs has recently been rekindled by the discovery that some RALs, 
including radicicol (4b) and pochinon D (7), are inhibitors of the molecular chaperone 
Hsp90. Hsp90 is one target currently being investigated for potential new 
chemotherapy development.14 
 
1.4.1 Previous Syntheses of RALs 
 
Conventional retrosynthesis of RALs such as (S)-zearalenone (3) divide the molecules 
into two portions: an aromatic moiety and a functionalised aliphatic chain, both of 
which must be prepared and then joined accordingly. (S)-Zearalenone in particular has 
been utilised to demonstrate several new macrocyclisation methods and to date many 
total syntheses of both racemic and naturally occurring (S)-zearalenone have been 
completed. Three main strategies have been utilised: macrolactonisation,67-72 
intramolecular alkylation of stabilised carbanions4, 73-76 and most recently transition 
metal-catalysed C=C bond formation or metathesis (Figure 8).77, 78 
 
O
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strategy 1: macrolactonisation
strategy 2: alkylation
strategy 3: metathesis
3
 
 
Figure 8.  Previous Strategies in the Synthesis of (S)-Zearalenone (3). 
 
Interestingly, the most problematic steps of the syntheses appeared to be removal of 
the phenolic protecting groups. Typically, methoxy ethers have been employed which 
require two steps with a maximum yield of 50-55% to deprotect, generating the 
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natural product.79 More recently silyl ethers80 or MOM-ethers81 have been utilised, 
allowing deprotection yields of 60% and 74% respectively. 
 
Only one attempt at RAL synthesis from non-aromatic building blocks has so far been 
attempted. In 2001, Danishefsky et al. undertook synthesis of monocillin I (4a) and 
radicicol (4b), employing a key Diels-Alder reaction between 1,3-disubstituted 
allene 76 and Chan’s bis(trimethylsilyl)enol ether 45. This resulted in 50% yield of 
the desired resorcylate 77 and 15% of the unwanted regioisomer 78 (Scheme 18).80 
 
OO
C
Cl
HO
H
OO
HO
H
Cl
HO
OH
OO
HO
H
Cl
HO
OH
+
76
77  (56%) 78  (15%)
O
OROR
45
∆
 
 
Scheme 18. Key Step of Danishefsky et al.’s Attempted Monocillin I (4a)  
Synthesis (R = TMS). 
 
Due to the disappointing yield and regioselectivity of this step, Danishefsky et al.  
returned to aromatic starting materials. They found that the notoriously difficult 
esterification of the hindered and electronically deactivated resorcylate benzoic acid 
(also noted in our own synthetic studies towards 15G265-β, see Figure 7) was easier if 
the ortho-phenol was unprotected. Hence substrate 79 could be esterified with 
alcohol 80 to afford ester 81. Subsequent alkylation of the anion generated from 
dithiane 82 provided ester 83. 
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The meta-phenol was protected as a TBDPS-ether and the selected retrosynthetic 
analysis required ring-closing metathesis (RCM). Unfortunately however, the 
metathesis reaction would not work in the presence of the unprotected second phenol 
group in ester 83. Instead, it was necessary carry out further protecting group 
manipulations, protecting the phenol as a silyl ether before carrying out the RCM to 
afford macrocycle 84. Finally, deprotection yielded the natural product 4a  
(Scheme 19).80  
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Scheme 19. Danishefsky et al.’s Synthesis of Monocillin I  (4a). 
 
This example illustrates some of the traditionally encountered difficulties with RAL 
and resorcylate synthesis, which we hoped to avoid if the aromatic unit were to be 
constructed at a later stage in the synthesis.  
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A recent review of the synthesis and biology of RALs has been published by 
Winssinger and Barluenga14 and the reader is directed towards this if more 
information is required.  
 
 
1.4.2  Our Retrosynthetic Analysis of (S)-Zearalenone (3). 
 
We selected (S)-zearalenone (3) as the primary target to demonstrate our late-stage 
aromatisation strategy, due to the relative simplicity of the macrocyclic portion in 
comparison with other RALs. Our initial retrosynthetic analysis is shown in  
Scheme 20. 
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Scheme 20.  Retrosynthetic Analysis of (S)-Zearalenone (3) Utilising a Late-Stage 
Aromatisation Strategy. 
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Our retrosynthetic analysis of (S)-zearalenone (3) utilises a final stage aromatisation 
reaction of β-triketo ester 85 which in turn gives macrocyclic diketal 86 as an 
intermediate. Diketal 86 could be produced from the selective oxidative cleavage of 
diene 87. Disconnection of the macrocycle via RCEYM generates enyne 88, which 
could be formed from the transesterification of alkyne ester 89 and (S)-alcohol 93.  
 
Alkyne ester 89 could be produced from the Claisen condensation of alkyne 90 and 
ethyl acetate. Alkyne 90 can be derived from aldehyde 91, which in turn could be 
formed from readily available diethyl 1,3-acetonedicarboxylate (92). (S)-Alcohol 93 
may be synthesised in two steps from commercial lactone 95, via firstly a Grignard 
reaction with 5-bromo-1-pentene and secondly ketal protection of product ketone 94.  
 
 
1.5  Summary of  Objectives 
 
In order to validate our late-stage aromatisation strategy, we first planned to undertake 
the total synthesis of (S)-zearalenone (3). It was hoped that this would allow us to 
develop a high-yielding and selective method for the synthesis of resorcylates and in 
particular RALs. We would then endeavour to apply this method to the synthesis of 
other resorcylate natural products and RALs, towards the ultimate goal of 
15G256-β (5b). 
 
We hope that a biomimetic strategy for the construction of the resorcylate aromatic 
unit could compete with traditional resorcylate synthesis from aromatic precursors. 
Forming the aromatic unit after macrocyclisation would aim to eliminate problems 
associated with the resorcylate phenols, namely protecting group manipulations and 
macrolactonisation or esterification of the hindered and deactivated resorcylate 
benzoic acid. 
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Chapter Two:  
Results and Discussion – 
RCEYM Approach to 
(S)-Zearalenone 
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2.1 Introduction 
 
Our retrosynthetic analysis of (S)-zearalenone (3), the initial target for our studies, 
was discussed in section 1.4.2 (Scheme 20). The envisaged synthetic pathway can be 
split into four distinct goals: firstly the syntheses of (S)-alcohol 93 and alkyne ester 89 
(Figure 9); secondly their coupling via transesterification and ring-closing enyne 
metathesis (RCEYM). The third goal is the selective oxidative scission of the 
exocyclic double bond to give diketal 86 and finally, ketal deprotection and 
aromatisation to yield the natural product. In this chapter, efforts towards these goals 
will be discussed in turn.  
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Figure 9.  Primary Targets for Synthesis of (S)-Zearalenone (3) 
 
 
2.2  Synthesis of (S)-Alcohol 93 
 
Further retrosynthetic analysis of (S)-alcohol 93 is shown in Scheme 21. Opening of 
(S)-δ-hexanolactone (95) with 4-pentenylmagnesium bromide (96) would afford 
keto alcohol 94, which then would be protected to provide target (S)-alcohol 93.  
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Scheme 21.  Retrosynthetic Analysis of (S)-Alcohol 93. 
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(S)-Zearalenone (3) contains a single stereocentre which, following our retrosynthesis 
(Scheme 20), is contained in the alcohol fragment of the molecule. Due to the expense 
of (S)-δ-hexanolactone (95), it seemed sensible to first carry out a racemic synthesis. 
 
Another contributing factor to this decision was the knowledge that enantiomerically 
pure 1,5-keto alcohols can suffer spontaneous loss of optical activity. This 
phenomenon has been observed during previous studies of (S)-zearalenone synthetic 
intermediates by firstly Urry,10 then Taub68 and Fuerstner,78 being attributed to a rapid 
and reversible intramolecular 1,5-hydride shift, a type of internal oxidation-reduction 
(Scheme 22).  
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Scheme 22. Mechanism of Intramolecular Hydride Shift. 
 
This would suggest that (S)-1,5-keto alcohol 94, generated by the opening of 
(S)-δ-hexanolactone (95), could racemise by this mechanism. This would mean that   
(S)-δ-hexanolactone (95) could not be utilised in the synthesis of the desired 
(S)-alcohol 93 (Scheme 23). 
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Scheme 23.  Effect of Racemisation of 1,5-Keto alcohol 94. 
 
 39 
The synthesis of (±)-alcohol 93 from (±)-δ-hexanolactone (95) via the envisaged two 
step procedure was therefore a primary goal, to enable us to continue with the 
synthesis of (±)-zearalenone (3) and establish a viable synthetic route. 
Simultaneously, an alternative route to the (S)-alcohol 93, necessary to introduce 
chirality, would be investigated. 
 
2.2.1  Synthesis of (±)-Alcohol  93 
 
Synthesis of (±)-alcohol 93 began with reaction of 4-pentenylmagnesium 
bromide (96) with (±)-δ-hexanolactone (95). 1H NMR analysis showed crude (±)-keto 
alcohol 94 to exist approximately 40% as cyclised hemi-ketal 97, exhibiting an 
additional equilibria 1,5-keto alcohols are prone to (Scheme 24).  
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Scheme 24. Reagents and conditions: i) THF, –78 °C, 2 h. 
 
(±)-Keto alcohol 94 proved to be unstable to chromatography, so ketal protection was 
attempted on the crude product. Treatment with ethylene glycol in toluene using 
PPTS catalysis was unsuccessful, therefore milder reaction conditions were 
investigated. Use of 1,2-bis(trimethylsilyl)oxyethane with TMSOTf catalysis82 gave 
(±)-alcohol 93 in moderate yield (47%) over two steps following chromatography 
(Scheme 25).   
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Scheme 25.  Reagents and conditions: i) TMSOCH2CH2OTMS, TMSOTf, CH2Cl2, –78 °C, 3 h, 47% 
over two steps. 
 
It was possible that the difficulties encountered during the protection of 
(±)-keto alcohol 94 were caused by acidic conditions and elevated temperatures, 
which encouraged competing side reactions, such as hemi-ketal formation. We 
proposed that these could be reduced or eliminated by firstly protecting the alcohol 
group as an acetate, which would require basic conditions. 
 
Acetylation of (±)-keto alcohol 94 gave acetate 98 in good yield, which was then ketal 
protected under a number of conditions. It was found that refluxing in toluene led to a 
complex mixture of compounds of which no desired product was detected, however 
the use of milder 1,2-bis(trimethylsilyl)oxyethane as used previously, this time gave 
no reaction at all. The solution we found was to use benzene as a solvent to lower the 
reflux temperature, yielding product (±)-ketal 99 in 88%. Deprotection of the acetate 
group proceeded smoothly to give (±)-alcohol 93 in an improved overall yield of 61% 
over four steps (Scheme 26).  
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Scheme 26. Reagents and conditions: i) Ac2O, pyr., 60 °C, 24 h, 71% over two steps; 
ii) HOCH2CH2OH, PPTS, PhH, 80 °C, 18 h, 88%;  iii) KOH (3 M aq.), MeOH, 23 °C, 3 h, 98%. 
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This route was thus employed on large scale to provide approximately 20 g of 
(±)-alcohol 93 for initial studies into the synthesis of (±)-zearalenone (3). In the 
remainder of this section, our investigations into the synthesis of enantiopure 
(S)-alcohol 93 will be discussed. 
 
 
2.2.2  Enantiopure Synthesis of (S)-Alcohol 93 
 
Fuerstner et al reported the synthesis of (R)-alcohol 93 in a six step procedure, 
beginning with commercial (R)-propylene oxide (100).78 As only (R)-propylene oxide 
and not the (S)-enantiomer was readily available to us, it was decided to first test the 
reliability of this exact reaction sequence and therefore its potential for large scale 
use. To this effect, opening of (R)-epoxide 100 was accomplished with 
vinylmagnesium bromide, using CuCl(COD) catalysis. Distillation gave (R)-alcohol 
101 in only 37% yield, with subsequent TBS protection  to afford silyl ether 102 
occurring in 52% (Scheme 27).   
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Scheme 27. Reagents and conditions: i) vinylmagnesium bromide, CuCl(COD), THF,  –78 °C to 
23 °C, 18 h, 37%;  ii) TBSCl, Imid., DMF, 23 °C, 16 h, 52%. 
 
Next, hydrocyanation of silyl ether 102 using Schwartz’s reagent was carried out 
according to Buchwald’s procedure,83 however the only isolated product from the 
initial attempt was aldehyde 103 (Scheme 28).  
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Scheme 28. Reagents and conditions: i) a) Cp2ZrHCl, CH2Cl2, 23 °C, 2 h;  b) t-BuNC, 23 °C, 2 h;  
c) I2, PhMe, 0 °C, 0.5 h, 21%. 
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The proposed mechanism for the hydrocyanation reaction is illustrated in Scheme 29. 
Initial hydrozirconation of alkene 102 is regioselective towards the least hindered, 
terminal end and is followed by insertion of the isocyanate. Addition of a 
stoichiometric amount of iodine results in halogen/metal exchange, forming imidoyl 
iodide 106, which is then spontaneously converted to nitrilium ion 107 by loss of 
iodide. The tert-butyl group is then lost, either as a carbonium ion or by assisted 
attack of iodide, to form the product nitrile 108. The formation of aldehyde 103 
suggests water was present in the reaction before the iodine quench, hydrolysing 
imino compound 105 (Scheme 29). 
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Scheme 29. Mechanism of Nitrile Formation by Buchwald’s Procedure.83 
 
Careful repetition with rigorously dried solvents afforded nitrile 108 in moderate yield 
(60%). Subsequent reaction with 4-pentenylmagnesium bromide (96) gave 
(R)-ketone 109, which was then protected to form (R)-ketal 110. Silyl deprotection 
afforded 42 mg of (R)-alcohol 93, which had a recorded optical rotation of [α]D –6.7 
(c 1.22, CH2Cl2). The literature optical rotation for (R)-alcohol 93 has previously been 
recorded as [α]D –6.8 (c 1.02, CH2Cl2),84 a comparable value to ours (Scheme 30).  
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Scheme 30. Reagents and conditions: i) a) Cp2ZrHCl, CH2Cl2, 23 °C, 2 h;  b) t-BuNC, 23 °C, 2 h; 
c) I2, PhMe, 0 °C, 0.5 h, 60%;  ii) 96, Et2O, 80 °C, 4 h, 74%;  iii) HOCH2CH2OH, PTSA, PhMe, 
120 °C, 12  h, 28%;  iv) n-Bu4NF, THF, 23 °C, 24 h, 68%. 
 
The synthesis of (R)-alcohol 93 was thus completed in an unsatisfactory 2.7% yield 
over six steps from commercial (R)-propylene oxide 100. This prompted the search 
for an alternative synthetic route to (S)-alcohol 93.  
 
2.2.3  Alternative Strategy from Chiral Starting Materials 
 
As mentioned in section 2.2, 1,5-keto alcohols, such as alcohol 94, are reported to 
undergo spontaneous racemisation and also exist in equilibrium with a six-membered 
hemi-ketal form. However contrary to this observation, Keinan et al. published a 
synthesis of (S)-zearalenone (3) which in fact employs enantiopure (S)-1,5-keto 
alcohol 114 with no reported loss of optical activity. The key step in the synthesis is 
the stereoselective reduction of (±)-diketone 113 with Thermoanaerobium brokii  
alcohol dehydrogenase (TBADH).85 This enzyme is selective for the least hindered 
ketone.  
 
Keinan notes that (S)-keto alcohol 114 can be isolated and characterised, but it will 
undergo spontaneous cyclisation to its hemi-ketal, which concurs with our own 
observations. Instead of carrying out the direct ketal protection of 
(S)-keto alcohol 114, the crude product was firstly acetylated and purified as the 
(S)-acetate 115. This was then utilised in the total synthesis of (S)-zearalenone (3) 
resulting in an optical purity exceeding 99.5% (Scheme 31).  
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Scheme 31. Keinan et al.’s Synthesis of (S)-alcohol 117. 
 
Thus, it may be envisaged that our previous method for the synthesis of 
(±)-alcohol 93 (Scheme 26) actually would be applicable to the synthesis of 
(S)-alcohol 93, via the opening of (S)-δ-hexanolactone (95) (Scheme 32).  
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Scheme 32.  Proposed Route to (S)-Alcohol 93 
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However, due to expense of lactone (S)-95, we first became interested in introducing 
chirality to the (±)-alcohol 93 already in hand, for example by kinetic resolution. This 
strategy will be discussed in the following section. 
 
2.2.4  Kinetic Resolution of (±)-Alcohol 93 with CAL-B 
 
In the last decade, the tools available for the synthesis of enantiomerically pure 
compounds have been vastly expanded by the use of enzymes as chiral catalysts. 
Biocatalysis employing lipases or esterases is no longer regarded as exotic, due to the 
ease of use and commercial availability of many enzymes. Mild reaction conditions, 
the lack of sensitivity to air or water and the high chemo-, regio- and 
stereoselectivities demonstrated by lipases has led biocatalysis to become a popular 
way to introduce chirality by resolution. Screening sets of enzymes and tools to 
predict which enantiomer will react faster86 allow chemists to select the best enzyme 
for their desired transformation. 
 
Our desired transformation was to carry out a kinetic resolution of secondary 
(±)-alcohol 93 to provide optically pure (S)-alcohol 93 (Scheme 33).  
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Scheme 33.  Proposed Kinetic Resolution Route to (S)-Alcohol 93. 
 
It is known that lipases such as Candida antarctica lipase B (CAL-B) can be used to 
enable the stereoselective transformation of alcohols (amines) or carboxylic acids to 
esters (amides) by esterification87 (amidation) or transesterification88 and also for the 
stereoselective hydrolysis of esters (amides) to alcohols (amines). CAL-B is 
commercially available immobilised on a macroporous resin and has previously been 
used in our group66 to carry out achiral transesterification reactions. 
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CAL-B can be applied to the kinetic resolution of (±)-alcohol 93 in two ways: either 
via selective hydrolysis of the (R)-enantiomer of (±)-acetate 99 to provide 
(R)-alcohol 93 and (S)-acetate 99 (Scheme 34), or via the selective acetylation of the 
(R)-enantiomer of (±)-alcohol 93 to generate (R)-acetate 99 and (S)-alcohol 93 
(Scheme 35). These two strategies will be discussed in turn in the following sections.  
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Scheme 34. CAL-B Mediated Hydrolysis 
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Scheme 35. CAL-B Mediated Transesterification 
 
For any kinetic resolution the theoretical maximum yield is 50%, therefore reactions 
can be monitored to 50% conversion and then halted (work-up) and products 
separated to give enantiomerically pure products and starting materials. It is also 
important to be able to measure the ee values obtained for products and starting 
materials, for example by chiral HPLC, chiral GC or by utilising chiral shift reagents 
in NMR spectroscopy.  
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2.2.4.1 CAL-B Mediated Hydrolysis of Acetate (±)-99 
 
The hydrolysis of (±)-acetate 99 was carried out utilising 10% w/w CAL-B in pH 7.2 
phosphate buffer, at a concentration of 0.1 M at 35 °C under air. The conversion of 
acetate to alcohol was monitored by GC (Table 1, Graph 1).  
 
Time (h) % Acetate 99† % Alcohol 93† 
   
0 100 0 
1 98.6 1.4 
2 96.7 3.3 
4 87.1 12.9 
8 84.0 16.0 
24 65.0 35.0 
32 65.4 34.6 
48 63.4 36.6 
 
Table 1 
†percentage determined by GC analysis 
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Graph 1. Graph of CAL-B Mediated Hydrolysis 
 
As indicated by Graph 1, the hydrolysis reaction failed to reach 50% conversion even 
after 48 h. With less than 50% conversion, it would be expected that the product 
alcohol would be enantiomerically pure but the starting material would only be 
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slightly enantiomerically enriched, as it would still contain some of the 
(R)-enantiomer along with the unreactive (S)-enantiomer.  
 
A possible reason for the slow rate of hydrolysis is a solubility problem, hence 
investigations into various co-solvents were carried out. It is known that CAL-B 
hydrolyses can be performed in a variety of solvents and even with bi-phasic systems, 
however in all attempted cases the results were either similarly sluggish (10% MeOH) 
or worse than the buffer-only system (10% THF, 50% PhMe; Graph 2).  
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Graph 2. CAL-B Mediated Hydrolysis with Co-Solvents 
 
A second possible reason for the slow rate of the hydrolysis reactions is the acetic 
acid produced, which raises the pH of the system and may inhibit the enzyme and thus 
retard the reaction rate. It is possible to combat this by the controlled addition of 
concentrated aqueous sodium hydroxide, to maintain a steady pH. A further reaction 
was carried out and after 24 h the conversion was again only ~35%, but the pH was 
shown to be pH 5.0. Careful addition of sodium hydroxide to pH 7.0 enabled the 
reaction to reach 44% conversion after a further 10 h (Scheme 36).  
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Scheme 36. Reagents and Conditions: i) CAL-B, pH 7.2 phosphate buffer, 0.1 M, pH 7-7.2, air, 35 °C, 
34 h, (R)-93: 27%, (S)-99: 35%. 
 
This procedure was repeated on a multi-gram scale and the reaction mixture purified 
via column chromatography to provide (S)-acetate 99 (35%, [α]D +0.9 
(c 1.64, CH2Cl2)) and (R)-alcohol 93 (27% , [α]D –4.3 (c 1.22, CH2Cl2)). The 
literature optical rotation for (R)-alcohol 93 is [α]D –6.8 (c 1.02, CH2Cl2)).84 The 
apparent lower optical activity may be due to the extended reaction times being less 
ideal for a kinetic resolution.  
 
Although these initial kinetic resolution studies were promising, it was expected that 
the enzyme-mediated transesterification of (±)-alcohol 93 with an acetate group could 
be more suited to our needs, as the transesterification procedure would directly form 
our desired (S)-alcohol 93 without the need for further steps (see Scheme 35). 
 
2.4.2.2 CAL-B Mediated Transesterification of (±)-Alcohol 93 
 
Biocatalysed transesterifications of alcohols 118 are commonly employed as 
resolution techniques, with the most common transesterification partners being vinyl  
acetate (119) or isoprenyl acetate (121). During the resolutions the acetate is 
transferred from the vinyl or isoprenyl group to one of the alcohol enantiomer 
preferentially, forming an enantiopure acetate 120. The by-products are vinyl 
alcohol (121) or isoprenyl alcohol (124), which rapidly tautomerise to the more 
favoured keto-tautomers acetaldehyde (122) and acetone (125), which can take no 
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further part in the reaction. Removal of these ‘alcohol’ by-products shifts the reaction 
equilibrium towards the product side (Scheme 37).  
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Scheme 37. Enzyme-mediated Transesterifications with Vinyl- and Isoprenyl-acetate 
 
The CAL-B mediated transesterification of (±)-alcohol 93 was carried out with ten 
equivalents of vinyl acetate (119) in hexanes, with a concentration of 0.1 M at 35 °C 
under air. Conversion to the acetate was monitored by GC (Table 2, Graph 3). 
 
 
Time (min) % Acetate†  Time (min) % Acetate† 
0 0  30 32.2 
5 5  35 35.6 
10 12.2  45 40.4 
15 15  60 47.6 
20 21.6  90 56.1 
25 25  120 58.4 
 
Table 2 
†percentage determined by GC analysis 
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Graph 3. CAL-B Mediated Transesterifications of Alcohol (±)-93 
 
The transesterification reaction proved to be much faster than the CAL-B mediated 
hydrolysis, approaching 50% conversion at approximately 65 minutes. At longer 
reaction times however, the conversion approaches 60%. This suggests that although 
the reaction is highly selective for the (R)-enantiomer, the (S)-alcohol will also react 
slowly. 
 
The reaction procedure was repeated on a multi-gram scale, halted after 65 min and 
the reaction mixture purified via column chromatography to provide (R)-acetate 99 
(51%, [α]D –1.1 (c 1.10 CH2Cl2)) and (S)-alcohol 93 (48%, [α]D +5.8 (c 1.19 
CH2Cl2)).  These values suggest a slightly higher degree of optical purity than 
obtained  via hydrolysis, although not yet comparable to the `literature observations.  
 
To improve the optical purity during the transesterification reaction, it was thought to 
halt the reaction after 60 min, at ~45% conversion. At this time the products would be 
separated by chromatography. This would theoretically provide (R)-acetate 99 with a 
high optical purity, along with a lower optical purity (S)-alcohol 93. 
 
This isolated (S)-alcohol (contaminated with some remaining (R)-alcohol) would then 
be re-exposed to the same reaction conditions for a longer time. This would ensure 
that any remaining (R)-alcohol will be converted to its acetate, although according to 
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our initial observations that the reaction proceeded to >50% conversion, some of the 
(S)-alcohol would also be converted to its acetate. After a second chromatography 
step, this would result in an enhanced optical purity of the isolated (S)-alcohol, albeit 
with lower isolated yield. The time for the second ‘resolution’ would be chosen to 
counterbalance the increase in optical purity with the drop in yield.  
 
Following this procedure, with a second ‘resolution’ time of 3 h, (R)-acetate 99 (46%, 
[α]D –1.1 (c 1.05 CH2Cl2)) and (S)-alcohol 93 (41%, [α]D +6.9 (c 1.19 CH2Cl2)) were 
isolated (Scheme 38).  
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Scheme 38. Reagents and Conditions: i) CAL-B (10% w/w), vinyl acetate (119) (10 eq.), hexanes, air, 
35 °C, 1 h, (R)-99: 46%; ii) CAL-B (10% w/w), vinyl acetate (10 eq.), hexanes, air, 35 °C, 3 h, 
(S)-93: 41%. 
 
The (S)-alcohol 93 obtained via the resolution method had thus proven to have a level 
of optical purity equal to that obtained previously from chirally pure starting materials 
(see Section 2.2.2). However, to determine the precise degree of optical purity it was 
necessary to measure the ee value. This will be discussed in the next section. 
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2.2.5  Determining Enantiomeric Excess of the Resolution Products 
 
2.2.5.1  Chiral HPLC Method 
 
To determine the enantiomeric excess of the products obtained from the biocatalysed 
resolution studies, we first sought to use chiral HPLC. The ee’s can be determined by 
integrating the peaks obtained from each enantiomer, as given by Equation 1: 
 
ee (%) = IR – IS  × 100 
     IR + IS 
 
Equation 1. 
 
Where IR (or IS) is the intensity or integral of the respective (R)- or (S)- peak in the 
HPLC output.  
 
The samples were run using a CHIRALPAK AD amylase carbamate column with a 
HP 1100 chiral-HPLC with a UV detection method at a range of 200-280 nm 
(reference 525 nm), eluting with 1%-10% i-PrOH / hexanes. Unfortunately, neither 
alcohol 93 or acetate 99 have chromophores and so do not absorb UV-radiation 
strongly, hence spectra with messy baselines were obtained and the results were 
ambiguous. It was thought that forming the benzoyl esters 126 would increase the UV 
absorption, thus acylation of (±)-alcohol 93 with benzoyl chloride was carried out 
(Scheme 39). However (±)-benzoyl ester 126 still did not enhance the chiral-HPLC 
spectra sufficiently to resolve the two enantiomeric peaks.  
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Scheme 39. Reagents and conditions: i) BzCl, pyr., 23 °C, 4 h, 92%. 
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2.2.5.2  Chiral Shift Reagent Method.  
 
In  Keinan’s85 synthesis of (S)-zearalenone (3) outlined in Scheme 31, section 2.2.3, 
the ee of (S)-acetate 115 (Figure 10) is determined using a europium chiral shift 
reagent, Eu(tfc)3 (127, Figure 11). 
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Figure 10.  Acetate 115                                 Figure 11.  Eu(tfc)3 (127) 
 
 
Eu3+ is a Lewis acid and thus can coordinate to both the carbonyl oxygen and one of 
the acetyl oxygens, causing a spreading of chemical shifts over a wider range of the 
spectrum. As Eu(tfc)3 (127) is chiral, a diastereomeric complex is formed which will 
display visibly different chemical shifts in its 1H NMR spectrum. In the case of 
Keinan et al.’s acetate 115, the methyl doublet at 1.2-1.5 ppm is examined and 
different chemical shifts are observed for each of the two diastereomeric complexes 
formed, which can be integrated to provide the ee using the same equation as for the 
chiral HPLC.  
 
In light of the structural similarity between (S)-acetate 115 and our (S)-acetate 99 
(Figure 12), the 1H NMR spectra of (±)-acetate 99, (S)-acetate 99 and (R)-acetate 99 
with chiral shift reagent Eu(tfc)3 (127) were examined at 400 MHz. Unfortunately, the 
method proved extremely sensitive to the quantity of europium in the samples.  
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Figure 12. (S)-Acetate 99 
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Portions of the spectra of (±)-acetate 99 corresponding to the methyl group, recorded 
with 0.7, 1.0 and 1.2 equivalents of Eu(tfc)3, are shown in Figure 13. Without the shift 
reagent this is usually visible as a doublet at 1.2 ppm (J = 6.0 Hz) (Figure 13a), 
however even with 0.7 eq. of Eu(tfc)3 this shifted downfield to 1.4 ppm (Figure 13b). 
Increasing the amount of europium increased this shift further.  
 
Although splitting of the methyl peak into two doublets was observed, the close 
proximity of other peaks in the spectra made it impossible to integrate the doublets to 
a satisfactory degree to obtain an ee value. No alternative proton signals were 
observed which could be integrated satisfactorily. 
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b) 
 
c) 
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Figure 13.  Portions of the 1H NMR Spectra of (±)-acetate 99  
with a) 0 eq.; b) 0.7 eq.; c) 1.0 eq.; d) 1.2 eq. of Eu(tfc)3 (127)  
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2.2.5.3  Mosher’s Esters Method 
 
A further way to determine an ee is to synthesise diastereoisomers. Whilst 
enantiomers cannot be distinguished by their NMR spectra, diastereoisomers can be. 
Thus by using an enantiomerically pure acid, esterification of (±)-alcohol 93 would 
lead to a mixture of diastereoisomers. Integration of the 1H NMR spectra would prove 
the ratio of diastereoisomers, hence the enantiomers, of the alcohol substrate by 
Equation 1. A popular acid employed in this technique is Mosher’s acid 128,89 as the 
presence of the trifluoromethyl group allows the use of 19F NMR spectroscopy, which 
would only show one peak for a single diastereoisomer.  
 
Mosher’s esters of (±)-alcohol 93, (S)-alcohol 93 and (R)-alcohol 93 were synthesised 
from the corresponding Mosher’s acid chloride 12989 (Scheme 40).  
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Scheme 40. Reagents and conditions: i) SOCl2, 80 °C, 46 h; ii) pyr., 23 °C, 24 h. 
 
To avoid ambiguity, the esterifications carried out until complete starting material 
consumption was observed by GC. As isolated yields were poor, the Mosher’s 
esters 130 were examined by crude 19F NMR and 13C NMR. Unfortunately extra 
peaks were visible, attributed to the presence of excess acid chloride 129 and acid 128 
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and therefore it was impossible to determine an ee value. The non-quantitative yield 
of the reactions also hinted that any result obtained would be unreliable. 
 
 
 
2.2.5.4  Chiral GC Method 
 
Finally, samples of (±)-alcohol 93, (S)-alcohol 93 and (R)-alcohol 93 were sent to 
AstraZeneca in Bristol,90 where utilising an 80 °C isotherm, the enantiomers were 
visualised as two peaks and successfully quantified.  
 
Gratifyingly, both the (S)-alcohol 93 and the (R)-alcohol 93 (obtained through 
hydrolysis of (R)-acetate 99) were shown to have ee’s of >99%  (Table 3, Figure 14).  
 
 
Entry Rt 27.5 min Rt 29.0 min Assignment ee† 
1 50.0% area 50.0% area racemic - 
2 99.6% area 0.4% area (R)-enantiomer >99% 
3 0.2% area 99.8% area (S)-enantiomer >99% 
 
Table 3 
†
enantiomeric excess determined by Equation 1 
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a) 
 
b) 
   
c)  
    
 
Figure 14: Chiral GC Traces of a) (±)-, b) (R)- and c) (S)-alcohols 93. 
 
With these results in hand, a series of further CAL-B transesterification reactions 
were carried out in a similar fashion on large scale. The products were either acylated 
or hydrolysed to give the corresponding alcohols/acetates and the subsequent [αD]’s 
for all four compounds recorded and compared to the known >99% ee samples. The 
only drawback of the transesterification procedure was that the overall yield of the 
conversion from the racemic alcohol (±)-93 to (S)-alcohol 93 was just 41%. If it was 
possible to somehow recycle the unwanted (R)-alcohol 93, this would be an 
advantage. 
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2.2.6 Recovery of the (R)-Enantiomer 
 
One general method for inverting a hydroxy chiral centre 131 is by utilising the well 
known Mitsunobu reaction.91 This proceeds via the SN2 attack of a nucleophile 132 on 
an activated alcohol substrate to generate inverted product 135. The activation is 
achieved by treatment with triphenylphosphine (134) and an azo-compound, 
DIAD (133), which together remove one molecule of water forming by-product 136 
and triphenylphosphine oxide (137) (Scheme 41).  
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Scheme 41. Mitsunobu Reaction. 
 
By employing acetic acid as the nucleophile and hydrolysing the resultant acetate, it is 
possible to directly invert the configuration of the alcohol.  
 
Pleasingly, the Mitsunobu reaction of (R)-alcohol 93 with acetic acid provided 
(S)-acetate 99 in 91% ([α]D +1.1 (c 1.12 CH2Cl2)) which enabled the unwanted 
alcohol from the transesterification to be ‘recycled’(Scheme 42).  
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Scheme 42. Reagents and Conditions: i) AcOH, PPh3 (134), DIAD (133), PhMe, –15 to 23°C, 91%. 
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2.2.6.1 Potential for Dynamic Kinetic Resolution. 
 
Dynamic kinetic resolution (DKR) is an active area of research in organic synthesis 
and can be used as a powerful tool to overcome the 50% yield limitation of traditional 
kinetic resolutions. The principle of DKR is based on combining a kinetic resolution 
procedure with a simultaneous in situ racemisation process, which only affects the 
substrate and not the reaction product (Scheme 43). Standard conditions for 
racemisation involve the use of a ruthenium-based hydrogen transfer catalyst (such as 
(C5Ph5)Ru(CO)2Cl) at elevated temperatures. More recently, biocatalysed DKR 
reactions have been investigated and proven facile.92-94  
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Scheme 43. DKR Principles. 
 
Were it not for the fact that using DKR in combination with our CAL-B 
transesterification procedure would yield the wrong enantiomer, (R)-acetate 99, this 
would be an ideal strategy. There is still potential to employ this procedure in the 
future, converting the (R)-acetate 99 to (S)-alcohol 93 in three steps by hydrolysis, 
Mitsunobu and a second hydrolysis - all proven reliable reactions.  
 
With (S)-alcohol 93 in hand in excellent optical purity, the next section will discuss 
the synthesis of the coupling partner, alkyne ester 89.  
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2.3 Synthesis of Alkyne Ester 89 
 
The second coupling partner from our retrosynthetic analysis (Scheme 20) is alkyne 
ester 89. Further analysis of this target reveals a carbonylmethyl homologation 
(Claisen condensation) and disconnection of alkyne function to aldehyde 
(Scheme 44). Aldehyde 91 is a literature known compound, which can be made from 
citric acid (138).  
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Scheme 44. Retrosynthetic Analysis of Alkyne ester 89 
 
 
2.3.1 Synthesis of Aldehyde 91 via Literature Procedure 
 
Aldehyde 91 was first synthesised in 1972 by Bruchter et al.95 in an eight step 
procedure from citric acid (138) and thence utilised in the synthesis of keto 
lactam 142, which is a precursor for indole alkaloids (Scheme 45). 
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Scheme 45. Bruchter et al.’s Synthesis of Aldehyde 91. 
 
Today, diethyl 1,3-acetone dicarboxylate (92) is a cheap, readily available starting 
material, thus work was begun by carrying out the ketal protection of ketone 92 using 
boron trifluoride catalysis.96 This gave diester 139, which was sufficiently pure to use 
crude in the next step (Scheme 46). 
 
O
O O
O
O i)
92 139
O
O
O
OOO
 
 
Scheme 46. Reagents and conditions: i) HOCH2CH2OH, BF3·OEt2, PhMe, 120 °C, 18 h. 
 
Saponification of diester 139 with sodium hydroxide gave disodium salt 143 in 62% 
yield over two steps, after recrystalisation. Upon treatment with oxalyl chloride, 
disodium salt 143 cyclised to afford anhydride 140 in 68% yield. The latter reaction 
was found to be sensitive to the method of stirring utilised, with overhead stirring 
proving the most efficient to enable satisfactory mixing of the insoluble starting 
material with the reagents. Treatment of anhydride 140 with excess absolute ethanol 
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followed by heating to reflux yielded 99% of carboxylic acid 141, which was 
subsequently transformed to the acid chloride 144 by oxalyl chloride (Scheme 47).  
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Scheme 47. Reagents and conditions: i) NaOH, EtOH, 80 °C, 1 h, 62% over two steps;  ii) (COCl)2, 
CH2Cl2, 45 °C, 2h, 68%; iii) EtOH, 80 °C, 18 h, 99%; iv) (COCl)2, PhMe, 23 °C, 3 h. 
 
Acid chloride 144 proved unstable to chromatography or distillation, therefore a 
method to convert the crude product to aldehyde 91 was sought. Bruchter’s synthesis 
had employed a Rosenmund reduction for this step, using a ‘poisoned’ palladium on 
barium sulphate catalyst and hydrogen gas.97 Unfortunately our attempts to apply 
these conditions gave only starting material or decomposition (Scheme 48).  
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Scheme 48. Reagents and conditions: i) H2 (g), 5% Pd/BaSO4, xylene, 130 °C, 1 h. 
 
We therefore sought to modify the literature procedure, as will be discussed in  
section 2.3.2. 
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2.3.2  Synthesis of Aldehyde 91 via Modifications to the Literature Procedure 
 
Our attention was drawn to Fleet et al.’s alternative method for reduction of acid 
chlorides to aldehydes, utilising bis(triphenylphosphine)copper(I) borohydride, 
synthesised from copper (I) chloride, sodium borohydride and triphenylphosphine.49 
Promisingly, the initial trial of this method allowed isolation of aldehyde 91 in 48%. 
This was later optimised to 88% over two steps from carboxylic acid 141, by both 
reducing the reaction time from 30 to 15 minutes and an improved workup procedure. 
This involved dissolving the crude product in the minimum amount of Et2O and 
chilling, which facilitated the precipitation of the triphenylphosphine oxide 
by-product which could thus be removed by filtration (Scheme 49).   
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Scheme 49. Reagents and conditions: i) (COCl)2, PhMe, 120 °C, 2 h; ii) Cu(PPh3)2BH4, PPh3 (134), 
acetone, 23 °C, 15 min, 88% over two steps. 
 
Further optimisation of the route revealed that it was possible to synthesise 
aldehyde 91 in good yield from diethyl 1,3-acetone dicarboxylate (92) in six steps, 
using each intermediate crude and with only one purification step at the final stage.  
 
Unfortunately however, on more than one occasion the reaction of disodium salt 143 
with oxalyl chloride failed to provide anhydride 140 and results of this reaction 
proved unreliable. Therefore a more efficient route was investigated. 
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2.3.2.1  Mono-hydrolysis of Diester 139 
 
It was envisaged that the six-step procedure could be shortened by carrying out the 
mono-hydrolysis of diester 139 to directly provide carboxylic acid 141. Control of 
this reaction proved difficult, with a mixture of product and starting material being 
isolated in low yield along with, it was assumed, the very polar diacid. A variety of 
different conditions for the reaction were screened (Scheme 50, Table 4).  
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Scheme 50. Mono-hydrolysis of Diester 139. 
 
 
Entry Reagent† Solvent Yield (141)* S.M. Recovery (139)* 
1 0.25 M NaOH in H2O EtOH 24% 39% 
2 0.25 M NaOH in H2O PhMe 15% 33% 
3 solid NaOH PhMe 0% 100% 
4 0.25 M KOH in H2O EtOH 56% 35% 
5 0.25 M KOH in EtOH EtOH 0% 100% 
6 0.25 M CsOH in EtOH PhMe 28% 58% 
7 0.25 M CsOH in H2O EtOH 52% 22% 
8 0.5 M CsOH in H2O EtOH 48% 33% 
 
Table 4 
† 
reactions carried out with 1.0 eq. base at 23 °C for 18 h; * isolated product yields 
 
 
Initial conditions, with the use of dilute aqueous sodium hydroxide in ethanol gave a 
low yield of desired acid 141, along with recovery of starting diester 139 (Table 4, 
Entry 1). The use of toluene to encourage precipitation of the mono-sodium salt failed 
to improve the procedure (Entry 2). Increasing the concentration of sodium hydroxide 
resulted in quantitative starting material recovery, presumably due to insolubility of 
the sodium hydroxide in the reaction medium (Entry 3). Changing to potassium 
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hydroxide resulted in a slight improvement (Entry 5), however the use of caesium 
hydroxide gave no significant change (Entries 7-10).   
 
The best conditions found were the use of aqueous potassium hydroxide with ethanol 
as a solvent, which afforded the acid 141 in a moderate 56% yield. Employing the 
mono-hydrolysis route saves two steps in the synthesis of aldehyde 91, thus also 
saving time and costs. Although the yield is moderate, significant starting material is 
also recovered, resulting in a yield of 91% based on recovery of starting material, 
hence this route was deemed to have a greater overall efficiency. 
 
2.3.2.2  Reduction-Oxidation Strategy 
 
Although excellent results were obtained from the bis(triphenylphosphine)copper(I) 
borohydride reduction of acid chloride 144 on small scales, it was found that scaling 
up this procedure resulted in less satisfactory yields. This was due to the 
stoichiometric quantities of solid reagents required, which were difficult to separate 
from the product during chromatography. Often the isolated product aldehyde 91 still 
contained triphenylphosphine (134) as an impurity. 
 
An alternative conversion of acid 141 to aldehyde 91, via borane reduction to 
alcohol 145 and then Swern oxidation, was trialled. The yields proved similar overall, 
however this second route proved more reproducible, the purification was simpler and 
the procedure was more readily adapted to large scale (Scheme 51).  
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Scheme 51. Reagents and conditions: i) BH3·THF, THF, 0 °C, 3 h then MeOH, 23 °C, 2 h; ii) (COCl)2, 
DMSO, –78 °C, 30 min then Et3N, –78 °C to 23 °C, 1 h, 84% over two steps. 
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2.3.3 Conversion of Aldehyde 91 to Alkyne 90 
 
2.3.3.1 Corey-Fuchs Strategy 
 
Initial attempts to convert aldehyde 91 to alkyne 90 focused on the well known two-
step Corey-Fuchs homologation procedure.98 The intermediate product in the 
Corey-Fuchs procedure is a dibromoalkene 152. The first step involves a Wittig-like 
reaction between the aldehyde 150 and reactive dibromo ylide 149, which is 
generated from carbon tetrabromide (146) and triphenylphosphine (134) through 
intermediates 147 and 148. The resultant oxaphosphetane 151 eliminates 
triphenylphosphine oxide (137) to generate the dibromoalkane 152 (Scheme 52). 
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Scheme 52. Mechanism of the Corey-Fuchs Procedure, Step One. 
 
A base, such as n-BuLi, is then utilised to transform the dibromide 152 to the product 
alkyne 155. The mechanism of the elimination proceeds via lithium-halogen exchange 
forming intermediate 153, followed by α-elimination to generate an olefinic 
carbene 154. A Fritsch-Buttenberg-Wiechell99 type rearrangement via a 1,2-hydride 
migration provides the alkyne 155 (Scheme 53). 
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Scheme 53. Mechanism of the Corey-Fuchs Procedure, Step Two. 
 
Following this procedure, the treatment of aldehyde 91 with carbon tetrabromide 
(146) and triphenylphosphine (134) enabled dibromide 156 to be isolated in good 
yield. The subsequent bromide elimination to afford the alkyne 90, however, was not 
straightforward. Treatment with n-BuLi gave an isolated product yield of just 10%. 
This was attributed to the presence of the ester group, along with other acidic protons 
in the molecule which led to significant side reactions.  
 
Fortuitously, it was found that magnesium could be used to carry out the elimination 
and this procedure improved the yield of alkyne 90 to 65% (Scheme 54).  
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Scheme 54.  Reagents and conditions: i) CBr4 (146), PPh3 (134), CH2Cl2, 23 °C, 48 h, 77%;  ii)  Mg, 
THF, 70 °C, 1 h, 65%.  
 
The initial complications encountered during the Corey-Fuchs procedure prompted us 
to search for an alternative, single step procedure and our findings will now be 
discussed. 
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2.3.3.2  One-Pot Procedures 
Our first idea was to employ a phosphonate azide ester, for example the 
Ohira-Bestmann reagent (158), as a one-carbon homologating agent.100 The 
Ohira-Bestmann reagent (158) is a modification of the Gilbert-Seyforth 
reagent (157)101 and the key reacting species in both cases is the same: deprotonated 
azide 159. This reacts with the aldehyde 150 following a similar pathway to both the 
first step of the Corey-Fuchs reaction and the Wittig reaction, with alkenation of the 
carbonyl and oxaphosphetane 161 formation. The difference in this case is that the 
elimination of dimethyl phosphate (162) leads to an unstable diazo alkene 163, which 
spontaneously loses nitrogen to generate an olefinic carbene 154. A Fritsch-
Buttenberg-Wiechell type rearrangement via a 1,2-hydride migration provides the 
alkyne 155, analogous to the Corey-Fuchs elimination step (Scheme 55). 
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Scheme 55. Mechanism of Alkyne formation from Phosphonate Azide Esters. 
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The Ohira-Bestmann modification allows the use of potassium carbonate as a milder 
base instead of t-BuOK which is traditionally utilised with the Gilbert-Seyforth 
reagent and hence this reagent is compatible with a wider range of functional groups. 
It has been reported that the Ohira-Bestmann reagent (158) can be generated by in situ 
azo transfer from tosyl azide to commercial phosphonate ester 165. Thus, the alkyne 
can be formed in a one-pot process upon addition of the aldehyde and base.102 
The one-pot procedure was initially attempted with 4-carboxybenzene sulfonazide 
(164) instead of tosyl azide, as this material was available within our group  
(Scheme 56).100  
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Scheme 56. Reagents and conditions: i) a) K2CO3, CH3CN, 23 °C, 2 h;  b) 91, 23 °C, 8h. 
 
Disappointingly, desired alkyne 90 could not be detected and instead the only isolated 
product was the Horner-Wadsworth-Emmons reaction product 166 (MS (CI) m/z 243 
[M+H]+), from the reaction of phosphonate ester 165 with aldehyde 91 (Figure 15).  
This suggested a problem with the diazotisation process and therefore investigations 
were made into isolation of the Ohira-Bestmann reagent. 
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Figure 15 
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Due to concern for the ethyl ester present in our aldehyde 91, both the 
Ohira-Bestmann reagent (158) and the analogous phosphonate azide ethyl ester 179 
were isolated. It was hoped that the latter could be utilised with ethanol as a solvent 
thus preventing transesterification, a side-reaction possible under the basic reaction 
conditions. The azo transfer103 from 4-carboxybenzene sulfonazide (164) to either 
phosphonate ester resulted in the recovery of starting material. Therefore, it was 
assumed that the reactivity of azide 164 was lower than that of tosyl azide (177), or 
our starting azide had decomposed.  
 
Thus tosyl azide (177) was synthesised from tosyl chloride and sodium azide 
according to the literature procedure104 in 99% yield. The diazotisations were then 
repeated to afford 96% of the Ohira-Bestmann reagent (158) and 90% of the 
analogous ethyl ester product 179 after chromatography (Scheme 57). 
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Scheme 57. Reagents and conditions: i) K2CO3, CH3CN, 23 °C, 2 h, 158: 96%, 179: 90%. 
 
With both phosphonate azide esters 158 and 179 in hand, the conversion of 
aldehyde 91 to alkyne ester 90 was attempted under several different sets of 
conditions (Scheme 58, Table 5). 
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Scheme 58. Homologation of Aldehyde 91 
 
Entry Azide Reagents and conditions Yield of Alkyne† 
1 158 NaOMe (4.0 eq.), THF, –78 °C, 2 h 25%  
2 179 NaOMe (2.5 eq.), THF, –78 °C, 2 h105 33%  
3 158 K2CO3 (2.0 eq.), MeOH, 23 °C, 18 h100 57%*  
4 179 K2CO3 (2.0 eq.), EtOH, 23 °C, 18 h 
 
$ 
 
 
Table 5 
† isolated product yields; * product from transesterification, 180;  $ S.M recovery 
 
The use of sodium methoxide as a base led to low yields of product 90 (Table 5, 
Entries 1 and 2) but proved that the reaction was working. Switching to potassium 
carbonate in methanol gave 57% of alkyne product, however with concomitant 
transesterification to afford methyl ester 180 (Entry 3). The use of ethyl phosphonate 
ester 179 in ethanol resulted in starting material recovery (Entry 4). 
 
Disappointingly, when these same reaction conditions were applied on a larger scale, 
the yields dropped to 9-16%. The unreliability of this method prompted investigation 
into a third method using trimethylsilyldiazomethane (181). In the same way that the 
Ohira-Bestmann homologation mechanism is analogous to the Wittig reaction 
mechanism, so trimethylsilyldiazomethane (181) reacts with aldehydes to provide 
alkynes by a mechanism similar to that of the Peterson olefination reaction.106 The 
key steps follow a similar mechanism to that outlined previously (see Scheme 55), the 
main differences being that in this case the attacking species is anion 182 and 
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secondly, trimethylsiloxane (185) is the stable elimination product instead of 
triphenylphosphine oxide (137) (Scheme 59).  
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Scheme 59. Mechanism of Homologation with TMS-Diazomethane (181). 
 
The advantages of this procedure over the Ohira-Bestmann protocol are firstly that 
only one equivalent of base is necessary to generate the attacking species and 
secondly, that this is formed before the addition of the aldehyde, which would 
hopefully prevent side reactions. 
 
Following the literature procedure,107 TMS-diazomethane (181) was treated with 
n-BuLi at –78 °C, followed by the addition of aldehyde 91. After 1 h, TLC analysis 
showed product formation and starting material consumption, thus the reaction was 
quenched at –78 °C with pH 7.0 buffer and extracted with diethyl ether several times. 
Subsequent column chromatography, however, provided alkyne 90 in just 16% yield 
(Scheme 60). 
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The poor isolated yield was attributed to the work-up procedure and indeed, when the 
reaction was repeated but this time simply evaporated in vacuo upon completion, 
column chromatography provided alkyne 90 in an improved 39% yield. Further 
modifications of the work-up procedure were carried out, however the results proved 
to be similarly irreproducible as with the Ohira-Bestmann reagent (Scheme 60,  
Table 6).  
 
conditions
O
O OO H
O
O OO O
H
91 90
 
 
Scheme 60. Homologation of Aldehyde 91. 
 
 
Entry Quench/ Workup† Yield 90* 
1 
 
Quench pH 7.0 buffer 
Extract Et2O 
16% 
 
2 Evaporate 39% 
3 
 
Evaporate to 1/3 volume 
Quench pH 7.0 phosphate buffer 
Extract CH2Cl2 
24-42% 
4 
 
Quench AcOH (2.0 eq.) at –78 °C 
Dilute with pH 7.0 phosphate buffer 
Extract CH2Cl2 
11-31% 
 
Table 6 
†
 Reagents and conditions: a) 181, n-BuLi, THF, –78 °C, 30 min; 
 b) 91, THF, –78 °C,  1 h; * isolated product yield 
 
 
The lack of reproducible yields observed for both this procedure and the 
Ohira-Bestmann method prompted us to conclude that the two-step Corey-Fuchs 
protocol was most suitable for repetition on large scale during our synthesis.   
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2.3.4 Claisen Condensation of Alkynes 90 and 180 
 
With the alkyne-moiety in place, the next step to be investigated was the Claisen 
condensation to generate the β-keto ester functionality. As both ethyl- and methyl- 
esters 90 and 180 were in hand, studies commenced by looking at their condensations 
with ethyl acetate and methyl acetate respectively. 
 
Initial trials into the Claisen condensations were performed by addition of the acetate 
to lithium diisopropylamine in order to preform the enolate under kinetic control. 
Three equivalents of both base and acetate were used in order to reduce the degree of 
self-condensation. 
 
The alkyne was added to the enolate, resulting in the disappointing yields of 29% and 
30% of methyl ester 186 and ethyl ester 89 respectively (Scheme 61). tert-Butyl 
acetate was also reacted with ethyl ester 90, giving an improved yield of 69% of the 
corresponding tert-butyl ester 187. This suggested that the nature of the alkyl group 
on the acetate had an effect on the yield, with bulkier acetates favouring product 
formation. 
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Scheme 61. Reagents and conditions: i) CH3CO2R (3.0 eq.), LDA (3.0 eq.), THF, –78 °C to 0 °C, 3 h,  
186: 29%; 89: 30%; 187: 69%.   
 
We postulated that the extra bulk of the ester group in the Claisen product might pose 
a problem in the subsequent transesterification step, thus it was decided to optimise 
the ethyl acetate procedure.   
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Encouragingly, when LDA (189) was formed in situ from n-BuLi and DIPA (188) at 
–78 °C before the addition of ethyl acetate (190), with the additional use of six 
equivalents of enolate 191, homologous ethyl alkyne ester 89 could be isolated in a 
greatly improved 86% yield (Scheme 62). 
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Scheme 62. Reagents and conditions:  i) n-BuLi, THF, 0 °C, 15 min; ii) 190 , –78 °C, 30 min; iii) 90,  
–78 °C to 23 °C, 4 h, 86%.   
  
Therefore, we now had access to both alkyne ester 89 and (S)-alcohol 93 in gram 
scale quantities. In the next section, their coupling via transesterification and 
ring-closing enyne metathesis will be examined. 
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2.4 Coupling of (S)-Alcohol 93  and Alkyne Ester 89  
 
Our retrosynthetic analysis of (S)-zearalenone (3) (Scheme 20) involves disconnection 
of macrocyclic diene 87 via RCEYM, giving enyne 88 as a target which can be 
generated from the transesterification of (S)-alcohol 93 and alkyne ester 89  
(Scheme 63).  
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Scheme 63. Retrosynthesis of Macrocyclic Diene 87. 
 
Efforts towards these two steps will be discussed in turn in this section. 
 
2.4.1  Transesterification  
 
As detailed in section 2.2.1, (±)-alcohol 93 had been synthesised before the 
introduction of chirality via the kinetic resolution. In fact, it had then taken some time 
to find a viable route to control the stereochemistry and subsequently to measure the 
ee of resulting (S)-alcohol 93, to be confident of our results. While this work was in 
progress, the transesterification of (±)-alcohol 93 with alkyne ester 89 was also 
examined, to enable us to test further steps in the route to (S)-zearalenone (3). 
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2.4.1.1 CAL-B Mediated Transesterifications 
 
Before we had realised the potential of CAL-B for the kinetic resolution of 
(S)-alcohol 93 (section 2.2.4), we had intended to see if CAL-B could be employed in 
the transesterification of (±)-alcohol 93 and alkyne ester 89.  CAL-B had been used 
previously within our group66 and in the literature108, 109 to enable transesterifications 
under mild conditions and with good yields, regardless of stereochemistry. 
 
Janda108 reports that the use of CAL-B is effective for transesterifications of 
β-keto esters with a wide range of alcohols. The procedure involves treating 
equimolar amounts of the neat alcohol and β-keto ester with CAL-B (10% w/w of 
alcohol) and swirling in a flask connected to a Büchi rotavapor at 40 °C and 10 Torr 
for 8 h. The reduced pressure allows easy removal of the alcohol by-product. More 
recently Nanda and Scott109 reported the use of CAL-B for transesterifications at 
atmospheric pressure and 50 °C.  
 
To this end, the transesterification was carried out employing three equivalents of 
(±)-alcohol 93, at 40 °C under an air condenser, without additional solvent. The 
reaction was monitored until alkyne ester 89 was consumed, which took about 5 days. 
Product enyne 88  was isolated via chromatography in 54%.  
 
At this time, the moderate yield of this transesterification method prompted us to look 
at other possible reactions. However, as we became aware of the stereoselectivity of 
CAL-B, we returned to the reaction product and measured its optical rotation. 
Interestingly, the product enyne was found to have some optical activity, with  
[α]D –1.7 (c = 1.25, CH2Cl2). Examination of the literature however,86 revealed that 
CAL-B would have preference for the transesterification of the (R)-enantiomer of the  
alcohol 93 and that therefore it was likely that the product was in fact (R)-enriched 
enyne 88 (Scheme 64).   
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Scheme 64. Reagents and conditions: i) CAL-B (10% w/w), 40 °C, 5 d, 54% 
 
Inversion of the product enyne stereochemistry with a Mitsunobu reaction, which had 
been successful for (R)-alcohol 93 (see Section 2.2.6), would not be possible in this 
case and therefore this CAL-B transesterification would be of no use in our synthesis 
of (S)-zearalenone (3). This was confirmed by the reaction of S-alcohol 93 with 
alkyne ester 89 under identical conditions, which yielded only starting materials 
(Scheme 65). An alternative transesterification procedure was definitely necessary. 
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Scheme 65. Reagents and conditions: i) CALB (10% w/w), 40 °C, 5 d. 
 
These results however, led to the successful kinetic resolution of (±)-alcohol 93 
described in section 2.2.4.  
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2.4.1.2 Transition Metal Mediated Transesterifications 
 
Transition metal catalysed transesterifications are well described in the literature.110, 
111
 Two known protocols were screened and compared, employing (±)-alcohol 93 and 
a substitute β-keto ester, ethyl benzoylacetate (192), to give product ester 193 
(Scheme 66, Table 7). 
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Scheme 66. Transesterification Model Study. 
 
Entry Reagent Conditions Yield 193† 
1 Ti(OiPr)4 (10 mol%) 140 Torr, PhMe, 80 °C, 18 h 0% 
2 Zn dust (10 mol%) PhMe, 110 °C, 1.5 h* 15%* 
3 Zn dust (20 mol%) PhMe, 110 °C, 18 h* 64% 
 
Table 7 
†
 isolated product yields; *reaction carried out under a distillation condenser. 
 
Firstly, according to Krasik’s procedure,110 (±)-alcohol 93 and β-keto ester 192 were 
treated neat with catalytic titanium isopropoxide at 80 °C and 140 Torr. However, 
after 18 h only starting material remained and no product could be detected (Table 7,  
Entry 1).  
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Secondly, according to the procedure of Bandgar and Uppalla,111 (±)-alcohol 93 and 
β-keto ester 192 were treated with catalytic zinc dust in toluene at 110 °C at 
atmospheric pressure, under a distillation condenser to remove the alcohol by-product. 
This time a new product was isolated (Entry 2). Extending the reaction time and 
increasing the amount of catalyst (Entry 3) enabled the desired product 193 to be 
isolated by chromatography in 64% yield.   
 
With this result, the zinc-mediated transesterification was attempted on our real 
system, employing (S)-alcohol 93 and alkyne ester 89. Gratifyingly, despite initial 
difficulties in separating product (S)-enyne 88 from starting alkyne ester 89, it was 
possible to optimise the conditions and obtain (S)-enyne 88 in 68% yield using 
2.5 equivalents of (S)-alcohol 93. The product optical activity was measured as 
[α]D25 +2.9 (c = 1.10 CH2Cl2). Furthermore, we were able to recover the excess 
equivalents of (S)-alcohol 93 with undiminished optical purity (Scheme 67).   
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Scheme 67. Reagents and conditions: i) Zn dust (20 mol%), PhMe, 110 °C, 18 h, 68%. 
 
 
With (S)-enyne 88 in hand, the next step was to investigate the ring-closing enyne 
metathesis (RCEYM).  
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2.4.2   Ring-closing Enyne Metathesis (RCEYM) 
 
Ring-closing metathesis (RCM) is an extremely powerful carbon-carbon bond 
forming synthetic tool. Molybdenum or ruthenium carbene catalysts for olefin 
metathesis have been pioneered by Schrock et al.112 and Grubbs et al.113 respectively, 
with further developments leading to increasingly robust and reactive catalysts, as 
exemplified in Figure 16. RCM has found increasing use as a key step for the total 
synthesis of many polyfunctional natural products.114-117  
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Figure 16. Metathesis Catalysts: Schrock’s Catalyst 194, Grubbs’ First Generation Catalyst 195,  
Grubbs’ Second Generation Catalyst 196, Hoveyda-Grubbs’ Second Generation Catalyst 197. 
 
The Chauvin118 mechanism of olefin metathesis proceeds via the cycloaddition of the 
active metallocarbene catalyst 198 with the olefin 199 to produce a 
metallocyclobutane intermediate, such as 200. This then cycloreverts into a new 
olefin 202 and a new metallocarbene 201, which can continue the catalytic cycle 
(Scheme 68). All steps of the reaction are reversible.119-121 
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Scheme 68. Mechanism of Olefin Metathesis.118, 120 
 
RCEYM, utilising Grubbs’ second generation catalyst (196) (Figure 16) under mild 
reaction conditions, was demonstrated by Kinoshita and Mori to generate conjugated 
dienes.122 RCEYM involves cleavage of both double and triple bonds, with the 
formation of two new double bonds. In the case of macrocyclic RCEYM there are two 
potential products from an enyne 203, the exo-mode product 202 or the endo-mode 
product 204. The mode of selectivity also dictates the ring size that is formed, with 
endo-mode products having one additional carbon in the ring compared with products 
derived from exo-mode closure (Figure 17). 
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Figure 17.  Exo/endo-mode Selectivity in RCEYM 
 
RCEYM has been examined extensively by Hansen and Lee123 for 10- to 15-
membered macrocycles. Their findings imply that 12-membered rings or larger have a 
preference for forming endo-mode products, whereas adversely 10-membered rings or 
smaller prefer to form exo-mode products. Hansen and Lee went on to examine in 
detail the mechanism of RCEYM, in an attempt to explain the observed selectivity 
switch. 
 
The fundamental mechanistic consideration of RCEYM is whether it is the alkyne or 
the alkene moiety of the enyne substrate which first reacts with the catalyst. The 
catalytic cycles of both of these possible mechanisms will now be discussed. 
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Mechanism A, the –yne before –ene mechanism, shows initial formation of 
metallocyclobutenes 207 or 209 by reaction of the active catalyst 208 with the alkyne 
moiety of enyne 203. Metallocyclobutenes 207 or 209 then decompose to give 
intermediates 205 or 210, which then react with the alkene moiety to generate exo- or 
endo-mode products 202 or 204, via metallocyclobutanes 206 or 211 respectively 
(Scheme 69). 
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Scheme 69. Proposed Mechanism A for RCEYM: -yne Before -ene. 
 
The difference in product selectivity following this mechanism would therefore be 
governed by the alignment of the alkyne moiety with the active catalyst 208 for the 
initial [2+2] cycloaddition, forming metallocyclobutenes 207 or 209. As this process 
is reversible, there is no obvious reason how the size of the ring could cause a sudden 
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reversal in mode of selectivity and a statistical mixture of products would be 
expected. 
 
Mechanism B, the –ene before –yne mechanism, shows the initial reaction occurring 
with the alkene moiety forming metallocarbene 214. This then reacts with the alkyne 
moiety to generate one of the metallacyclobutene intermediates, 212 or 216. Opening 
to metallocarbenes 213 or 217 and recombination with ethylene (215) generates the 
exo- or endo-mode products 202 or 204 (Scheme 70). 
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Scheme 70.  Proposed Mechanism B for RCEYM: -ene before -yne. 
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The exo/endo-mode selectivity, following this mechanism, would arise from the 
intramolecular alignment of the alkyne moiety with the metallocarbene moiety of 
intermediate 214, for the [2+2] cycloaddition to provide either metallocyclobutene 
212 or 216. This could be explained as a consequence of ring strain associated with 
intermediates, 212 or 216, which would be influenced by the tether length.124  
 
An improved reaction protocol for RCEYM was published by Mori and co-workers in 
the late 1990s and involved performing the reaction under an atmosphere of ethylene 
gas.125 The excess ethylene present forces a different mechanism (Scheme 71 and 
Scheme 72).124, 126, 127  
 
As a result of the relatively slow macrocyclic ring-closure rate, RCEYM in the 
presence of ethylene gas is dominated by the cross-metathesis (CM) of the alkyne 
moiety and ethylene (215). Initial reaction of the alkyne with the active catalyst 208 
occurs similarly to that discussed in Mechanism A, forming intermediate 
metallocarbene 210. However, in the presence of ethylene (215), metallocarbene 210 
then undergoes a cycloaddition-retrocycloaddition to form triene 219 (Scheme 71). 
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Scheme 71.  Possible Mechanism of Ethylene Catalysed RCEYM Step One: CM 
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Triene 219 is a substrate for RCM, hence removal of ethylene by flushing with an 
inert atmosphere and addition of further catalyst 196 allows RCM to occur to form the 
product diene 202 or 204 (Scheme 72).  
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Scheme 72.  Possible Mechanism of Ethylene Catalysed RCEYM Step Two: RCM 
 
Reaction of active catalyst 208 with the alkene portion of triene 219 would form 
metallocarbene 221, through metallocyclobutane 220. There would now be a choice 
of two alkenes for the metallocarbene moiety to react intramolecularly with. Thus, 
depending on whether the proximal or distal double bond of the 1,3-diene moiety 
underwent RCM, the exo- or endo-mode products 202 or 204 would be produced, 
through intermediates 222 or 223. 
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Although all steps in a metathesis mechanism are reversible, catalyst 196 is reported 
to be sensitive towards steric and stereoelectronic factors. Therefore, the almost 
exclusive selectivity for endo-mode products for the RCEYM of large ring 
macrocycles in the presence of ethylene can be explained by the least sterically 
demanding, isolated double bond reacting first.  
 
As the first step in this procedure consumes one molecule of ethylene per cycle and 
the second step releases one molecule of ethylene per cycle, the overall net 
consumption is 0. Today, the majority of RCEYMs are carried out utilising ethylene, 
as a result of both the increased selectivity for the endo-mode product and also the 
greatly increased reaction rate.124 
 
In our (S)-zearalenone (3) system, our target diene 87 has an endo-substitution pattern 
and a 14-membered ring, which suggests that the correct product selectivity should be 
favoured. 
 
2.4.2.1 Model Study of RCEYM 
 
Before attempting the RCEYM of our authentic substrate, we decided to carry out a 
simple model study on a similar sized 14-membered macrocycle in order to trial the 
reaction conditions. To this end, simple enyne 230 was prepared from commercial 
6-bromo-1-hexanol (224) and 5-hexenoic acid (228) as shown in Scheme 73.  
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Scheme 73. Reagents and Conditions: i) DHP, PPTS, CH2Cl2, 23 °C, 18 h, 99%; 
ii) LiC≡CH·H2N(CH2)2NH2, NaI, DMSO, 23 °C, 4 h, 80%; iii) pTSA, EtOH, 23 °C, 45 min, 99%; 
iv) (COCl)2, DMF, CH2Cl2, 23 °C, 2 h; v) DIPEA (2.0 eq.), CH2Cl2, 23 °C, 18 h, 92%. 
 
6-Bromo-1-hexanol (224) was protected as the THP-ether 225 and then coupled with 
lithium acetylide ethylene diamine complex following the procedure of Morimoto et 
al.128 to form alkyne 226 in 80% yield. Deprotection proceeded quantitatively to give 
alcohol 227. 5-Hexenoic acid (228) was converted to the acid chloride 229129 in 
quantitative yield following careful concentration. Esterification of acid chloride 229 
with alcohol 227 in the presence of excess base gave 92% of enyne 230 after 
purification. 
 
The RCEYM of enyne 230 was performed by bubbling ethylene gas through the 
CH2Cl2 solvent for 10 minutes prior to addition of Grubbs’ second generation catalyst 
(196), then stirring the reaction under an atmosphere of ethylene (balloon) for 72 h. 
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Promisingly, spot to spot conversion was observed by TLC and the product triene 231 
was isolated via column chromatography in 77% yield. Refluxing triene 231 in 
CH2Cl2 with further catalyst under a nitrogen atmosphere for 48 h gave product 
macrocycle 232 in an excellent 98% yield (Scheme 74).  
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Scheme 74. Reagents and conditions: i) 1 atm CH2=CH2 (g), Grubbs’ II (196) (10 mol%), CH2Cl2, 
23 °C, 72 h, 77%;  ii) Grubbs’ II (196) (10 mol%), CH2Cl2, 45 °C, 48 h, 98%. 
 
A one-pot procedure was also successful. The conversion of enyne 230 to 
intermediate triene 231 was monitored by TLC. Once complete, the reaction was 
flushed with nitrogen and further Grubbs’ second generation catalyst added.  Heating 
to reflux allowed cyclised product 232 to be isolated in 62% yield (Scheme 75). 
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Scheme 75. Reagents and conditions: i) a) 1 atm CH2=CH2 (g), Grubbs’ II (196) (10 mol%), CH2Cl2, 
23 °C, 72 h; b) Grubbs’ II (196) (10 mol%), N2 (g), CH2Cl2, 45 °C, 18 h, 62%. 
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2.4.2.2 . RCEYM of Enyne 88 
 
Following this achievement, RCEYM of the genuine substrate was examined. Thus 
treatment of (S)-enyne 88 with Grubbs’ second generation catalyst (196) in CH2Cl2 
under an ethylene atmosphere yielded the predicted triene intermediate 233 in 72% 
yield, after 72 h (Scheme 76). 
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Scheme 76. Reagents and conditions: i) 1 atm CH2=CH2 (g), Grubbs’ II (196) (10 mol%), CH2Cl2, 
23 °C, 72 h, 72%. 
 
As RCEYM is an intramolecular process, typically concentrations of ~1 mM are 
necessary. This means large quantities of solvents are necessary upon scale up. It was 
found that an efficient method to combat this was to use two syringe pumps, one 
adding a solution of catalyst and the other a solution of substrate, to the degassed 
solvent. The additions were carried out slowly over an 8-hour period. This allowed up 
to a hundred-fold increase in concentration without any observed cross-metathesis or 
intermolecular reactions.   
 
To close the macrocycle, triene 233 was treated with Grubbs’ second generation 
catalyst (196) in refluxing CH2Cl2 under a nitrogen atmosphere, however after 18 h a 
quantitative amount of starting material was recovered. Gratifyingly, changing solvent 
to toluene with its higher refluxing temperature and switching from a nitrogen to an 
argon atmosphere, enabled macrocyclic diene 87 to be isolated in an excellent 85% 
yield after 3 h at 120 °C (Scheme 77). A similar double-syringe pump set up as used 
previously was also employed, however this time with the additions to pre-heated 
toluene.  
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Scheme 77. Reagents and conditions: i) Grubbs’ II (196) (10 mol%), PhMe, 120 °C, 3 h, 85%. 
 
The alkene protons in the ring show a coupling constant of J = 15.4 Hz, which is 
consistent with E-geometry as hoped. There is no evidence of the Z-isomer and indeed 
it may be that the high refluxing temperature of toluene has allowed interconversion 
of these forms, so that the more thermodynamically stable E-isomer is the only 
product formed.  
 
Another observation from ring-closure was the increased complexity of the 1H NMR 
spectrum. For example, where previously the spectrum of triene 233 contained three 
singlet CH2 peaks in the 2.5-3.5 region, there are now 12 peaks in this region of the 
spectrum for macrocyclic diene 87. This can be attributed to the formation of one 
specific conformation of the product, in which the environments of the methylene 
protons is no longer equivalent. This allows the methylene protons to couple with 
each other and therefore what is observed is actually three AB quartets. The observed 
coupling constants of the methylene geminal protons are between 13 and 17 Hz 
(Figure 18). 
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Figure 18. a) Region of triene 233 1H NMR spectrum showing methylene singlets; b) Same region of 
RCEYM product diene 87 spectrum showing the same methylenes splitting into AB quartets. 
 
 95 
A crude sketch of diene 87, produced using a ChemDraw 3D* MM energy 
minimisation, can be used to show that the protons on each methylene are orientated 
either inside or outside the ring, which will cause a different chemical environment 
for each proton and hence inequivalence (Figure 19). 
 
 
 
Figure 19. ChemDraw 3D plot of Macrocycle 87 with 3 CH2s highlighted. 
 
 
Building on the success of the two-step RCEYM method, investigations into a 
one-step procedure were begun. Firstly, enyne 88 was treated with Grubbs’ second 
generation catalyst (196) in toluene under an atmosphere of ethylene for 72 h. 
Unfortunately, only starting material was isolated and no evidence of any new product 
could be detected. It was postulated that lack of reaction in this case was due to the 
lack of solubility of ethylene gas in toluene.  
 
Changing to dichloroethane as a solvent consequently allowed spot to spot conversion 
to desired triene intermediate 233 to be observed after 18 h. Flushing the system with 
argon and heating to reflux (80 °C) promoted complete ring closure after a further 
18 h, with an overall isolated yield of 86%. It was also possible to reduce the amount 
of catalyst to just 5 mol% (Scheme 78).   
 
 
                                               
*
 Energy minimisation on basis of steric effects only, electronic effects not taken into consideration. 
 96 
O
O O
O
O O
O
88
O
O O
O
O O
O
87
i), ii)
 
 
Scheme 78. Reagents and conditions: i) 1 atm CH2=CH2 (g), Grubbs’ II (196) (5 mol%), (CH2Cl)2, 
23 °C, 72 h; ii) Grubbs’ II (196) (5 mol%), (CH2Cl)2, 80 °C, 18 h, 86% over two steps. 
 
Thus the coupling of (S)-alcohol 93 and alkyne ester 89 had been achieved and the 
macrocycle of (S)-zearalenone (3) was in place. The next goal was the elaboration of 
the terminal alkene to a carbonyl, via selective oxidative scission. This topic will be 
discussed in the next section. 
 
 
2.5  Investigations into Selective Oxidative Cleavage of Diene 87 
 
Disconnection of (S)-zearalenone (3) (see Scheme 20) gave diketone 86 as a precursor 
to the natural product. Disconnection to diene 87 is possible via selective oxidative 
cleavage of the exo-cyclic double bond (Scheme 79). Strategies towards this 
transformation will be explored in this section.  
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Scheme 79. Retrosynthetic Analysis of Diketone 86. 
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2.5.1 Oxidative Cleavage by Epoxidation 
 
Literature examples of selective oxidative scissions of conjugated dienes remain 
scarce. Our initial proposed method involved the use of a DMDO-like dioxirane 
oxidant to perform a mono-epoxidation, followed by cleavage of the crude product 
with sodium periodate, catalysed by periodic acid.  
 
Dioxiranes react with both electron-poor and electron-rich alkenes under mild, neutral 
conditions. Methyl(trifluoromethyl)dioxirane (235) has one of the highest reactivities 
of dioxiranes known, hence was chosen for our first studies.130 Dioxirane 235 is 
usually generated in situ from ketone 234, and Oxone® with the use of NaHCO3 to 
maintain constant pH. During the reaction, an oxygen atom is transferred from 
dioxirane 235 to the substrate 236, regenerating the ketone 234 at the same time as 
producing the epoxide 237. This allows catalytic amounts of the dioxirane to be 
sufficient for the transformation. Cleavage of epoxide 237 with sodium periodate 
generates α,β-unsaturated ketone 238 (Scheme 80).  
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Scheme 80. Proposed use of Methyl(trifluoromethyl)dioxirane 235 for Selective Oxidative Cleavage. 
 
Epoxidations of alkenes are usually governed by electronic factors, with electrophilic 
reagents used to carry out the transformations. This means that more electron rich 
alkenes, such as those with more alkyl-substituents, are usually epoxidised 
preferentially. In the case of macrocyclic diene 87, both alkene groups have two 
substituents, the only difference being the substitution pattern (Figure 20). This 
suggests that the electronics will be similar and that selectivity may be a problem. 
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Figure 20. a) disubstituted terminal alkene; b) E-alkene 
 
With this concern in mind, it was decided to perform a simple model study on a 
macrocyclic conjugated diene to test the reaction scope. 
 
 
 
2.5.1.1 Model Study for the Selective Oxidative Cleavage 
 
 
A model study employing commercial 15-membered ring cyclopentadecanone (239)  
was devised. Dehydrogenation adjacent to the carbonyl would provide 
cyclopentadec-2-enone (240), which would undergo olefination by the Petasis reagent 
to form diene 241. This would form our model substrate for cleavage. This reaction 
sequence was carried out as depicted in Scheme 81.  
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i) ii)
240 241239
 
 
 
Scheme 81. Reagent and conditions: i) IBX (1.8 eq.), DMSO : fluorobenzene 7 : 1, 65 °C, 18 h, 51%; 
ii) Cp2TiMe2 (0.33 M in PhMe), 75 °C, 4 h, 74%. 
 
The dehydrogenation131 was performed using IBX (generated from 2-iodobenzoic 
acid and Oxone® according to the procedure of Frigerio et al.132) and gave 51% of the 
desired trans-enone 240, along with 30% starting material and 9% of the over-
oxidised diene 242 (Figure 21).  
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Figure 21. Over-oxidation Product 242. 
 
Next the olefination was carried out using the Petasis reagent, Cp2TiMe2,133, 134 
formed in 94% yield from treatment of Cp2TiCl2 with methyl lithium in toluene at 
0 °C.135 The reagent was not isolated, but stored and utilised as a deep red 0.33 M 
solution in toluene. The precise molarity was calculated from integration of the 
1H NMR spectrum. The olefination proceeded to give diene 241 in 74% yield 
(Scheme 81). 
 
With model diene 241 in hand, studies commenced into the mono-epoxidation 
(Scheme 82). Initially, investigations into the required equivalents of 
1,1,1-trifluoroacetone (234) and Oxone® were carried out and products identified by 
GC-MS monitoring. Table 8 summarises the GC results for the first set of 
experiments carried out.  
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Scheme 82. Mono-epoxidation of Diene 241 
 
Entry CF3COCH3† Oxone® Time S.M.* Product* 
other unknown 
products* 
1 0.5 eq. 0.5 eq. 1 h 90% 10% - 
2 0.5 eq. 0.5 eq. 4 h 73% 15% - 
3 1.0 eq. 1.0 eq. 2 h 10% 77% 1 other product. 
4 1.0 eq. 1.0 eq. 4 h <2% 64% 3 other products. 
5 1.2 eq. 1.2 eq. 6 h 0% 56% 3 other products. 
 
Table 8 
†Reagent and conditions: i) CF3COCH3, Oxone®, NaHCO3, CH3CN, aq. Na2·EDTA 10-4 M, 0 °C, time; 
*
 yields determined by GC analysis. 
 
The GC results indicated that sub-stoichiometric equivalents of 1,1,1-trifluoroacetone 
and Oxone® allowed clean conversion to one product with the correct mass for a 
mono epoxide (Table 8, Entry 1). Extended reaction times did not show other 
products (Entry 2). With stoichiometric quantities of reagents, however, by-products 
were observed, with increasing reaction times resulting in further by-products 
(Entries 3 and 4). Excess reagents encouraged complete starting material 
consumption, however resulted in lower product yield by GC (Entry 5). 
 
These results indicated that the best conditions for mono-epoxidation would be with 
stoichiometric quantities of 1,1,1-trifluoroacetone and Oxone® and reaction times of 
~2 h. At this time however, it was not certain which monoepoxide had formed, or if 
both were present.  
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A sample reaction was carried out (Scheme 82), using the optimal conditions, and this 
time worked-up and the products separated by column chromatography on silica gel. 
Inspection of the alkene signals in the 1HNMR spectra indicated that the isolated 
monoepoxide (15% yield) was the desired regioisomer 243. Diepoxide 
by-product 244 (Figure 22) was also identified in 4% yield, although no other 
products or starting material were recovered. The low yields and overall mass 
recovery suggested instability to silica.  
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Figure 22. Diepoxide side product. 
 
It was resolved to try the oxidative cleavage of the crude mixture of 
monoepoxide 243, diepoxide 244 and other products, in order to try and isolate 
product enone 240 and thus obtain a realistic overall yield for the two-step process. 
The epoxidation was carried out as before but this time the crude reaction mixture was 
treated with sodium periodate and catalytic periodic acid.136 
 
The epoxidation of diene 241 on a 20 mg scale gave 90% of the desired 
monoepoxide 243 by GC and to our delight, after periodate cleavage desired 
enone 240 was isolated by silica gel chromatography in an excellent overall 77% 
yield (Scheme 83). This process was repeated to give 81% and 83% overall yields 
respectively of the oxidative cleavage on scales of 66 mg and 360 mg. 
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Scheme 83. Reagent and conditions: i) CF3COCH3, Oxone®, NaHCO3, CH3CN, aq. Na2·EDTA 10-4 M, 
0 °C, 2 h; ii) NaIO4, cat. HIO4, t-BuOH : H2O : THF, 45: 45 : 10, 23 °C, 4 h, 83% over two steps. 
 
These excellent results gave us confidence to apply our reaction protocol to the real 
(S)-zearalenone (3) system. 
 
 
 
2.5.1.2 Selective Oxidative Cleavage of the Real (S)-Zearalenone (3) System 
 
 
The success of our model study was encouraging, although we remained aware that 
the real (S)-zearalenone (3) system was more complicated. Therefore additional 
factors, such as electronic effects, could play a role in deciding this reaction outcome. 
 
The reaction conditions employed in the model study, along with a variety of 
modified conditions, were attempted on the authentic substrate 87 (Scheme 84) and 
the initial results are shown in Table 9. 
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Scheme 84. Oxidative Scission Investigations. 
 
Entry Ketone (eq.)† Buffer 
 
Crude Mass 
Recovery 
Product Step i)* Product Step ii)* 
1 234 (1.0) NaHCO3 29% 
 
S.M. 
monoepoxide 
diepoxide 
Decomposition. 
2 
 
234 (1.0) 
Stock 
solution 
NaHCO3 90% 
 
S.M. 
monoepoxide 
diepoxide 
Decomposition. 
3 245 (0.04) K2CO3 53% S.M. - 
4 234 (2.0) K2CO3 88% monoepoxide (major product) Decomposition. 
 
Table 9 
†Reagents and conditions: i) ketone, Oxone® (1.0 eq.), buffer (5.0 eq.), CH3CN, aq. Na2·EDTA 10-4 M, 
0 °C, 2 h; ii) NaIO4, cat. HIO4, t-BuOH : H2O : THF, 45: 45 : 10, 23 °C, 4 h; 
 
*
 products determined by MS analysis. 
 
The first attempted mono-epoxidation used the same conditions which had previously 
been successful in the model study. Whereas promisingly the correct mass for the 
monoepoxide was found by MS, (along with smaller peaks for starting material and 
the diepoxide) the crude mass recovery was low. Upon treatment of the crude product 
with sodium periodate and periodic acid no desired enone 86 was found by MS  
(Table 9, Entry 1).  
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To control more precisely the equivalents of dioxirane, the reaction was repeated 
utilising a stock solution of 1,1,1-trifluoroacetone 234. Ketone 234 has a low boiling 
point and even with a precooled syringe it had proven difficult to measure precisely 
the minimal quantities required on this scale. A 1 M solution of ketone 234 in 
acetonitrile was used. As a result the crude mass recovery was much better (Entry 2), 
however once again no product was observed from sodium periodate treatment.  
 
The Shi catalyst (245, Figure 23) catalyses selective epoxidations upon slow addition 
of a stoichiometric amount of Oxone® to generate the active dioxirane.137 This 
procedure was attempted on diene 87 with the hope that this bulky epoxidant may be 
more selective for the least hindered alkene, which could be the terminal alkene. 
Unfortunately, although the reaction looked much cleaner by TLC, no desired 
epoxidation product was observed in the MS spectrum and only starting material was 
recovered (Entry 3). 
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Figure 23. Shi’s catalyst.137 
 
Finally, using the Shi reaction protocol with an excess of ketone 234 gratifyingly gave 
a good mass recovery and mainly the monoepoxide product by MS. Unfortunately, 
again sodium periodate cleavage failed to produce product 86 (Entry 4). At this point 
it appeared that the mono-epoxidation strategy for selective oxidative cleavage of the 
authentic substrate 87 would not work (Scheme 85). 
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Scheme 85. Reagents and conditions: i) 234, Oxone®, buffer, CH3CN, aq. Na2·EDTA 10-4 M, 0 °C, 2h; 
ii) NaIO4, cat. HIO4, t-BuOH : H2O : THF, 45: 45 : 10, 23 °C, 4 h. 
 
The conclusions which could be drawn from this work are that either a) the wrong 
epoxide is forming, which is leading to decomposition under the cleavage conditions; 
b) the periodate conditions are leading to side reactions and decomposition or 
c) enone 86 is unstable and decomposing spontaneously.  
 
If the wrong epoxide is forming preferentially, it may be difficult to find any reagent 
which will epoxidise the desired alkene selectively. This may be due to steric 
hindrance of the ketal group or the electron-withdrawing effect of the nearby oxygen 
atom in macrocyclic diene 87 (Figure 24).  
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Figure 24. Potential Selectivity issues of Mono-epoxidation of Macrocyclic Diene 87. 
 
It was proposed that the steric bulk could be reduced by deprotecting the ketal group. 
This was attempted on a 10 mg scale with 90% acetic acid, however TLC and MS 
indicated a mixture of starting material and mono-deprotection, as well as desired 
product 246 (MS (CI) m/z 334 [M+H]+, 352 [M+NH4]+) (Scheme 86).  
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Scheme 86. Reagents and conditions: i) 90% AcOH, 40 °C, 72 h, mixture of products. 
 
An alternative method of cleavage to epoxidation was sought. 
 
2.5.2 Oxidative Cleavage by Dihydroxylation  
 
An alternative strategy for the oxidative scission of an alkene is the cleavage of a 
1,2-diol, formed from dihydroxylation, which is usually carried out with osmium 
catalysis. Literature searches revealed a couple of examples of selective 
dihydroxylations of conjugated dienes, which had been generated by enyne 
metathesis.138, 139 In both cases the terminal alkene was selectively dihydroxylated in 
the presence of the more substituted, electron-rich double bond. 
 
The first example was from a publication by Neipp and Martin,138 who formed 
aldehyde 249 in 54% yield from diene 247, via diol 248. AD-mix-α, which is catalytic 
in osmium, was used for the selective dihydroxylation. (Scheme 87).  
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Scheme 87. Neipp and Martin’s Selective Oxidative Cleavage of Diene 247. 
 
The second example used stoichiometric osmium tetroxide for the dihydroxylation, 
with triethylamine as a tertiary amine ligand to accelerate the reaction. The desired 
diol 251 was isolated in 76% yield from diene 250, along with 13% of the undesired 
diol. Cleavage with sodium periodate proceeded to give ketone 252 (Scheme 88).139 
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Scheme 88. Selective Oxidative Cleavage of Diene 250. 
 
The second system is similar to diene 87, in that both alkenes are disubstituted. 
However there is clearly still less bulk around the terminal alkene compared to the 
(S)-zearalenone (3) system and in addition the second alkene geometry is cis, whereas 
in diene 87 it is trans.  
 
Sharpless et al. reported the order of reactivity towards alkene dihydroxylation in the 
absence of a ligand to be that shown in Figure 25.140  This would suggest that 
dihydroxylation of the required terminal alkene is less favoured than that of the 
E-alkene inside the ring. This would also explain why in the two examples discussed, 
terminal alkenes such as c) are dihydroxylated faster than the Z-alkenes b). 
 
a) b) c) e) f)
increasing reactivity to OsO4
d)
 
 
Figure 25. Order of reactivity of alkenes to dihydroxylation with OsO4 
 
Sharpless also proved that the effects of adding tertiary amine ligands (Figure 26), are 
an increase in the reaction rate (quinuclidine (253) : ~200 fold; (DHQ)2PHAL (254),  
the ligand in AD-mix-α : ~1400 fold) and an increase in selectivity. The precise 
tertiary amine ligand used with osmium tetroxide was shown to have an effect on the 
reaction rates with different alkene geometries. 
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Figure 26. Tertiary amine ligands. 
 
 
The reaction of diene 87 with osmium tetroxide in the presence of different amine 
ligands was investigated (Scheme 89, Table 10.) 
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Scheme 89.  Oxidative Scission by Dihydroxylation. 
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Entry Reagents and conditions i) Product from Step i)† 
Product from 
NaIO4 cleavage†,*  
1 OsO4 (1.0 eq.),  Et3N, t-BuOH, THF,  
–78 °C to 23 °C, 18 h 
Mono-diol  
(major product) Decomposition. 
2 OsO4 (1.0 eq.),  quinuclidine (253), 
t-BuOH, THF, –78 °C to 23 °C, 18 h 
Mono-diol  
(major product) Decomposition. 
3 AD-mix-α, MeSO2NH2, t-BuOH, H2O, 23 °C, 18 h 
Mono-diol  
(major product) Decomposition. 
 
Table 10 
†products determined by MS analysis; *Reagents and conditions: NaIO4, cat. HIO4, 
t-BuOH : H2O : THF, 45: 45 : 10, 23 °C, 4 h; 
 
All three sets of reaction conditions showed a product diol, such as diol 255, by 
MS ([M+NH4+–H2O] = 456), although the they were visibly different by TLC. This 
suggested different selectivities. In each case the crude mass recovery was low 
(∼40%) and unfortunately when each crude product was treated with sodium 
periodate, none of the desired cleavage product 86 could be detected. This suggested 
similar behaviour of diene 87 towards dihydroxylation as previously observed for 
epoxidation.  
 
At this time, due to difficulties encountered with the selective oxidative cleavage and 
the fact that no material remained, we decided to pursue an alternative retrosynthesis.  
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2.6 Conclusions 
 
The synthesis of (S)-alcohol 93 from (±)-δ-hexanolactone (95) was achieved in six 
steps, including a biocatalysed kinetic resolution to introduce chirality. Synthesis of 
alkyne ester 89 by a modification of a literature procedure allowed access to gram 
scale quantities. The coupling of the two fragments by zinc-mediated 
transesterification and RCEYM enabled macrocyclisation, forming diene 87 in 
excellent yields (Scheme 90).  
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Scheme 90. Synthesis of Diene 87 via RCEYM 
 
At this point however, the attempted selective oxidative scission of the exo-cyclic 
methylene group to generate enone 86 had been unsuccessful under a variety of 
conditions. Results indicated a lack of regioselectivity, or undesired regioselectivity as 
neither starting materials or desired products had been detected from periodate 
cleavage of either mono-epoxides or mono-1,2-diols.  
 
In 2005 Nicolaou et al. attempted the total synthesis of amphidiolide N (256) via 
RCEYM of enyne 258 and mono-epoxidation of product diene 257 (Scheme 91).141  
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Scheme 91.  Nicolaou’s Proposed Retrosynthesis of Amphidiolide N.141 
 
In this example, the desired mono-epoxidation would have the opposite 
regioselectivity than we wished for in our (S)-zearalenone (3) system. 
 
Interestingly, Nicolaou’s model study on diene 259 produced conflicting results. 
When alcohol 259 was treated with a vanadium catalyst and tert-butyl peroxide, a 
moderate yield of product 261, from mono-epoxidation of the terminal alkene 
function, was observed. However, reacting silyl ether 260 under Katsuki-Sharpless 
conditions allowed their desired mono-epoxidation with the opposite regioselectivity 
(and excellent stereoselectivity) to occur in moderate yields, producing the regiomer 
262 (Scheme 92). It was also observed both products were susceptible to 
decomposition on chromatography. 
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Scheme 92. Nicolaou’s Mono-epoxidation of intermediates 259 and 260. 
 
However when the previously successful Katsuki-Sharpless epoxidation was 
attempted on their real amphidiolide N system, this failed. Under no conditions could 
they observe their desired regioselectivity. When diene 263 was treated with DMSO, 
regioisomeric iso-epoxy-amphidiolide N 264 was generated as a single undetermined 
diastereoisomer in 31% yield (Scheme 93). They concluded that the precise three-
dimensional conformation of the diene is influential in the epoxidation selectivity. 
 
OO
Me
Me
OH OH
Me
O
O
HO
O
HO
H
OH
Me
OO
Me
Me
OH OH
Me
O
O
HO
O
HO
H
OH
Me
O
263 264  (31%)
DMDO
 
 
Scheme 93. Nicolauo’s Mono-epoxidation of Diene 263. 
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These results highlight the non-trivial nature of the mono-epoxidation of conjugated 
dienes and suggest that the difficulties encountered in our studies were warranted. 
They also underline the lack of reliability of model studies: indeed our own model 
study of selective oxidative cleavage had been a success, but the real system proved 
more troublesome.  
 
With these conclusions, we decided to abandon the RCEYM route to 
(S)-zearalenone (3) and to devise an alternative retrosynthesis, avoiding the need for 
the selective oxidative scission. This would mean having the oxygen at C-25 in place 
before macrocyclisation (Figure 27). 
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Figure 27. Primary Target Diketone 86. 
 
The next chapter of the results and discussion section details our new disconnection 
strategy and synthetic work carried out to this end.  
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Chapter Three: 
Results and Discussion - 
RCM Approach to 
(S)-Zearalenone 
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3.1 Introduction 
 
Chapter 2 was concerned with our initial retrosynthetic analysis of 
(S)-zearalenone (3), which involved disconnecting the molecule via enyne metathesis. 
This route encountered difficulties in performing the required selective oxidative 
cleavage of the terminal alkene of intermediate diene 87 (Scheme 94).   
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Scheme 94. Failed Selective Oxidative Cleavage. 
 
In order to avoid this transformation, an alternative retrosynthetic analysis with the 
oxygen at C-25 already in place at the time of macrocyclisation was necessary. An 
obvious alternative to RCEYM is ring-closing metathesis (RCM).142, 143 
Disconnection of target diketone 86 by RCM would provide α,β-unsaturated ketone 
265. This in turn could come from the transesterification of (S)-alcohol 93, previously 
synthesised (see Section 2.2), with vinyl ketone 266 (Scheme 95). This new 
retrosynthetic analysis identified vinyl ketone 266 as a primary target. 
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Scheme 95.  Alternative Retrosynthetic Analysis of (S)-Zearalenone (3) 
 
 
In this chapter, efforts towards this revised synthetic route will be discussed, 
beginning with the synthesis of vinyl ketone 266.  
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3.2 Synthesis of Vinyl Ketone 266 
 
Further retrosynthetic analysis of target vinyl ketone 266 reveals that this could be 
prepared by the oxidation of alcohol 267, which is produced via the Claisen 
condensation of alcohol 268. This in turn could be generated from aldehyde 91, a 
previous intermediate (Section 2.3), by a Grignard addition (Scheme 96). 
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Scheme 96.  Retrosynthetic Analysis  of Vinyl Ketone 266 
 
It was thought that carrying out the Claisen condensation before the oxidation would 
prevent competing aldol reactions occurring. Also, if the alcohol moiety was shown to 
interfere in the reaction, this could be protected. 
 
3.2.1 Grignard Additions to Aldehyde 91 
 
 
Dropwise addition of commercial vinylmagnesium bromide was carried out at  
–78 °C, to ensure reaction at the more reactive aldehyde centre rather than the ester. 
Alcohol 268 was isolated, albeit in a disappointing 39% yield. The Claisen 
condensation of alcohol 268 with ethyl acetate (190) gave a mixture of products, the 
major being cyclised hemi-ketal 269 in 29% yield. Unfortunately, the attempted 
oxidation of hemi-ketal 269 to α,β-unsaturated ketone 266 using mild Dess-Martin 
periodinane144 was unsuccessful (Scheme 97). 
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Scheme 97. Reagents and conditions: i) Vinylmagnesium bromide, THF, –78 °C, 39%; 
ii) EtOAc (190) (3.0 eq.), LDA (3.0 eq.), THF, –78 °C, 29%; iii) DMP, CH2Cl2, 23 °C.  
 
 
 
3.2.2 Improvements to the Synthetic Strategy 
 
Two main improvements to the procedure were envisaged: firstly it was hoped that 
inclusion of a methyl group on the terminal alkene position would improve the yield 
of the initial Grignard addition, for example by preventing side products from the 
polymerisation of vinylmagnesium bromide. This methyl group would be cleaved 
during the RCM process. 
 
Secondly, to prevent the formation of a 1,5-keto alcohol which would cyclise to a 
hemi-ketal, a protecting group would be added to the alcohol before the Claisen 
condensation. A silyl ether protecting group was chosen, as this would be stable to the 
basic conditions required for the condensation step (Scheme 98). 
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Scheme 98. Modified Retrosynthetic Analysis of Transesterification Partner 270. 
 
To this end, 1-propenylmagnesium bromide was added dropwise to aldehyde 91 at  
–78 °C to yield product alcohol 274 in a greatly improved 76% yield. The alcohol was 
then protected as silyl ether 273 in 96% yield and Claisen condensation with ethyl 
acetate gave 77% of β-ketoester 272 (Scheme 99). 
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Scheme 99. Reagents and conditions: i) 1-Propenylmagnesium bromide, THF, –78 °C, 76%; 
ii) TBSCl, DMAP, Imid., DMF, 0 °C to 23 °C, 18 h, 96%; iii) DIPA, n-BuLi, THF, 0 °C, 15 min; 
EtOAc, –78 °C, 30 min; 273, –78 °C to 23 °C, 4 h, 77%.   
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The TBAF deprotection of silyl ether 272 gave a single product, which proved to be  
hemi-ketal 275. Oxidation with Dess-Martin periodinane gave no desired product, 
with  only starting material or the possible dehydration products 276 observed by MS  
(Scheme 100).   
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Scheme 100. Reagents and conditions: i) TBAF (1.0 M in THF, 5.0 eq.), THF, 23 °C, 18 h, 79%;  
ii) DMP, CH2Cl2, 0 °C to 23 °C, 1 h. 
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3.3 Coupling of Vinyl Ketone 272 with (S)-Alcohol 93 
 
It was decided to couple vinyl ketone 272 to (S)-alcohol 93 and to form 
macrocycle 278 before deprotection of the silyl group and oxidation to target 86. It 
was hoped that once the ring was closed, there would be greater hindrance to 
hemi-ketal formation (Scheme 101). 
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Scheme 101. Proposed New Synthetic Route.  
 
Closing the macrocycle would be accomplished firstly via transesterification, then 
RCM and these will now be discussed in turn. 
 
3.3.1 Transesterification 
 
The coupling was carried out in an analogous method to that previously used to 
couple ester 89 with (S)-alcohol 93: zinc mediated transesterification. As previously, 
the reaction was carried out at a temperature of 110 °C under a distillation condenser 
to remove the excess ethanol by-product (see Section 2.4.1.2). Diene 277 was formed 
in 84%, an improvement on the previous transesterification yield. This was mainly 
due to simpler chromatography (Scheme 102).  
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Scheme 102. Reagents and conditions: i) Zn dust (20 mol%), PhMe, 110 °C, 18 h, 84% 
 
 
3.3.2 Ring Closing Metathesis (RCM) 
 
Gratifyingly, when diene 277 was treated with Grubbs’ second generation catalyst in 
toluene at 120 °C under argon for 72 h, spot to spot conversion to a new product was 
observed. The product was isolated in 88% yield and shown to be the desired 
ring-closed macrocycle 278 (Scheme 103). This was achieved despite previous 
literature evidence which suggested that bulky silyl ethers adjacent to alkenes could 
prevent ring-closing metathesis, presumably from steric effects.145, 146 
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Scheme 103. Reagents and conditions: i) Grubbs’ II (196) (10 mol%), PhMe, 120 °C, 72 h, 88%. 
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3.4 Elaboration of Macrocyclic Silyl Ether 278 to Diketone 86 
 
The next synthetic goal was the formation of diketone 86. From macrocyclic silyl 
ether 278 this involved silyl deprotection and then oxidation of the product alcohol 
279 (Scheme 104). 
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Scheme 104. Synthetic Steps to Diketone 86. 
 
 
3.4.1 Silyl Deprotection of Macrocyclic Silyl Ether 278 
 
As feared, the TBAF deprotection of macrocyclic silyl ether 278 gave rise to a 1:1 
mixture of diastereoisomeric hemi-ketals, 280a and 280b, each in 42% yield. 
Interestingly, one diastereoisomer, 280b, was crystalline and we were able to obtain a 
crystal structure of this material in order to assign the configuration as that shown. 
The open-chain alcohol 279 was not be observed by crude 1H NMR or TLC  
(Scheme 105).  
 
 124 
O
O O
OTBS
O
O O
O
278
i)
O
OH O
O
O O
OO
280a
O
OH O
O
O O
OO
280b
+
 
 
Scheme 105. Reagents and conditions: i) TBAF, THF, 23 °C, 5 d, 84%. 
 
 
The crystal structure clearly shows an intramolecular hydrogen bond between the 
alcohol proton and ester carbonyl oxygen, whilst also unambiguously confirming the 
14-membered macrocycle is in place (Figure 28). 
 
 
 
 
Figure 28. Crystal Structure of Hemi-Ketal 280b 
 
Intramolecular Hydrogen Bond 
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The TBAF deprotection of macrocyclic silyl ether 278 was slow (5 days), hence 
investigations into alternative and possibly milder deprotection conditions were made 
(Scheme 106, Table 11). Disappointingly however, no improvements were found. 
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Scheme 106. Attempted Silyl Deprotection. 
 
 
Entry Reagents and conditions Products† 
 
1 
 
TBAF (3.0 eq.), THF, 24 h 
 
S.M. 
2 TBAF (10 eq.), THF, 5 d Hemi-ketals 280 
3 Zn(BF4)2 (3.0 eq.), H2O, THF, 24 h147 S.M. 
4 CAN (1.0 eq.), MeOH, 0 ºC, 3 h 148 Decomposition 
 
Table 11 
†products determined by MS and 1H NMR analysis. 
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3.4.2 Oxidation 
 
To complete the synthesis of diketone 86, oxidation was necessary. Based on the 
principle that hemi-ketals 280 will be in equilibria with the open chain alcohol 279, it 
should be possible to oxidise this directly. Failing this, macrocyclic silyl ether 278 
may potentially be oxidised directly to diketone 86 (Scheme 107). 
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Scheme 107. Possible Oxidations to form Diketone 86. 
 
 
3.4.2.1 Oxidation of Hemi-Ketals 280a and 280b 
 
 
Investigations into the oxidation of hemi-ketals 280a and 280b failed to isolate any 
desired product dione 86, despite a wide range of conditions being attempted 
(Scheme 108, Table 12). It is interesting to note that hemi-ketal 280a and 
hemi-ketal 280b behave slightly differently under the same conditions (Entries 1, 2, 5 
& 8-10).  
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Scheme 108. Attempted Oxidation of Hemi-Ketals 280. 
 
Entry Hemi-ketal Reagent and conditions† Products* 
1 a DMP144 S.M. 
2 a DMP, pyr.149 S.M. 
3 a TPAP, NMO, 4Å m.s. S.M. 
4 a PCC, MgSO4, celite150 S.M. 
5 a PCC, NaOAc, 4Å m.s.151 S.M. 
6 a tBuOCl, pyr. 152, 153 Dehydration 
7 a PhSNHtBu (10 mol%), NCS, DBU154 S.M. 
8 b DMP S.M. 
9 b DMP, pyr. Dehydration 
10 b PCC, NaOAc, 4Å m.s. S.M. 
 
Table 12 
†
reactions carried out in CH2Cl2 at 23 °C for 5 h; 
*products determined by MS and 1H NMR analysis. 
 
Both the difficulty observed in the oxidation of hemi-ketals 280 and also the absence 
of detection of any free alcohol 279 during silyl deprotection, suggest that the 
hemi-ketal forms are extremely stable with respect to the open chain alcohol. Most of 
these oxidation procedures would rely on the oxidation of the small amount of free 
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alcohol present in equilibria. Neither basic conditions (Entries 2, 6 and 7) or acidic 
conditions (Entry 4) seemed to promote the hemi-ketal opening.  
 
A similar effect was observed by Julian et al. during their attempted synthesis of 
(+)-tedanolide (281) (Figure 29).149  
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Figure 29 (+)-Tedanolide (281) 
 
Upon deprotection of their TES ether intermediate 282 they observed facile 
hemi-ketal formation and then were unable to oxidise product 283. They attributed the 
increased stability of the closed hemi-ketal with respect to its open chain form to the 
Thorpe-Ingold effect155 of the presence of substituents on the newly formed 
six-membered ring. In their example there is an alcohol moiety at the C-13 position 
and indeed, when they remove this group they are able to oxidise deoxygenated 
hemi-ketal 284 under mild conditions to diketone 285 in 71% yield (Scheme 109). 
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Scheme 109. Julian et al.’s Synthesis of Diketone 285. 
 
This suggests that the presence of the tertiary carbon at C-5 of macrocyclic silyl 
ether 278 is key in shifting the equilibrium from the open-chain alcohol to favour 
hemi-ketal 280, as this tertiary carbon becomes positioned within the new 
six-membered ring (Scheme 110).  
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Scheme 110. Hemi-Ketal Formation. 
 
Unfortunately in our case, synthesis of a resorcylate natural product analogue would 
not be possible without the presence of this ketal, as the carbonyl at this position is 
necessary for the late-stage aromatisation. 
 
 
3.4.2.2 Direct Oxidation of Macrocyclic Silyl Ether 278 
 
Several literature procedures for direct oxidation of macrocyclic silyl ether 278 were 
endeavoured, however in no case was the desired product diketone 86 identified 
(Scheme 111, Table 13). 
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Scheme 111. Attempted Direct Oxidation of Macrocyclic Silyl Ether 278. 
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Entry Reagents and conditions Products† 
1 Jones’ Reagent, KF, acetone, 0 °C, 18 h156 Decomposition 
2 PCC, celite, MgSO4, CH2Cl2, 23 °C, 5 d150 S.M. 
3 NHPI, Co(Ac)2, 1 atm O2 (g), CH3CN, 23 °C, 20 h157 S.M 
4 (COCl)2, DMSO, Et3N, CH2Cl2, –78 °C, 3 h158 Decomposition 
5 DDQ, pH 7 buffer, CH2Cl2, 23 °C, 2 h159 S.M. 
5 DDQ, CH2Cl2, 40 °C, 18 h S.M. 
6 DDQ, һν, CH2Cl2, CH3CN, 3 h160 S.M. 
 
Table 13 
†
 products determined by crude MS and 1H NMR analysis. 
 
 
The failure of both the oxidation of hemi-ketals 280, or macrocyclic silyl ether 278 
meant a modification of our strategy was necessary.  
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3.4.3 Protection Strategies 
 
Thus far our synthetic work towards diketone 86 has proven firstly that we must have 
an oxygen in place at C-25 (failure of selective oxidative scission) and secondly that 
any 1,5-hydroxy-ketone intermediate must be avoided at all costs (failure of 
hemi-ketal oxidation, Figure 30).  
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Figure 30. Summary of Synthetic Discovery. 
 
Our RCM disconnection strategy could still be viable, provided we fulfil these 
criteria. This implied the need to modify our protecting group strategy and our efforts 
in this area will now be described. 
 
With macrocyclic silyl ether 278 in hand, it was resolved to protect the carbonyl at 
C-7. This would preclude attack by the C-25 alcohol. Although ketalisation with 
ethylene glycol would mean that the three ketals could be removed in one step, we 
guessed that the equilibriating  ketalisation conditions would result in simultaneous 
deprotection and therefore a mixture of several different ketal products. Instead, we 
recognised the potential to protect C-7 as an enol ether, due to the adjacent acidic 
protons. This would require only mildly basic conditions, leaving existing protecting 
groups intact whilst only adding one step to the planned synthesis (Scheme 112). 
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Scheme 112. Strategy for Protecting β-Ketoester 278 as an Enol Ether. 
 
As acyclic silyl ether 272 was also in hand, methyl enol ether protection was 
simultaneously carried out on this substrate (Scheme 113, Table 14). 
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Scheme 113. Enol Ether Protections. 
   
Entry β-Ketoester Reagents and conditions† Products* 
1 272 
 
Me2SO4, K2CO3, 
18-crown-6, CH2Cl2161 
 
Product: C-alkylation: unknown 
1 : 2 : 1 
2 272 
 
TMSCHN2, DIPEA,  
CH3CN : MeOH, 9 : 1162, 163 
 
Product: C-alkylation: unknown 
1 : 1 : 2 
3 278 TMSCHN2, DIPEA  CH3CN : MeOH, 9 : 1 
 
Product: C-alkylation: unknown 
1 : 2 : 4 
 
Table 14 
†
reactions carried out at 23 °C for 18 h; *ratio determined by crude 1H NMR analysis. 
 
Reactions were low yielding, with side-products formed as well as the desired 
product. One identified side-product seemed to be that from competing C-alkylation. 
The isolated yields from the TMS-diazomethane procedure were 10% for the open 
chain enol ether 289 and just 5% for the macrocyclic product 286.  
 
Open chain enol ether 289 was subjected to TBAF and disappointingly, the only 
isolated product was ketal 290, in an isolated 69% yield as a 5 : 3 mixture of 
diastereoisomers (Scheme 114). 
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Scheme 114. Reagents and conditions: i) TBAF, THF, 23 °C, 3 d. 
 
It was concluded that enol ether formation provided no protection from cyclisation 
and hence the route was abandoned. 
 
At this time it appeared that a complete new retrosynthetic route would be necessary. 
One proposal was to simply replace the TBS group with an oxidisable protecting 
group, such as the ortho-bromobenzyl group which is known to undergo oxidation 
under radical conditions via 1,5-hydrogen atom transfer.164 However before beginning 
the synthesis again, we first wished to make sure that all other possibilities from the 
materials in hand were exhausted. 
 
3.4.4 Ketal Deprotection of Hemi-Ketals 280 
 
As discussed in section 3.4.2.1, facile hemi-ketal formation was attributed to the 
presence of the ketal group at C-5, according to the Thorpe-Ingold effect. It was 
decided to try to deprotect the ketal groups of hemi-ketals 280. It was thought that 
changing the bond angle around C-5 from sp3 to sp2 could influence the equilibria 
between hemi-ketal 291 and open-chain alcohol form 292, thus potentially allowing 
oxidation to occur, generating aromatisation precursor 85 (Scheme 115).  
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Scheme 115. Planned Ketal Deprotections 
 
The ketal deprotections of hemi-ketals 280 and also macrocyclic silyl ether 278 under 
mild conditions (PPTS in acetone and H2O) were first explored (Scheme 116, 
Table 15).  
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Scheme 116. Attempted Ketal Deprotections. 
 
 
 137 
Entry Starting material† Product(s)* 
1 280a 
 
Mixture of mono- and di-ketal deprotection. 
Evidence of dehydration. 
2 280b Single product: mono-deprotected ketal 293 (94%) 
3 278 
 
Full silyl deprotection. 
Mixture of mono- and di-ketal deprotection. 
Evidence of dehydration. 
 
Table 15 
†
 Reagents and conditions: PPTS, Acetone, H2O, 23 °C, 18 h; 
*
 products determined by crude 1H NMR analysis. 
 
Interestingly, the two diastereoisomers gave different results under the same 
conditions. A mixture of partial deprotection and full deprotection was observed for 
diastereoisomer 280a, (Table 15, Entry 1) whilst the crystalline diastereoisomer 280b 
gave only one product, ketal 293 (Entry 2, Scheme 117). Macrocyclic silyl ether 278 
underwent full TBS-deprotection under the reaction conditions, resulting in a mixture 
of hemi-ketals 280a and 280b, plus their ketal deprotection products (Entry 3).  
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Scheme 117. Reagents and conditions: i) PPTS, Acetone, H2O, 23 °C, 18 h, 94%. 
 
 
Harsher deprotection conditions were also investigated, namely sodium perchlorate in 
acetic acid. These conditions had been utilised in a study by Yamaguchi et al.,61 to 
facilitate the aromatisation of polycarbonyl compounds to resorcylates (Section 1.3).  
It was hoped that these deprotection conditions would also encourage spontaneous 
aromatisation (Scheme 118, Table 16).  
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Scheme 118. Attempted Ketal Deprotections. 
 
Entry 
 
Starting 
material† 
 
Product(s) Yield* 
1 280a 
 
O
O
O
OO
294a
 
 
97% 
2 280b 
 
O
O
O
OO
294b
 
 
99% 
3 278 
 
O
O
O
OO
294
 
 
71% 
 
Table 16 
†
 Reagents and conditions: NaClO4, AcOH, 23 °C, 18 h, 97-99%; 
*
 isolated product yields. 
 
In all three cases, complete ketal deprotection occurred, along with dehydration to 
form the dihydropyrones 294 in excellent yields. For macrocyclic silyl ether 278, this 
meant five operations occurring in one pot: TBS deprotection, hemi-ketal formation, 
dehydration and two ketal deprotections. 
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Dihydropyrones 294 pose a problem in the synthesis of (S)-zearalenone (3), as no 
literature examples could be found where similar systems have been converted to 
resorcylates. Oxidation of the dihydropyrone is likely to provide the 4-pyrones, which 
are alternative aromatisation products from β-triketo esters to resorcylates (see 
Section 1.2).  
 
In order to convert 4-pyrones to resorcylates, a novel reaction protocol would need to 
be developed. As discussed in Section 1.3, 2-pyrones such as pyrone 21 are known to 
rearrange to resorcylates 18, via open chain β-triketo ester 17, by the use of a base 
(Scheme 119). 
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Scheme 119. Base-catalysed Rearrangement of 2-Pyrones 21 to Resorcylates 18. 
 
Thus we anticipated that 4-pyrones 20 might also be encouraged to rearrange, under 
the right conditions, presuming that resorcylates 18 are the thermodynamically most 
stable β-triketo ester aromatisation product (Scheme 120). Lack of literature support 
for the hypothesis could be due the fact that only few examples 4-pyrones 20 have 
been reported.  
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Scheme 120. Possible Rearrangment/Isomerisation of 4-Pyrones 20 to Resorcylates 18 
 
Before the isomerisation investigations however, it was necessary to dehydrogenate 
dihydropyrones 294 to 4-pyrone 295 (Scheme 121).  
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Scheme 121. Possible Synthetic Strategy from Dihydropyrones 294 
 
 
3.4.4.1 Attempts towards the Synthesis of 4-Pyrone 295 
 
 
4-Pyrones are scarce in the literature and indeed, only very few simple 4-pyrones with 
adjacent carbonyl groups have been synthesised.37 4-Pyrone 295 not only represents a 
novel structural class of compounds, but is also an isomer of the natural product 
(S)-zearalenone (3), thus could be of biological importance.  
 
Despite a range of dehydrogenation/oxidation conditions being applied, 4-pyrone 295 
has thus far proved elusive. Both diastereoisomers have been used, and in neither case 
has any product been detected (Scheme 122, Table 17). 
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Scheme 122. Attempted Dehydrogenation of Dihydropyrones 294. 
 
Entry Reagents and conditions Product† 
 
1 
 
DDQ (1.8 eq.), CH2Cl2, 23 °C, 6 h 
 
S.M. 
2 DDQ (2.0 eq.), CH2Cl2, 40 °C, 6 h S.M. 
3 DDQ (1.5 eq.), PhMe, 80 °C, 6 h S.M. 
4 DDQ (1.5 eq.), PhMe, 120 °C, 24 h S.M. 
5 IBX (2.0 eq.), DMSO : PhMe, 1 : 2, 65 °C, 4 h S.M. 
6 IBX (Fresh batch, 2.0 eq.), DMSO : PhMe, 2 : 1, 65 °C, 6 h S.M. 
7 HIO3 (1.0 eq.), DMSO, 80 °C, sealed tube, 18 h165  S.M. 
8 I2O5, (1.0 eq.), H2O, 18 h166  S.M. 
9 CAN (3.0 eq.), CH3CN:H2O, 5 : 1, 23 °C, 18 h S.M. 
 
Table 17 
†products determined by crude MS and 1H NMR analysis. 
 
The range of conditions tolerated by dihydropyrones 294 imply that they are robust 
and chemically stable. It was decided instead to screen the biological activity of these 
compounds as they are structurally similar in size to RALs, however regrettably at the 
time of writing no results have yet been obtained. Our focus instead returned to 
devising an alternative retrosynthesis of the resorcylate target, completely avoiding 
hemi-ketal formation and consequent problems. 
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3.4.5 Revised Retrosynthetic Analysis of (S)-Zearalenone (3) 
 
As discussed in section 3.4.3, in order to form target diketone 86 a synthetic strategy 
avoiding the simultaneous presence of a carbonyl at C-7 and alcohol at C-25 was 
necessary (Figure 31). 
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Figure 31. Target Diketone 86. 
 
A completely new retrosynthetic analysis was devised in order to initially protect the 
carbonyl at C-7, rather than the carbonyl at C-5. Thus the desired aromatisation 
precursor would be macrocyclic diketone 296 instead of diketone 86. 
Macrocyclisation would still be accomplished by RCM, this time from diene 297. 
This in turn would come from the transesterification of alcohol (S)-alcohol 93 (see 
Section 2.2) with vinyl ketone 298 (Scheme 123). 
 
O
OH
HO
O
O
O
O
O
O
OO
O
O
O O
O
O
O
O
O
O
O OO
3 85
296
298 (S)-93
OH
O
OO
OO
OO
O
O
O
O
+
297
late-stage
aromatisation deprotection
RCM transesterification
 
 
Scheme 123. New Retrosynthetic Analysis to Protect the Carbonyl at C-7. 
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This new retrosynthetic analysis gave vinyl ketone 298 as a primary target. 
 
 
 
3.4.5.3 Towards the Synthesis of Vinyl Ketone 298 
 
 
Further analysis of target vinyl ketone 298 yielded an allylic oxidation of ketone 299. 
This could be obtained from a Grignard addition onto aldehyde 91 (see Section 3.2) 
and oxidation of the resultant alcohol 300 (Scheme 124). 
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Scheme 124. Retrosynthetic Analysis of Vinyl Ketone 298  
 
 
The Grignard reaction of aldehyde 91 with 4-pentenylmagnesium bromide (96) 
afforded only poor conversion to desired alcohol 300, which proved difficult to 
separate from remaining aldehyde 91. Instead the crude mixture was oxidised with 
Dess-Martin periodinane, allowing ketone 299 to be isolated in a disappointing 11% 
yield over the two steps (Scheme 125). Enough material was obtained however, to 
enable investigations to be made into the allylic oxidation step.  
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Scheme 125. Reagents and conditions: i) a) 96, THF, –78 °C, 2.5 h; ii) DMP, CH2Cl2, 0 °C to 23 °C, 
1h, 11% over two steps. 
 
Endeavours towards the allylic oxidation of ketone 299 proved unsuccessful  
(Scheme 126, Table 18). 
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Scheme 126. Attempted Allylic Oxidation of Ketone 299. 
 
 
Entry Reagents and conditions Product† 
 
1 
 
SeO2, EtOH, 23 °C, 6 h167 
 
S.M. 
2 SeO2, EtOH, 80 °C, 18 h S.M. 
3 
Mn(OAc)3·2H2O (0.1 eq.), O2, t-BuOOH (5.0 eq.), 
nonane, EtOAc, 23 °C, 36 h168 
S.M. 
4 SeO2 (0.5 eq.), t-BuOOH (2.0 eq.), CH2Cl2, 23 °C, 18 h S.M. 
5 PDC (15 eq.), CH2Cl2, 23 °C, 18 h S.M. 
6 MnO2 (15 eq.), CH2Cl2, 23 °C, 18 h S.M. 
 
Table 18 
†products determined by crude MS and 1H NMR analysis. 
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Fortunately, at this time an alternative route was shown to be successful, so work in 
this area was discontinued.  
 
3.4.6 Successful Method: Reduction-Oxidation Strategy 
 
A method thus-far overlooked which would prevent the simultaneous presence of a 
carbonyl at C-7 and alcohol at C-25, was to carry out the selective reduction of the 
ketone at C-7 of macrocyclic silyl ether 278 before deprotection of silyl ether 302, 
producing diol 301 (Scheme 127).  
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Scheme 127. Synthetic Strategy via Reduction of Ketone at C-7 of Macrocyclic Silyl Ether 278. 
 
It was anticipated that after silyl deprotection, oxidation of the diol 301 via a Swern 
oxidation would avoid any hemi-ketal formation,169 for the reason that the mechanism 
would proceed with complete formation of dialkoxysulfonium ion 303 before 
base-promoted elimination to the ketone in a separate step (Scheme 128).  
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Scheme 128. Mechanism of  Swern Oxidation of Diol 301. 
 
 
To model the system, the reduction of the ketone at C-7 was first carried out on the 
open chain silyl ether 272 which was in hand. The use of sodium borohydride at 0 °C 
allowed the selective reduction of the more reactive ketone in the presence of the ester 
group in excellent yield, producing alcohol 304. TBAF deprotection allowed diol 305 
to be isolated. The key double-Swern reaction proved more troublesome, with the 
crude reaction mixture containing several spots. Unfortunately, column 
chromatography failed to isolate enough material to characterise due to the small scale 
of the reaction, however the desired product 270 was detected in the crude mixture by 
MS (Scheme 129). 
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Scheme 129. Reagents and conditions: i) NaBH4, EtOH, 0 °C, 20 min, 89%; ii) TBAF (1.0 M in THF), 
THF, 23 °C, 18 h, 47%; iii) a) (COCl)2, DMSO, CH2Cl2, –78 °C, 1 h, b) Et3N, –78 °C to 0 °C, 1h. 
 
In light of these encouraging results, the reduction of macrocyclic silyl ether 278 was 
also carried out, yielding 88% of alcohol 302. Silyl deprotection afforded diol 301 
quantitatively (Scheme 130).  
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Scheme 130. Reagents and conditions: i) NaBH4, EtOH, 0 °C, 20 min, 88%; ii) TBAF (1.0 M in THF), 
THF, 23 °C, 18 h, 99%. 
 
The double-Swern oxidation of diol 301 was attempted and desired product 86 was 
observed in the crude MS spectrum. Disappointingly, decomposition was observed 
during column chromatography and diketone 86 could not be isolated. Instead, the 
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major product identified was ketal deprotected triketone 306 in 15% yield, as 
evidenced by only one ketal and three ketone signals in the 13C NMR spectrum data 
(Scheme 131).  It would be expected that if the western ketal had been deprotected, 
the resultant β-triketo ester would exist in a mixture of enol forms hence show 
increased complexity in the 1H  and 13C NMR spectra.  
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Scheme 131. Reagents and conditions: i)  a) (COCl)2, DMSO, CH2Cl2, –78 °C, 1 h, b)  Et3N, –78 °C to 
0 °C, 1h, 15%. 
 
Gratifyingly, when the procedure was repeated with minimal exposure to silica gel 
(increased polarity eluent), desired diketone 86 was isolated in a excellent yield 
(Scheme 132). This time both ketals and only the two expected ketones were evident 
in the 13C NMR spectrum. 
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Scheme 132. Reagents and conditions: i)  a) (COCl)2, DMSO, CH2Cl2, –78 °C, 1 h, b) Et3N, –78 °C to 
0 °C, 1h, 91%. 
 
Finally, we had completed the synthesis of diketone 86, which meant we were close to 
testing our key aromatisation step. These investigations will be discussed in the 
following section. 
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3.5 Aromatisation Studies of Diketone 86 
 
The final goal in the synthesis of (S)-zearalenone (3) was ketal deprotection and 
aromatisation of diketone 86 (Scheme 133). It was expected that the aromatisation of 
β-triketo ester 85 would be optimal in basic conditions, although it was possible that 
polyketide intermediate 85 could aromatise spontaneously under the acidic ketal 
deprotection conditions.45 
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Scheme 133. The Final Steps for (S)-Zearalenone (3) Synthesis. 
 
The primary goal was examination of the ketal deprotection conditions.  
 
3.5.1 Diketone 86 Under Acidic Conditions.  
 
Due to the fact that deprotection of the eastern ketal group of diketone 86 had already 
been observed simply upon exposure to silica gel, along with evidence from the 
attempted ketal deprotection investigations of hemi-ketals 280 (see Section 3.4.4), it 
was postulated that the western ketal would be more robust than the eastern. At this 
stage material was valuable, hence initial attempts were carried out on a small scale 
and MS spectra examined for evidence of products or starting materials (Scheme 134, 
Table 19) 
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Scheme 134.  Attempted Deprotection of Diketone 86 Under Acidic Conditions. 
 
Entry Reagents and conditions  [M+H]+  † Suggested Product 
1 PPTS, acetone, H2O, 23 °C, 72 h 381 Mono-deprotection 
2 NaClO4, AcOH, 23 °C, 72 h61 319 
Dehydration of 
desired product 
3 Ni(OAc)2, AcOH, 80 °C, 6 h61 425 S.M. 
4 3 M HCl, THF, 23 °C, 18 h 425 S.M. 
5 1.25 M HCl in MeOH, 23 °C, 72 h 425 S.M. 
6 c. HCl (2 drops), CH2Cl2, 40 °C, 2 h 425 + 381 S.M. and mono-deprotection 
7 85% aq. TFA, 50 °C, 18 h  * Decomposition 
 
Table 19 
†
 determined from crude MS analysis; * no obviously identifiable products. 
 
Surprisingly, under several sets of conditions only starting material was recovered 
(Table 19, Entries 3-5), despite our previous findings of the instability of diketone 86 
to acidic silica. Desired β-triketo ester 85 (expected MS (CI) m/z 337 [M+H]+) was 
not observed under any attempted conditions. However, the subsequent dehydration 
product was observed with sodium perchlorate in acetic acid (MS (CI) m/z 319 
[M+H]+, Entry 2). Interestingly, this is the same mass of the natural product, 
(S)-zearalenone (3). Unfortunately however, both the crude 1H NMR spectrum and 
TLC analysis revealed many products and the natural product could not be identified. 
This suggests other undesired aromatisations may be occurring.  
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As discussed in section 1.2, there are four major aromatisation pathways for β-triketo 
esters. In addition, acidic conditions have been demonstrated by Harris et al. to favour 
O-cyclisations or Claisen condensations over aldol condensations. Thus aromatisation 
of β-triketo ester 85 may have occurred spontaneously under the acidic ketal 
deprotection conditions, to give an alternative product or a mixture of products. 
Alternative aromatisation products include 4-pyrone 295, Claisen product 307 or 
2-pyrone 308 (Scheme 135).   
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Scheme 135. Possible Aromatisation Products of β-Triketo ester 85 
 
3.5.2 Diketone 86 Under Basic Conditions.  
 
The desired resorcylate forming aromatisation occurs via an aldol-type pathway, with 
the attack of the β-keto ester carbon to the vinyl ketone. It was postulated that an 
intramolecular Knöevenagel reaction of precursor diketone 86 under basic conditions 
could be utilised to control the regioselectivity of the condensation.170 This would 
promote selectively by the mild base deprotonating only the most acidic β-keto ester 
proton, generating diketal 309 as an intermediate. We postulated that aromatisation of 
diketal 309 would also occur under the reaction conditions, via enolisation, to 
generate (S)-zearalenone analogue 310 (Scheme 136).  
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Scheme 136. Proposed Knöevenagel Condensation of Diketone 86. 
 
 
Our initial Knöevenagel studies were carried out on small scale and this time crude 
1H NMR spectra were examined for evidence of products or starting materials 
(Scheme 137, Table 20). 
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Scheme 137. Attempted Knöevenagel Condensation of Diketone 86. 
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Entry Reagents and conditions Product† 
1 DBU (1.1 eq.), PhMe, 65 °C, 18 h170 Many products 
2 
t-BuOK (0.95 eq.), t-BuOH, 50 °C, 
sealed vial, 6 h 
Many products 
3 0.1 M KOH in MeOH, 23 °C, 18 h Unknown product ‘a’ 
4 K2CO3, i-PrOH, CH2Cl2, 50 °C, 5 h65 Many products 
5 K2CO3, i-PrOH, CH2Cl2, 23 °C, 24 h then 1 M HCl in MeOH, 2 h Unknown product ‘b’ 
 
Table 20 
†
 products determined by crude 1H NMR analysis. 
 
Disappointingly, neither diketal 309 or aromatised product 310 could be detected 
from standard Knöevenagel reaction conditions, only a complex mixture of products 
which could not be identified (Table 20, Entries 1 and 2). 
 
The use of methanolic potassium hydroxide had previously been demonstrated within 
our group to instigate aromatisation (see Chapter 4), however employing these 
conditions to diketone 86 led to the formation of unexpected product ‘a’. 
Mysteriously, this product had no protons in the alkene or aromatic region of the 
1H NMR spectrum, and only two carbonyl peaks, at 169.9 and 206.1 respectively, in 
the 13C NMR spectrum. The two ketals looked to have remained intact. This led us to 
suspect possible transannular additions from intramolecular attack of anion 311 on the 
conjugated enone (Scheme 138).  
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Scheme 138. Postulated Intramolecular Transannular Additions of Diketone Anion 311 
 
Unfortunately, insufficient quantity of unknown product ‘a’ was isolated to allow 
precise characterisation and speculation at the structure could not be confirmed. 
 
At this time, we were reminded of Krohn et al.’s report of a mild base-catalysed 
biomimetic aldol reaction used in the synthesis of benzo[a]naphthacenequinones (see 
Section 1.3).65 When diketone 312 had been subjected to the reaction conditions, a 
mixture of two regioisomeric products 313 and 314 had been obtained in 57% and 
24% yields respectively. However, ketal deprotected β-triketo ester 71 had given only  
a single regioisomer 72 in 70% yield (Scheme 139). 
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Scheme 139. Krohn et al’s Synthesis of benzo[a]naphthacenequinones. 
 
These findings suggest that the presence of ketals can affect the regioselectivity of 
condensations occurring under basic conditions.  
 
Krohn’s conditions were attempted on our system, resulting in many products  
(Table 20, Entry 4). However, when the reaction temperature was lowered and the 
time extended, after acidification a single product was recovered with 80% mass 
recovery (Entry 5). Fascinatingly, yet again it was an unidentified product, product ‘b’ 
(Scheme 140). 
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Scheme 140. Reagents and conditions: i) K2CO3, i-PrOH, CH2Cl2, 45 °C, 80% by mass. 
 
The 1H NMR spectrum of product ‘b’ clearly showed two coupling triplets integrating 
for 2H at approximately 4 ppm, which suggested that the western ketal had partially 
deprotected, possibly due to aromatisation. There were six protons above 5 ppm, three 
of which appeared as singlets. Significantly, the two alkene protons did not have 
greatly altered chemical shifts from starting diketone 86, suggesting that they were 
still next to an unsaturated carbon joined to oxygen. 
 
The 13C NMR spectrum proved equally puzzling, with four peaks at around 
160-170 ppm, two at 120-140 ppm (assigned as the carbon-carbon double bond) and 
two at 90-100 ppm. Importantly, comparison to the spectra of (S)-zearalenone (3) and 
other literature analogues indicated that product ‘b’ was not a resorcylate, as the 
chemical shifts of the aromatic and styrene protons did not match those expected.  
 
31 mg (80% by mass) of product ‘b’ was isolated in excellent purity, allowing careful 
examination of 2-D correlation spectra (see Appendix 3). This culminated in our 
tentative assignment of product ‘b’ as the highly conjugated O-cyclised lactone 315 
(Figure 32 and  Figure 33).  
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Figure 32. Postulated Structure of Product ‘b’ with labelled 13C NMR Shifts (in ppm). 
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Figure 33. 13C NMR Spectrum of Product 315. 
 
Although product ‘b’ could not be confirmed as lactone 315 by MS, microanalysis 
was obtained to verify the molecular formula. Sadly, product ‘b’ is not crystalline 
hence absolute confirmation by X-ray crystallography was not possible. It is hoped 
that the biological activity of product ‘b’ will be tested once its identity can be 
authenticated.  
 
Unfortunately, at this time all material had been exhausted hence investigations into 
the aromatisations of diketone 86 could not continue. Our initial attempts had, 
however, indisputably demonstrated the sensitivity of our poly-β-carbonyl system to 
variations in reaction conditions, whilst underlining the need for precise optimisation 
to discover the prerequisite conditions for desired aromatisation to 
(S)-zearalenone (3). 
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3.6  Conclusions 
 
 
The second retrosynthetic analysis of (S)-zearalenone (3) discussed in this chapter had 
been a definite improvement on the first. Although the RCM strategy for 
macrocyclisation had been comparable to the previous RCEYM, the new route had 
enabled the synthesis of the elusive diketone 86 to be accomplished in three steps 
from silyl ether 278 (Scheme 141).  
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Scheme 141. Synthesis of Diketone 86 via RCM. 
 
Diketone 86 proved sensitive to both acidic and basic conditions, undergoing partial 
ketal-deprotection on silica gel and being prone to a variety of condensations and 
decomposition pathways upon treatment with strong acid or base.  
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Whilst with unlimited time and resources conditions could probably be established to 
optimise the aromatisation of diketone 86 to (S)-zearalenone (3), it would be by no 
means certain that the same conditions would work for other resorcylate systems. This 
study illustrates the power of biosynthesis via the polyketide pathway: the levels of 
organisation demonstrated by enzymes is phenomenal and reproducing this control 
under laboratory conditions is no mean feat.  
 
We concluded from this work that in order to discover a reliable and general 
biomimetic synthesis of resorcylates it will be necessary to introduce control into the 
system. This could be possible either by the introduction of directing groups for the 
condensation, or masking groups for the β-triketo ester functionality which do not 
require acid or strong base in order to remove. This has become the new focus of our 
group’s synthetic studies and our new general strategies will be discussed briefly in 
the next and final chapter, Chapter 4. 
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Chapter Four: 
 Results and Discussion –
Dioxinone Strategy for the 
Synthesis of Resorcylates 
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4.1 Introduction 
 
Our studies into the biomimetic synthesis of (S)-zearalenone (3) via a late-stage 
aromatisation strategy discussed in the previous two chapters had concluded that the 
key aromatisation step required an element of control in order to become feasible. It 
had initially been hoped that deprotection of the ketals of diketone 86 would provide 
β-triketo ester 85, which would aromatise to the resorcylate natural product under the 
correct conditions. Unfortunately this approach proved unsuccessful (Scheme 142). 
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Scheme 142. Unsuccessful Strategy for the Synthesis of (S)-Zearalenone (3) 
 
The aromatisation of a β-triketo ester to form a resorcylate occurs via an 
intramolecular aldol-dehydration reaction. The problem is that β-triketo esters can 
also undergo Claisen condensations or O-cyclisations to form a variety of different 
aromatic products. Controlling which of these various aromatisations occurs is 
essential for our approach to be a success (Scheme 143). 
 
 
 
 
 
 
 
 162 
 
 
R OR'
O O O O
OH
HO
OR'
O
R
R OR'
O O O O
OH
R
O
R OR'
O O O O
O
O
R OR'
O
R OR'
O O O O
O O
OH
R
O
aldol
Claisen
O-cyclisation
O-cyclisation
Resorcylates
Acylphloroglucinols
4-Pyrones
4-Hydroxy-2-pyrones
17
17
17
17
HO OH
18
19
20
21
 
 
Scheme 143. Potential Aromatisations of  β-Triketo esters 17. 
 
This chapter examines new strategies devised to regulate the condensations of 
β-triketo esters and generate resorcylates. 
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4.1.1 Dioxinones as β-Ketoester Synthons 
 
The diketene-acetone adduct, 2,2,6-trimethyl-4H-1,3-dioxin-4-one (316), can be 
opened at elevated temperatures with nucleophiles such as alcohols, amines and thiols 
to provide β-keto esters, β-keto amides or β-keto thio esters respectively. This 
reaction occurs via the pyrolysis of dioxinone 316  to form acetylketene 317, which 
then reacts with the nucleophile to give the desired product 318 (Scheme 144).171-173  
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Scheme 144. Nucleophilic Opening of Dioxinone 316. 
 
Dioxinones such as 316 can also be acylated with activated carbonyl derivatives 319 
to generate acyl dioxinone derivatives 320.174, 175 Silyl enol ethers such as 321 can 
also be made from dioxinones such as 316, and then employed in vinylogous 
Muikayama aldol reactions176 with aldehydes 322 to generate alcohols 323  
(Scheme 145).  
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Scheme 145. Acylation of Dioxinone 316 (Bt = benzo[1,2,3]triazole). 
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In 2005, Katritzky et al. carried out investigations into applications of dioxinone 316 
in polyketide chemistry and found that acyl dioxinone derivatives 324 will rearrange 
to 2-pyrones 326 by thermolysis, in the absence of nucleophiles. The mechanism 
involves intermediate 325 (Scheme 146).175 
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Scheme 146. Thermolysis of Acyl-dioxinones 324 
 
 
We became interested in dioxinone chemistry since the acylation of dioxinone 316 
with a β-keto acid derivative 327 could potentially generate dioxinone analogue 328. 
This could act as a masked β-triketo ester equivalent. It was hoped that the 
thermolysis of a dioxinone analogue 328 in the presence of an alcohol 330 could 
result in in situ β-triketo ester 17 generation, which could be followed by 
aromatisation to form the resorcylate 18 without the need for additional acid or base 
(Scheme 147).  
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Scheme 147. Proposed use of Dioxinones to Generate Resorcylates. 
 
 
4.1.2 Previous Unpublished Synthetic Work Within Our Group 
 
Initial results within our group66 had proven extremely encouraging: when dioxinone 
analogue 330 was heated with alcohol 331 in toluene at 100 °C, the only observed 
product was resorcylate 332 in 85% yield (Scheme 148). Neither the 2-pyrone nor the 
Claisen product, which could result from thermolysis and rearrangement (see  
Scheme 146), were detected. 
 
O O
O
330
OO
HO
O
O
331
O
O
O
332 (85%)
OOH
HO
PhMe, ∆
 
 
Scheme 148. Previous Demonstration of Aromatisation Utilising Dioxinone Analogue 330. 
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Following on from this lead, studies had commenced into employing dioxinone in the 
total synthesis of our primary resorcylate target, (S)-zearalenone (3). Retrosynthetic 
analysis by RCM gave target diene 333, formed from the pyrolysis of dioxinone 335 
and trapping of intermediate ketene 334 with previously synthesised (S)-alcohol 93 
(see Section 2.2). Our previous investigations had advocated better overall yields 
from the vinylogous Muikayama aldol procedure with aldehyde 336 followed by 
oxidation, rather than direct acylation of dioxinone 316 (Scheme 149).66  
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Scheme 149. Retrosynthetic Analysis of (S)-Zearalenone Employing Dioxinone 316 and RCM. 
 
Aldehyde 336 has recently been synthesised within our group177 in three steps with  
overall 82% yield, from crotonaldehyde (337) and ethyl acetate (190). The vinylogous 
Muikayama aldol reaction was moderate yielding, however allowed dioxinone 
analogue 335 to be obtained in four further steps, with overall 15% yield  
(Scheme 150). 
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Scheme 150. Synthesis of Dioxinone Analogue 335. 
 
Crucially, reaction of dioxinone analogue 335 with (S)-alcohol 93 in toluene at 
100 °C was shown to provide non-aromatic β-triketo ester 338, which existed as a 
mixture of tautomeric forms. Treatment of the crude product with excess potassium 
hydroxide in methanol, followed by acidification with methanolic HCl, resulted in 
ketal deprotection with concomitant aromatisation to afford resorcylate product 333 in 
an excellent 81% over the two steps. Ring-closing metathesis with Hoveyda-Grubbs’ 
second generation catalyst (197) was successful, constituting our first complete 
synthesis of the natural product, (S)-zearalenone (3) (Scheme 151).  
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Scheme 151. Summary of Successful (S)-Zearalenone (3) Synthesis. 
 
A second avenue of investigation178 has led to an improved procedure for acylation of 
dioxinones. Treatment of dioxinone analogue 339 with an acid chloride 340, followed 
by mild palladium-catalysed deallylation and decarboxylation of products 341, 
generated dioxinone analogues 342 in improved yields to the Muikayama procedures 
previously utilised (Scheme 152). 
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Scheme 152. Improved protocol for Dioxinone Analogues 342 Synthesis 
 
For example, following this procedure β-triketo ester equivalent 344 was synthesised 
from dioxinone analogues 339 and acid chloride 343 in excellent yields  
(Scheme 153). 
 
O O
OO
O O
339 343
TDSO O
Cl
+
344  (65% over two steps)
O O
O
O OHTDSO
i) MgCl2, pyr.
ii) Pd (PPh3)4, 
    morpholine
 
 
Scheme 153. Example of Dioxinone Analogue 344 Synthesis. 
 
With these two recent key discoveries in mind, our attention turned to improving our 
procedure and the possibility of performing an intramolecular dioxinone-opening 
macrolactonisation-aromatisation.  
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4.2 Investigations Towards An Intramolecular Macrolactonisation-
Aromatisation Procedure. 
 
During the aforementioned synthesis of (S)-zearalenone (3) (see Section 4.1.2), 
difficulties had initially been encountered during the RCM procedure. It was found 
that Grubbs’ second generation catalyst (196) was inactive in this system, which was 
attributed to the presence of phenol groups in the substrate.80 Eventually, the more 
robust Hoveyda-Grubbs’ second generation catalyst (197) (see Section 2.4.2, Figure 
16) had successfully provided (S)-zearalenone (3), but with an E/Z ratio of 85 : 15.  
 
It was hypothesised that reversing the order of the two key disconnections, metathesis 
and dioxinone pyrolysis, could result in improved overall efficiency. The modified 
retrosynthetic analysis envisaged thermolysis and intramolecular aromatisation of 
alcohol 346, through intermediate 345. It was anticipated the alcohol functionality 
would need to be masked during the alkylation of dioxinone analogue 339 with 
alkene 347. Alkene 347 could be made from cross-metathesis (CM) of a protected 
derivative of (S)-alcohol 93 and ethyl acrylate (349) (Scheme 154). 
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Scheme 154. Retrosynthetic Analysis of (S)-Zearalenone (3) Employing CM and Intramolecular 
Dioxinone Opening. 
 
 
4.2.1 Synthesis of Dioxinone Analogue 339.  
 
The synthesis of dioxinone analogue 339 commenced from allylic ester 351, which 
was formed from the opening of Meldrum’s acid (350)179 with allylic alcohol. 
Activation of ester 351 as the benzotriazole derivative 348 enabled acylation of 
dioxinone 316 to provide target 339 in good yield175 (Scheme 155).  
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Scheme 155. Reagents and conditions: i) allylic alcohol, 100 °C, 6 h, 62%; ii) 1H-benzotriazole, 
SOCl2, CH2Cl2, 23 °C, 4 h, 60%; iii) a) n-BuLi (4.0 eq.), HMDS (4.0 eq.), –78 °C, 30 min; 
b) 316 (4.0 eq.), –78 °C, 1.5 h; c) 348, –78 °C to 23 °C, 18 h, 65%.  
 
Acyl benzotriazole 348 was difficult to separate from dioxinone analogue 339 and 
also found to be partially hydrolysed upon column chromatography, which is reflected 
in the moderate isolated yields.  
 
4.2.2 Synthesis of the Acylation Partner  
 
Retrosynthetic analysis of acid chloride 347 proceeded via the activation of acid 352, 
which would be obtained from the hydrolysis of ester 353. This could be produced 
from CM of (S)-silyl ether 110 with ethyl acrylate (349) and in turn, (S)-silyl 
ether 110 would be formed from silyl protection of (S)-alcohol 93 (Scheme 156). 
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Scheme 156. Retrosynthetic Analysis of Acid Chloride 347. 
 
The  protection of (±)-alcohol 93 to hand as a TBS ether was first investigated. It was 
found that standard conditions of TBSCl with imidazole catalysis failed, hence 
Corey’s improved protocol using TBS-triflate and 2,6-lutidine180 was attempted and 
found to be a considerable improvement, yielding 86% of (±)-silyl ether 110 (Scheme 
157).  
 
OOOH
(±)-93
OOOTBSi)
(±)-110
 
 
Scheme 157. Reagents and conditions: i) TBSOTf, 2,6-lutidine, CH2Cl2, 23 °C, 20 min, 86%. 
 
Intermolecular metathesis of olefins has long been regarded as inferior to 
intramolecular procedures, however the evolution of new catalysts has allowed 
improvement of the selectivity and efficiency of CM procedures.181 The major 
drawback of CM is the competing dimerisation or self-metathesis reactions, which 
cause by-products and lowered yields. 
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The field of CM has been revolutionised by the advent of Grubbs’ and Hoveyda-
Grubbs’ second generation catalysts (196 and 197, see Section 2.4.2, Figure 16), 
which are tolerant to conjugated electron-deficient olefins. These olefins exhibit an 
extremely slow rate of dimerisation, meaning that they are able to be used in excess as 
cross-coupling partners, resulting in increased selectivity for the crossed product.  
 
Grubbs and co-workers observed that CM reactions between α,β-unsaturated esters, 
aldehydes and ketones with simple terminal olefins proceeded in excellent yields with 
impressive E-selectivity. For example, CM of ethyl acrylate (349) and alkene 354 
generated alkene 355 with and E/Z ratio of 4.5 : 1, one of the lower selectivities 
reported amongst the examples (Scheme 158).182 
 
OBz
7
OBz
7
CO2Et+
i)
354 355349
O
OEt
 
 
Scheme 158. Reagents and conditions: i) Grubbs’ II (196) (5 mol%), CH2Cl2, 45 °C, 91%, E/Z 4.5 : 1.  
 
With this in mind, the cross-metathesis of (±)-silyl ether 110 with ethyl acrylate (349) 
was attempted, following Grubbs’ protocol.182 To our delight, spot-to-spot conversion 
was observed and alkene ester 353 was isolated in 77% yield. Furthermore, 
alkene 353 was observed to have an alkene coupling constant of 15.5 Hz and no 
evidence of the cis-isomer could be detected (Scheme 159).   
 
OOOTBS OOOTBSi) O
OEt
353(±)-110
 
 
Scheme 159. Reagents and conditions: i) 349, Hoveyda-Grubbs’ II (197) (5 mol%), CH2Cl2, 45 °C, 
2.5 h, 77%, E/Z  >99 : 1. 
 
Saponification of ester 353 with sodium hydroxide yielded acid 352, however 
subsequent attempts to activate the acid as an imidazole derivative resulted in a 
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mixture of products. The desired product 357 and product 358 resulting from 
conjugate addition, were both indicated by crude MS and 1H NMR analysis  
(Scheme 160).  
 
353 352
OOOTBSi) O
OH
OOOTBS O
OEt
OOOTBS O
Im
OTBS O
Im
O
+
Imii) or iii)
357 358
 
 
Scheme 160. Reagents and conditions: i) 2.0 M NaOH, EtOH, 18 h, 78%; ii) CDI (1.5 eq.), DMAP, 
CH2Cl2, 23 °C, 3 h; iii) EDC·HCl (1.1 eq.), Imid. (1.0 eq.), DMF, 23 °C, 72 h. 
 
At this time, the supply of material was exhausted. During the re-synthesis of 
materials it was decided to replace the TBS ether with the more robust TIPS group. 
This was due to observations within our group that TBS ethers were prone to 
deprotection during the conditions employed for dioxinone analogue 339 
alkylation.178 
 
The analogous TIPS acid 362 was formed from (S)-alcohol 93 in three steps. Once 
again, excellent E-selectivity was observed during the CM of silyl ether 359 and ethyl 
acrylate (349). Curiously, difficulties were initially encountered during the 
saponification of ester 360 in ethanol, which were attributed to solvent impurities. 
Switching to methanol as a solvent yielded firstly transesterification product 361, 
however it was discovered that was due to solubility problems and increasing the 
amount of methanol allowed formation of desired acid 362 in 96% (Scheme 161).  
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Scheme 161. Reagents and conditions: i) TIPSCl, Imid., CH2Cl2, 18 h, 23 °C, 99%;  ii) 349, Hoveyda-
Grubbs’ II (197) (5 mol%), CH2Cl2, 45 °C, 2.5 h, 78%, E/Z  >99 : 1; iii) 2.0 M NaOH, MeOH, 23 °C, 
18 h, 58%;  iv) 2 M aq. NaOH, MeOH, 23 °C, 18 h, 96%. 
 
With acid 362 in hand, various conditions for activation were investigated. Activation 
as the corresponding acid chloride 363 was first attempted as it was hoped the harder 
chloride ion nucleophile would have an increased preference for direct (1,2) over 
conjugate (1,4) addition. Activation as the Yamaguchi mixed anhydride 366183, 184 was 
also explored (Scheme 162, Table 21). 
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Scheme 162. Activation of Acid 362. 
 
Entry Reagents and conditions† Product(s)* 
1 
 
(COCl)2 (1.3 eq.), cat. DMF, CH2Cl2 363 : 364, 1 : 3 
2 (COCl)2 (1.0 eq.), CH2Cl2 363 : 362, 2 : 1 
3 SOCl2 (1.2 eq.), pyr. (0.1 eq.), CH2Cl2 Decomposition 
4 365 (2.5 eq.), Et3N (3.0 eq.), THF 366, excess 365 
5 365 (1.0 eq.), Et3N (1.2 eq.), THF 366 : 362, 2 : 1 
 excess 365 
 
Table 21 
† 
reactions carried out at 23 °C for 3h; *products determined by crude MS + 1H NMR analysis. 
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Excess oxalyl chloride with catalytic DMF resulted in partial ketal deprotection to 
generate acid chloride 364 under the acidic conditions (Table 21, Entry 1). Reduction 
in the number of oxalyl chloride equivalents and removal of DMF resulted in clean 
acid chloride 363 formation, however starting acid 362 remained and acid 
chloride 363 was not stable to the purification methods attempted (Entry 2). Thionyl 
chloride with catalytic pyridine resulted in a complex mixture of products (Entry 3).  
 
Conversion to the Yamaguchi mixed anhydride 366 was successful, however excess 
Yamaguchi acid chloride 365 remained (Entry 4). Reducing the number equivalents 
of acid chloride 365 led to a mixture of starting material 362 and product 366, which 
was chromatographed on silica to yield mixed anhydride 366 in approximately 90% 
purity. It was decided to attempt the acylation of ester 339 with this material and try 
to isolate the acylation product, dioxinone analogue 368. 
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4.2.3 Acylation of Dioxinone Analogue 339 with Mixed Anhydride 366 
 
The conditions for the alkylation of dioxinone analogue 339 required pre-treatment of 
the dioxinone with pyridine and magnesium chloride to form magnesium enolate 367. 
Mixed anhydride 366 was then added and gratifyingly, after 3 h crude MS analysis 
showed the correct mass of product dioxinone analogue 368 as a major product 
(MS (ESI+) m/z 679 [M+H]+, 701 [M+Na]+, Scheme 163).  
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Scheme 163. Reagents and conditions: i) a) MgCl2 (1.1 eq.), pyr. (2.1 eq.), 0 °C, 30 min, b) 366, 
23 °C, 3 h. 
 
Regrettably, due to time constraints the synthesis could not be completed. This work 
is currently being finished by others within the Barrett group.  
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4.3 Future Work 
 
To complete this synthesis of (S)-zearalenone (3), four steps remain after the 
purification of dioxinone analogue 368: firstly decarboxylation under palladium 
catalysis, which has already been proven on similar substrates,178 to form dioxinone 
analogue 369 and then deprotection of the ketal and silyl groups to afford alcohol 346. 
Finally, the key intramolecular macrolactonisation-aromatisation of alcohol 346 to 
provide the natural product target can be tested (Scheme 164).  
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Scheme 164. Remaining Steps to Synthesise (S)-Zearalenone (3). 
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Once completed, this route will prove whether the overall procedure is preferable with 
CM followed by macrolactonisation-aromatisation, or with intermolecular 
esterification-aromatisation followed by RCM. One point of note from this synthetic 
route is the advantageous complete E-selectivity (E/Z ratio of >99 : 1) observed in the 
CM of alkene 359 with ethyl acrylate (349), compared with the E/Z ratio of 85 : 15 
from the RCM procedure of diene 333 (see Scheme 151). 
 
The CM yields were 77% and 78% for silyl ethers (±)-110 and 359 respectively, 
which are comparable with the RCM yield of 71%. Therefore, any improvement to 
the previously observed 81% yield of the intermolecular esterification-aromatisation 
of dioxinone analogue 335 and (S)-alcohol 93 (Scheme 151), will prove the 
intramolecular lactonisation-aromatisation a superior route.  
 
More significantly, if the intramolecular lactonisation-aromatisation reaction is 
successful, this will pave the way for other resorcylate syntheses utilising a variety of 
different methods to build up the macrocyclic portion. For example, we envisage that 
the use of palladium couplings, Wittig reactions or other carbon-carbon bond forming 
chemistry will be compatible with this new methodology. This is illustrated by our 
proposed synthesis of monocillin I (4a) and radicicol (4b) (Scheme 165). 
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Scheme 165. Proposed Synthesis of Monocillin I (4a) and Radicicol (4b) 
 
 
Radicicol (4b) can be prepared from monocillin I (4a) by chlorination.80 
Disconnection of monocillin I (4a) via our late-stage intramolecular lactonisation-
aromatisation procedure would give alcohol 370, which could come from acylation of 
previously prepared dioxinone analogue 339 with protected alcohol 371. This in turn 
can be derived from a palladium cross-coupling of bromide 372 with 
organoborane 373. Organoborane 373 can be formed from aldehyde 374 by firstly 
homologation to an alkyne (Corey-Fuchs) and then hydroboration.  
 
 183 
4.4 General Conclusions 
 
Although our initial strategies towards the synthesis of (S)-zearalenone (3) discussed 
in Chapters 2 and 3 were unsuccessful (Scheme 166), they demonstrated the level of 
control necessary for the aromatisation of β-triketo esters and the dependence upon 
the nature of the aromatisation substrate on the outcomes. 
 
O
OH O
3
O
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O
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O
O O
O
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conditions
 
 
Scheme 166. Initial Unsuccessful Strategy for the Synthesis of (S)-Zearalenone (3) 
 
Our revised dioxinone strategy discussed in this chapter has finally accomplished a 
selective aromatisation, with resorcylate 333 being formed from β-triketo ester 
precursor 338 in excellent yield (81% over two steps). This result clearly 
demonstrated the feasibility of late-stage aromatisation as a strategy for resorcylate 
synthesis and allowed synthesis of the natural product (S)-zearalenone (3)  
(Scheme 167). 
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Scheme 167. Successful Selective Resorcylate Synthesis.177 
 
An improved method of generating dioxinone analogues 342, β-triketo ester 
equivalents and aromatisation precursors to resorcylates 18, has also been developed. 
Dioxinone analogue 339, which is available in three steps from commercial materials, 
can be acylated with activated acid derivates such as acid chlorides 340. The product 
allyl esters 341 can then be decarboxylated with palladium to generate targets 342 
(Scheme 168).  
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Scheme 168. Successful Strategy for Resorcylate Synthesis. 
 
Our future aim is to optimise these reaction conditions further and to produce a 
general method which can be applied in resorcylate synthesis. One particular goal is 
to validate the potential intramolecular dioxinone analogue opening 
macrolactonisation-aromatisation reaction. It is hoped this will lead to an improved 
aromatisation protocol, compatible with a range of chemistry which will be used to 
synthesise resorcylate side-chains or macrocycles. 
 
As discussed in the introduction, before undertaking this work few aromatisations to 
form simple resorcylates had been employed in the literature, with the most recent 
reported being in 1988.62 Also, interest in these resorcylates has recently been 
rekindled by the discovery that some members of the RAL family are potent kinase 
inhibitors and inhibitors of the molecular chaperone Hsp90, thus may have potential 
applications in chemotherapy.14 We believe that our work will therefore provide a 
gateway to a new synthetic area and allow fast access to not only a range of natural 
products but also novel resorcylate derivatives.  
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Chapter Five:  
Experimental 
 187 
5.1 General Procedures 
 
5.1.1 Instrumental Procedures 
 
Melting points: obtained using a Reichert-Thermovar melting point apparatus and are 
uncorrected.  Infrared spectra: obtained using a Mattson 5000 FTIR apparatus with 
automatic background subtraction. Indicative features of each spectrum are given with 
adsorptions (νmax) reported in wavenumbers (cm-1). Samples were prepared on sodium 
chloride plates. Proton magnetic resonance spectra (1H NMR): recorded at 300 or 
400 MHz on Bruker DRX-300 or Bruker DRX-400 spectrometers respectively, or at 
500 MHz on a Bruker AM 500 spectrometer. Chemical shifts (δ) are quoted in parts 
per million (ppm) and referenced to the residual solvent peak (7.26 ppm for CDCl3).  
Coupling constants (J) recorded in Hertz (Hz) and quoted to the nearest 0.5 Hz.  
Carbon magnetic resonance spectra (13C NMR): recorded at 75 or 100 MHz on 
Bruker DRX-300 or Bruker DRX-400 spectrometers respectively, or at 125 MHz on a 
Bruker AM 500 spectrometer.  Chemical shifts (δ) are quoted in ppm and referenced 
to the residual solvent peak (77.0 ppm for CDCl3).  Spectra recorded at 500 MHz 
(1H NMR) and 125 MHz (13C NMR) were carried out by the Imperial College 
Department of Chemistry NMR Service. Gas chromatography mass spectrometry 
(GCMS): recorded on a Hewlett-Packard 5890 series 2 gas chromatograph.  Mass 
spectrometry: low and high resolution mass spectra (EI, CI, ESI) were recorded by 
Imperial College Mass Spectrometry Service using a Micromass Platform II and 
Micromass AutoSpec-Q spectrometer. Microanalysis:  determined by the University 
of North London Analytical Service. Optical Rotations: recorded at 25 °C on a 
Perkin-Elmer 241 Polarimeter with a path length of 1 dm, using the 589.3 nm D-line 
of sodium. Concentrations (c) are quoted in g/100 mL. X-ray Diffraction: X-ray 
diffraction data were recorded by the Imperial College Department of Chemistry 
X-ray diffraction service.  
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5.1.2 General Experimental Procedures 
 
Reaction Procedures: All reactions were carried out in flame-dried or oven-dried 
glassware in an atmosphere of dry nitrogen or argon unless otherwise stated. For the 
purpose of this thesis, ambient temperature was taken as 23 °C where no external 
heating or cooling was applied and temperatures other than this were recorded as the 
bath temperature unless otherwise stated. Prolonged periods of vessel cooling were 
attained by the use of CryoCool apparatus.  Solvents and reagents: All solvents and 
reagents were obtained from commercial suppliers and used without further 
purification unless otherwise stated.  The following reaction solvents were distilled 
under nitrogen: Et2O and THF from sodium benzophenone ketyl; PhMe from sodium; 
CH2Cl2 and Et3N from CaH2. MeOH was dried by refluxing over magnesium turnings 
and iodine, followed by distillation from CaH2 under nitrogen.  H2O refers to distilled 
H2O. Chromatography: Flash column chromatography was performed using BDH 
silica gel 60, particle size 40-63 mm unless otherwise stated. Thin layer 
chromatography (TLC) was performed on pre-coated aluminium backed or glass 
backed plates (Merck Kieselgel 60 F254), visualisation was accomplished by either UV 
light (254 nm) or chemical staining using basic potassium permanganate (KMnO4), or 
acidic vanillin stains as deemed appropriate. 
 
5.1.3 Conventions Adopted in Experimental Section 
 
All compounds reported herein are either novel or are known compounds which have 
been synthesised by modification of the literature experimental procedure. In the latter 
case, these have been referenced and the data obtained is consistent with the literature. 
Reported compounds are in sequential, rather than numerical order, to help readers 
follow the synthetic pathway. All compounds have been reported according to the 
J. Org. Chem. format. In cases where diastereoisomeric/regioisomeric compounds 
were observed, judgement was used to either report signals for the major isomer, the 
entire mixture of isomers or each isomer separately, depending upon the ease of 
analysis. 
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(±)-10-Hydroxyundec-1-en-6-one (94)84 
 
HO
O
 
 
 
To a suspension of Mg powder (2.45 g, 101 mmol) in Et2O (100 mL) was added two 
crystals of I2 and the resultant mixture was sonicated for 10 min before heating to 
60 °C, at which point the reaction mixture turned from brown to colourless. 5-Bromo-
1-pentene (12.0 mL, 101 mmol) was added dropwise and after a further 1 h at 60 °C, 
the reaction mixture was cooled to 23 °C. The resulting crude 4-pentenyl magnesium 
bromide (96) solution was transferred via canula to a solution of δ-hexanolactone (47) 
(13.3 g, 92.3 mmol) in THF (200 mL) at −78 °C and the ensuing reaction mixture was 
stirred for 2 h at that temperature before quenching by addition of sat. aq. NH4Cl (60 
mL) and H2O (100 mL). The aqueous layer was extracted with Et2O (3 × 100 mL) and 
the combined organic extracts washed with H2O (2 × 50 mL) and dried (Na2SO4). 
Concentration in vacuo afforded (±)-alcohol 94 (16.5 g) as a pale yellow oil which 
was used in the next step without purification: Rf  0.50 (EtOAc : hexanes, 1 : 1); IR 
(film) νmax 3444, 1732, 1711, 1068 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 1.19 (d, J = 6.0 Hz, 3H, CH3), 1.39 − 1.99 (m, 6H, CH2), 2.02 − 2.10 (m, 2H, 
CH2CH=CH2), 2.39 − 2.48 (m, 4H, CH2CO), 3.74 − 3.80 (m, 1H, CHOH), 
4.96 − 5.04 (m, 2H, CH2=CH), 5.74 − 5.79 (m, 1H, CH=CH2); 13C NMR (100 MHz, 
CDCl3) δ 19.7, 22.8, 23.4, 29.6, 33.1, 38.6, 42.6, 67.5, 115.2, 138.0, 211.3; MS (CI) 
m/z 185 [M+H]+, 202 [M+NH4]+; HRMS (CI) m/z calculated for C11H21O2 [M+H]+; 
185.1542, found: 185.1546. 
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Acetic acid 1-methyl-5-oxodec-9-enyl ester (98) 
 
O
O
O
 
 
A mixture of crude (±)-10-hydroxyundec-1-en-6-one (94) (5.0 g, 27 mmol), acetic 
anhydride (30 mL) and pyridine (30 mL) was heated to 60 °C. After 24 h the reaction 
mixture was cooled to 0 °C, quenched by addition of MeOH (40 mL) and 
concentrated in vacuo. The residue was taken up in H2O (30 mL) and extracted with 
CH2Cl2 (3 × 50 mL). The combined organic extracts were washed with brine (30 mL) 
and dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 4) to afford ketone 98 (4.92 g, 71% over two 
steps) as a colourless oil:  Rf  0.30 (EtOAc : hexanes, 1 : 3); IR (film) νmax 2941, 1733, 
1451, 1372, 1247, 1019 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.13 (d, J = 7.0 Hz, 3H, 
CH3CH), 1.12 − 1.20 (m, 2H, CH2) 1.37 − 1.65 (m, 4H, CH2), 1.95 (s, 3H, CH3CO2R) 
1.97 − 2.01 (m, 2H, CH2), 2.31 − 2.34 (m, 4H, CH2CO), 4.04 (q, J = 7.0 Hz,  1H, 
CH3CH), 4.78 − 4.96 (m, 2H, CH=CH2), 5.62 − 5.75 (m, 1H, CH=CH2); 13C NMR 
(100 MHz, CDCl3) δ 19.4, 19.8, 21.3, 22.7, 33.0, 35.2, 41.8, 42.2, 70.8, 115.1, 137.9, 
170.6, 210.4; MS (CI) m/z 227 [M+H]+, 244 [M+NH4]+;  HRMS (CI) m/z calculated 
for C13H23O3 [M+H]+: 227.1647, found: 227.1647; Anal. calculated for C13H22O3: 
C, 68.99; H, 9.80; found: C, 68.89; H, 9.68%. 
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(±)-Acetic acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester (99) 
 
O
O
OO
 
 
To a solution of (±)-acetic acid 1-methyl-5-oxodec-9-enyl ester (98) (5.00 g, 
22.1 mmol) in benzene (150 mL) was added ethylene glycol (37.0 mL, 66.4 mmol) in 
one portion, followed by pTSA (556 mg, 2.92 mmol). The reaction mixture was 
heated to 90 °C under Dean-Stark phase-separating apparatus. After 18 h the reaction 
mixture was allowed to cool to 23 °C, diluted with EtOAc (100 mL), washed with sat. 
aq. NaHCO3 (2 × 80 mL) and dried (Na2SO4). Concentration in vacuo was followed 
by flash column chromatography (EtOAc : hexanes, 1 : 9) to afford ketal 99 (5.25 g, 
88%) as a colourless oil: Rf  0.45 (EtOAc : hexanes, 1 : 9); IR (film) νmax 1732, 1451, 
1371, 1245, 1042 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.18 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.33 − 1.72 (m, 10H, CH2), 2.06 (s, 3H, CH3CO2R) 2.36 − 2.40 (m, 2H, 
CH2), 3.90 (s, 4H, O(CH2)2O), 4.85 − 4.91 (m, 1H, CHCH3), 4.95 − 5.01 (m, 2H, 
CH=CH2), 5.67 − 5.86 (m, 1H, CH=CH2); 13C NMR (100 MHz, CDCl3) δ 19.7, 19.9, 
21.4, 23.1, 33.9, 36.5, 36.8, 42.3, 64.9 (2C), 70.8, 111.5, 114.5, 138.6, 170.8; MS (CI) 
m/z 271 [M+H]+, 288 [M+NH4]+;  HRMS (CI) m/z calculated for C15H27O4 [M+H]+: 
271.1909, found: 271.1900; Anal. calculated for C15H26O4: C, 66.64; H, 9.69; found: 
C, 66.53; H, 9.59%. 
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(±)-5-(2-Pent-4-enyl-[1,3]dioxolan-2-yl)-pentan-2-ol (93)84 
 
 
OH OO
 
 
 
To a solution of (±)-acetic acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl 
ester (99) (915 mg, 3.39 mmol) in MeOH (5 mL) was added aqueous KOH (3 M, 
8.00 mL, 24.0 mmol). The mixture was stirred at 23 °C for 3 h after which time the 
reaction was concentrated in vacuo. The residue was dissolved in CH2Cl2 (20 mL), 
washed with H2O (10 mL), brine (10 mL), then dried (Na2SO4). Concentration in 
vacuo was followed by flash column chromatography (EtOAc : hexanes, 1 : 2)  to 
afford (±)-alcohol 93 (816 mg, 98%) as a colourless oil: Rf  0.55 (EtOAc : hexanes, 
1 : 3); IR (film) νmax 3422, 1456, 1147, 1044, 911 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 1.15 (d, J = 6.0 Hz, 3H, CH3CH), 1.35 − 1.47 (m, 6H, CH2), 1.55 − 1.61 (m, 4H, 
CH2), 2.07 (app. q, J = 7.0 Hz, 2H, CH2CHOH), 2.39 (br. s, 1H, OH), 
3.79 − 3.85 (m, 1H, CH3CH), 3.94 (s, 4H, O(CH2)2O), 4.97 (dd, J  = 1.0, 10.0 Hz, 1H, 
CH=CH2), 5.03 (dd, J = 1.0, 17.0 Hz, 1H, CH=CH2), 5.82 (tdd, J = 6.0, 10.0, 17.0 Hz, 
1H, CH=CH2); 13C NMR (100 MHz, CDCl3) δ 20.0, 22.8, 23.1, 33.9, 36.6, 37.0, 39.4, 
65.0 (2C), 67.9, 111.7, 114.7, 138.7; MS (CI) m/z 229 [M+H]+, 246 [M+NH4]+; 
HRMS (CI) m/z calculated for C13H28NO3 [M+NH4]+: 246.2069, found: 246.2068.  
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(R)-Pent-4-en-2-ol (101)77 
 
 
OH
 
 
 
Following the procedure of Kalivretenos et al.,77 to a suspension of CuI (1.64 g, 
8.61 mmol) in THF at –30 °C was added a solution of vinylmagnesium bromide 
(1.0 M in THF, 86.0 mL, 86.0 mmol) dropwise. The resultant dark brown solution 
was stirred for 10 min before addition of (R)-propylene oxide (100) (4.0 mL, 
57.2 mmol) and allowed to warm slowly to 0 °C. After 18 h the reaction mixture was 
poured into a slurry of ice (100 g) and sat. aq. NH4Cl (100 mL) and stirred for 3 h 
after which time the reaction mixture had turned from brown to blue. The aqueous 
layer was extracted with Et2O (3 × 100 mL) and the combined organic extracts 
washed with sat. aq. NH4Cl (50 mL), H2O (50 mL) and dried (Na2SO4). 
Concentration in vacuo was followed by distillation to afford alcohol 101 (1.82 g, 
37%) as a colourless oil:  b.p. 102-8 °C, 760 mmHg [lit.,185 b.p. 115 °C, 746 mmHg]; 
Rf  0.30 (EtOAc : hexanes, 1 : 4); 1H NMR (300 MHz, CDCl3) δ 1.20 (d, J = 6.0 Hz, 
3H, CH3CH), 2.15 − 2.27 (m, 2H, CH2), 3.73 − 3.77 (m, 1H, CH3CH), 5.16 (m, 2H, 
CH2=CH), 5.85 − 5.90 (m, 1H, CH=CH2); 13C NMR (75 MHz, CDCl3) δ 22.8, 43.7, 
68.0, 118.1, 134.8.  
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(R)-4-(tert-Butyldimethylsilanyloxy)pent-1-ene (102)84 
 
OTBS
 
 
Following the procedure of Kalivretenos et al.,77 to a suspension of (R)-pent-4-en-2-ol  
(101) (4.18 g, 48.5 mmol), imidazole (7.93 g, 116 mmol) and DMAP (0.59 g, 4.83 
mmol) in DMF (100 mL) at 0 °C, was added TBSCl  (8.78 g, 58.2 mmol) portionwise. 
The reaction was allowed to warm to 23 °C and maintained at this temperature for 
18 h then diluted with H2O (100 mL). The aqueous layer was extracted with Et2O 
(3 × 100 mL) and the combined organic extracts washed with 1 M HCl (2 × 25 mL), 
then dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 30) to afford alkene 102 (5.04 g, 52%) as a 
colourless oil: Rf  0.75 (EtOAc : hexanes, 1 : 19); [α]D –6.5 (c 1.09, CH2Cl2) [lit.,77 
[α]D –8.4, (c 9.46, Et2O)];  IR (film) νmax 3079, 1472, 1376, 1255, 1131 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 0.06 (s, 6H, (CH3)2Si), 0.90 (s, 9H, C(CH3)3), 1.14 (d, 3H, 
J = 6.0 Hz, CH3CH), 2.18 − 2.21 (m, 2H, CH2), 3.84 − 3.86 (m, 1H, CH3CH), 
5.01 (dd, J = 15.5 Hz, 2.0 Hz, 2H, CH2=CH), 5.70 − 5.89 (m, 1H, CH=CH2); 13C 
NMR (75 MHz, CDCl3) δ −4.7, −4.5, 18.2, 23.4, 25.5 (3C), 44.3, 68.4, 116.5, 135.6; 
MS (CI) m/z 201 [M+H]+; HRMS (CI) m/z calculated for C11H25SiO [M+H]+: 
201.1677, found: 201.1679.  
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(R)-5-(tert-Butyldimethylsilanyloxy)hexanal  (103)84 
 
OTBS
H
O
 
 
Following the procedure of Fuerstner et al.,84 a suspension of Schwartz’s reagent186 
Cp2ZrHCl (5.00 g, 19.4 mmol) in CH2Cl2 (50 mL) was stirred for 20 min prior to 
addition of (R)-4-(tert-butyldimethylsilanyloxy)pent-1-ene (102) (1.94 g, 9.70 mmol) 
in PhMe (30 mL). The resulting yellow suspension was stirred for 18 h at 23 °C in the 
dark. tert-Butyl isocyanate (2.20 mL, 19.4 mmol) was then added dropwise, at which 
point the reaction mixture turned from yellow to colourless. After 3 h the reaction 
mixture was cooled to 0 °C and a solution of iodine (2.46 g, 9.70 mmol) in PhMe (20 
mL) was added. After 5 min the reaction mixture was quenched by addition of sat. aq. 
Na2S2O3 solution (150 mL). The mixture was filtered, the filtrate diluted with sat. aq. 
Na2CO3 (100 mL), extracted with CH2Cl2 (3 × 100 mL) and the combined organic 
extracts dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 30 → 1 : 20) to afford only aldehyde 103 
(469 mg, 21%) as a brown oil: Rf 0.50 (EtOAc : hexanes, 1 : 19);  
[α]D –0.9 (c 1.32, CH2Cl2);  IR (film) νmax 1728, 1254, 1140, 1061 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 0.04 (s, 6H, (CH3)2Si), 0.89 (s, 9H, (CH3)3C), 1.14 (d, J = 6.0 
Hz, 3H, CH3CH), 1.41 − 1.45 (m, 2H, CH2), 1.68 − 1.71 (m, 2H, CH2), 2.39 − 2.44 
(m, 2H, CH2CHO), 3.79 − 3.81 (m, 1H, CH3CH), 9.75 (s, 1H, CHO); 13C NMR 
(75 MHz, CDCl3) δ −4.8 (2C), 18.1, 18.3, 23.7 (3C), 26.3, 38.9, 43.9, 68.2, 202.7; 
MS (CI) m/z 231 [M+H]+, 248 [M+NH4]+; HRMS (CI) m/z calculated for C12H27SiO2 
[M+H]+: 231.1767, found: 231.1770.  
 
Note : This aldehyde product 103 is obtained from reaction with traces of H2O in the  
reaction solvent. Rigorous drying of the PhMe solvent enabled the desired nitrile 
product 108 to be isolated (see next Experimental).  
 196 
 
 
 
(R)-5-(tert-Butyldimethylsilanyloxy)hexanenitrile  (108)84 
 
 
OTBS
N
 
 
 
Following the procedure of Fuerstner et al.,84 a suspension of Schwartz’s reagent 
Cp2ZrHCl (1.94 g, 7.52 mmol) in PhMe (40 mL) was stirred for 20 min prior to 
addition of (R)-4-(tert-butyldimethylsilanyloxy)pent-1-ene (102) (600 mg, 
3.00 mmol). The resulting yellow suspension was stirred for 18 h at 23 °C in the dark. 
tert-Butyl isocyanate (471 µL, 7.52 mmol) was then added slowly and at which point 
the reaction mixture turned from yellow to colourless. After 3 h the reaction mixture 
was cooled to 0 °C and a solution of iodine (5.71 g, 11.0 mmol) in PhMe (40 mL) was 
added. After 5 min the reaction mixture was diluted with CH2Cl2 (100 mL) and 
washed with sat. aq. NaHSO3 (50 mL), followed by H2O (50 mL) and brine (50 mL) 
and then dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 30 → 1 : 20) to afford nitrile 108 (409 mg, 
60%) as a brown oil: Rf  0.55 (EtOAc : hexanes, 1 : 19); [α]D –16.7 (c 1.01, CH2Cl2) 
[lit.,84 [α]D –20.6 (c 2.46, CH2Cl2); IR (film) νmax 2359, 2245, 1254, 1139, 1020 cm-1; 
1H NMR (300 MHz, CDCl3) δ 0.06 (s, 6H, (CH3)2Si), 0.89 (s, 9H, (CH3)3C), 1.17 (d, 
J = 6.0 Hz, 3H, CH3CH), 1.70 − 1.74 (m, 2H, CH2), 1.76 − 1.87 (m, 2H, CH2), 2.39 (t, 
J = 7.0 Hz, 2H, CH2CN), 3.85 − 3.90 (m, 1H, CH3CH); 13C NMR (75 MHz, CDCl3) 
δ −4.3, −4.8, 17.3, 18.4, 21.7, 23.7, 25.9 (3C), 38.9, 67.6, 119.8; MS (CI) m/z 228 
[M+H]+, 245 [M+NH4]+; HRMS (CI) m/z calculated for C12H26NSiO [M+H]+: 
228.1770, found: 228.1774.  
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(R)-10-(tert-Butyldimethylsilanyloxy)undec-1-en-6-one  (109)84 
 
 
OTBS O
 
 
 
Following the procedure of Fuerstner et al.,84 to a solution of 
(R)-5-(tert-butyldimethylsilanyloxy)hexanenitrile (108) (405 mg, 1.78 mmol) in Et2O 
(5 mL) at 60 °C was added a solution of 4-pentenyl magnesium bromide (96) [freshly 
prepared from 5-bromo-1-pentane (680 µL, 5.73 mmol) and magnesium (147 mg, 
6.01 mmol) in Et2O (25 mL)]. After 4 h the reaction mixture was allowed to cool to 
23 °C and quenched by addition of sat. aq. NH4Cl (30 mL). The aqueous layer was 
extracted with Et2O (3 × 50 mL) and the combined organic extracts dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 30) to afford ketone 109 (392 mg, 74%) as a colourless oil: Rf  0.65 
(EtOAc : hexanes, 1 : 9); [α]D –9.5 (c 1.09, CH2Cl2) [lit.,84 [α]D –10.9 (c 1.54, 
CH2Cl2);  IR (film) νmax 3077, 1713, 1462, 1252, 1002 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 0.05 (s, 6H, (CH3)2Si), 0.89 (s, 9H, C(CH3)3), 1.12 (d, 3H, J = 6.0 Hz, 
CH3CH), 1.22 − 1.72 (m, 8H, CH2), 2.01 − 2.09 (m, 2H, CH2), 2.36 − 2.43 (m, 2H, 
CH2), 3.74 − 3.86 (m, 1H, CH3CH), 4.95 − 5.05 (m, 2H, CH2=CH), 5.76 (ddt, 
J = 17.0, 10.0, 7.0 Hz, 1H, CH=CH2); 13C NMR (75 MHz, CDCl3) δ −4.8, −4.4, 14.1, 
20.2, 23.7, 25.9 (3C), 31.6, 33.1, 39.1, 41.8, 42.9, 68.3, 115.1, 138.0, 210.9; MS (CI) 
m/z 299 [M+H]+, 316 [M+NH4]+; HRMS (CI) m/z calculated for C17H35SiO2 [M+H]+: 
299.2406, found: 299.2418.  
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(R)-5-[2-(4-tert-Butyldimethylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]pent-1-ene (110)84 
 
 
 
OTBS OO
 
 
 
Following the procedure of Fuerstner et al.,84 to a solution of 
(R)-10-(tert-butyldimethylsilanyloxy)undec-1-en-6-one (109) (319 mg, 1.06 mmol) in 
PhMe (50 mL) was added ethylene glycol (2.30 mL, 4.10 mmol), followed by  pTSA 
(13.1 mg, 0.05 mmol). The reaction mixture was heated to 120 °C under Dean-Stark 
phase-separating apparatus. After 18 h the reaction mixture was allowed to cool to 
23 °C, diluted with EtOAc (50 mL), washed with sat. aq. NaHCO3 (2 × 30 mL) and 
dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 30) to afford ketal 110 (102 mg, 28%) as a 
colourless oil: Rf  0.70 (EtOAc : hexanes, 1 : 9); [α]D −9.3 (c 1.10, CH2Cl2) ) [lit.,84 
[α]D –10.3 (c 1.12, CH2Cl2); IR (film) νmax 3077, 1462, 1254, 1002, 835 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 0.06 (s, 6H, (CH3)2Si), 0.90 (s, 9H, (CH3)3C), 1.13 (d, J = 
6.0 Hz, 3H, CH3CH), 1.26 − 1.71 (m, 10H, CH2), 2.05 − 2.07 (m, 2H, CH2), 
3.74 − 3.81 (m, 1H, CHCH3 ), 3.94 (s, 4H, O(CH2)2O), 4.98 (dd, J = 1.5, 10.0 Hz, 1H, 
CH=CH2), 5.03 (dd, J = 1.5, 17.0 Hz, 1H, CH=CH2), 5.82 (tdd, J = 7.0, 10.0, 17.0 Hz, 
1H, CH=CH2); 13C NMR (75 MHz, CDCl3) δ −4.7, −4.3, 18.2, 20.2, 23.2, 23.9, 25.9 
(3C), 34.0, 36.7, 37.3, 40.0, 65.0 (2C), 68.6, 111.7, 114.7, 138.7; MS (CI) m/z 343 
[M+H]+; HRMS (CI) m/z calculated for C19H39SiO3 [M+H]+: 343.2668, found: 
343.2663.  
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(R)-5-(2-Pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93)84 
 
 
 
OH OO
 
 
 
 
Following the procedure of Fuerstner et al.,84 to a solution of (R)-5-[2-(4-tert-
butyldimethylsilanyloxypentyl)-[1,3]dioxolan-2-yl]pent-1-ene (110) (91 mg, 
0.27 mmol) in THF (5 mL) was added TBAF (1.0 M in THF, 0.53 mL, 0.53 mmol). 
After 24 h the reaction mixture was concentrated in vacuo, the residue taken up in 
brine (10 mL) and extracted with Et2O (3 x 20 mL), then the combined organic 
extracts were dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 2) to afford (R)-alcohol 93 (42 mg, 68%) as a 
colourless oil: Rf  0.55 (EtOAc : hexanes, 1 : 3); [α]D –6.7 (c 1.22, CH2Cl2)  [lit.,84 
[α]D –6.8 (c 1.02, CH2Cl2); IR (film) νmax 3422, 1456, 1147, 1044, 911 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 1.15 (d, J = 6.0 Hz, 3H, CH3CH), 1.35 − 1.47 (m, 6H, CH2), 
1.55 − 1.61 (m, 4H, CH2), 2.07 (q, J =7.0 Hz, 2H, CH2CHOH), 2.39 (br. s, 1H, OH), 
3.79 − 3.85 (m, 1H, CH3CH), 3.94 (s, 4H, O(CH2)2O), 4.97 (dd, J  = 1.0, 10.0 Hz, 1H, 
CH=CH2), 5.03 (dd, J = 1.0, 17.0 Hz, 1H, CH=CH2), 5.82 (tdd, J = 6.0, 10.0, 17.0 Hz, 
1H, CH=CH2); 13C NMR (100 MHz, CDCl3) δ 20.0, 22.8, 23.1, 33.9, 36.6, 37.0, 39.4, 
65.0 (2C), 67.9, 111.7, 114.7, 138.7; MS (CI) m/z 229 [M+H]+, 246 [M+NH4]+; 
HRMS (CI) m/z calculated for C13H28NO3 [M+NH4]+: 246.2069, found: 246.2068.  
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(S)-5-(2-Pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93)   and 
 
(R)- 5-[2-(4-Acetoxypentyl)-[1,3]dioxolan-2-yl]pent-1-ene (99) 
 
 
OH OO
            
O OO
O
 
 
 
To a solution of (±)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)-pentan-2-ol (93) (2.40 g, 
10.5 mmol) and vinyl acetate (1.95 mL, 31.6 mmol) in hexane (50 mL) was added 
CAL-B (105 mg, 10 mol%) and the resultant mixture stirred under air at 35 °C for 
65 min. After this time the reaction was filtered, concentrated in vacuo and purified 
by flash column chromatography (EtOAc : hexanes, 1 : 8 → 1 : 2) to afford 
(S)-enriched alcohol 93 (1.30 g) and (R)-acetate 99 (1.30 g, 46%) as colourless oils. 
(S)-enriched alcohol 93 (1.30 g) was re-subjected to the reaction conditions for a 
further 3 h. After this time the reaction was filtered, concentrated in vacuo and 
purified by flash column chromatography (EtOAc : hexanes, 1 : 8 → 1 : 2) to afford 
(S)-alcohol 93 (989 mg, 41%) as a colourless oil. 
 
(R)-Acetate 99 : Rf  0.45 (EtOAc : hexanes, 1 : 9); [α]D –1.1 (c 1.05, CH2Cl2); 
IR (film) νmax 1732, 1451, 1371, 1245, 1042 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.18 
(d, J = 6.0 Hz, 3H, CH3CH), 1.33 − 1.72 (m, 10H, CH2), 2.06 (s, 3H, CH3CO) 
2.36 − 2.40 (m, 2H, CH2), 3.90 (s, 4H, O(CH2)2O), 4.85 − 4.91 (m, 1H, CH3CH), 
4.95 − 5.01 (m, 2H, CH=CH2), 5.67 − 5.86 (m, 1H, CH=CH2); 13C NMR (100 MHz, 
CDCl3) δ 19.7, 19.9, 21.4, 23.1, 33.9, 36.5, 36.8, 42.3, 64.9 (2C), 70.8, 111.5, 114.5, 
138.6, 170.8; MS (CI) m/z 271 [M+H]+, 288 [M+NH4]+; HRMS (CI) m/z calculated 
for C15H27O4 [M+H]+: 271.1909, found: 271.1900; Anal. calculated for C15H26O4: 
C, 66.64; H, 9.69; found: C, 66.53; H, 9.59%. 
 
(S)-Alcohol 93 is spectroscopically identical to (±)-alcohol 93 except: [α]D +6.9 
(c 1.19, CH2Cl2). 
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Benzoic acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester (126) 
 
 
 
O OO
O
 
 
 
 
A mixture of (±)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (86 mg, 0.38 
mmol), benzoyl chloride (131 µL, 1.13 mmol) and dry pyridine (2.0 mL) were stirred 
together at 23 °C. After 4 h MeOH (2.0 mL) was added dropwise and the reaction 
mixture concentrated in vacuo. The residue was redissolved in CH2Cl2 (10 mL), 
washed with H2O (5 mL) then brine (5 mL) and dried (Na2SO4). Concentration 
in vacuo was followed by flash column chromatography (EtOAc : hexanes, 6 : 94) to 
afford benzoyl ester 126 (115 mg, 92%) as a colourless oil: Rf  0.80  (EtOAc : hexanes, 
1 : 3); IR (film) νmax 3072, 1715, 1451, 1275, 1111, 1070, 712 cm-1; 1H NMR (400 
MHz, CDCl3) δ 1.36 (d, J = 6.0 Hz, 3H, CH3CH), 1.40 − 1.56 (m, 4H, CH2), 1.58 
− 1.70 (m, 4H, CH2), 1.71 − 1.83 (m, 2H, CH2), 2.04 (app. q, J = 6.5 Hz, 2H, 
CH2CH=CH2), 3.91 (s, 4H, O(CH2)2O), 4.92 − 5.04 (m, 2H, CH=CH2), 5.14 − 5.22 
(m, 1H, CH3CH), 5.79 (tdd,  J = 6.5, 10.0, 17.0 Hz, 1H, CH=CH2), 7.43 − 7.48 (m, 
2H, m-ArH), 7.54 − 7.59 (m, 1H, p-ArH), 8.04 − 8.08 (m, 2H, o-ArH); 13C NMR 
(100 MHz, CDCl3) δ 19.8, 20.1, 23.1, 33.9, 36.2, 36.5, 36.9, 65.0 (2C), 71.5, 83.9, 
111.5, 114.7, 128.3 (2C), 129.7 (2C), 132.7, 138.6, 166.2; MS (CI) m/z 333 [M+H]+, 
350 [M+NH4]+; HRMS (CI) m/z calculated for C20H32NO4 [M+NH4]+: 350.2318, 
found: 350.2316. 
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(R)-3,3,3-Trifluoro-2-methoxy-2-phenylpropionyl chloride (129)89 
 
 
 
OMeF3C
O
Cl
 
 
 
 
Following the procedure of Mosher et al.,89 to a solution of (R)-3,3,3-trifluoro-2-
methoxy-2-phenylpropionic acid (128) (500 mg, 2.14 mmol) in thionyl chloride 
(5 mL) was added NaCl (50 mg) and the resultant mixture stirred at 80 °C for 46 h. 
Concentration in vacuo afforded acid chloride 129 (540 mg, 100% by mass) which 
was used crude without further purification:  IR (film) νmax 1790, 1496, 1451, 1262, 
1173, 804 cm-1;  1H NMR (400 MHz, CDCl3)  δ 3.80 (s, 3H, CH3O), 7.47 − 7.52 (m, 
3H, ArH), 7.58 − 7.62, 2H, ArH); 13C NMR (100 MHz, CDCl3) δ 56.7, 89.1, 121.2, 
124.1, 126.9, 128.8 (2C), 130.6 (2C), 171.0. 
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(R,S)-3,3,3-Trifluoro-2-methoxy-2-phenylpropionic acid 1-methyl-4-(2-pent-4-
enyl-[1,3]dioxolan-2-yl)butyl ester  (130) 
 
 
 
O OO
O
F3C OMe
 
 
 
 
To a solution of (S)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (20 mg, 
0.09 mmol) in pyridine (1 mL) was added (R)-3,3,3-trifluoro-2-methoxy-2-
phenylpropionyl chloride (129) (67 mg, 0.26 mmol). After 18 h, GC analysis 
indicated complete alcohol consumption. The reaction mixture was concentrated 
in vacuo and crude analysis performed. A small sample was purified by flash column 
chromatography (EtOAc : hexanes, 1 : 9) to afford ester 130 as a colourless oil: 
Rf  0.70 (EtOAc : hexanes, 1 : 3); IR (film) νmax 3433, 2953, 2874, 1742. 1452, 1271, 
1169, 1123, 1019 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.36 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.40 − 1.70 (m, 10H, CH2), 2.05 (app. q, J = 7.0 Hz, 2H, CH2CHCH3), 3.58 
(s, 3H, CH3O), 3.87 − 3.92 (m, 4H, O(CH2)2O), 4.97 (dd, J = 2.0, 10.0 Hz, 1H, 
CH=CH2), 5.02 (dd, J = 2.0, 17.0 Hz, 1H, CH=CH2), 5.18 (qd, J = 6.0, 12.5 Hz, 1H, 
CH3CH), 5.80 (tdd, J = 6.7, 10.0, 17.0 Hz, 1H, CH=CH2), 7.39 − 7.44 (m, 3H, 
ArH), 7.54 − 7.57 (m, 2H, ArH); 13C NMR (100 MHz, CDCl3) δ 19.5, 19.8, 23.1, 
33.9, 35.7, 36.6, 36.7, 55.4, 64.9 (2C), 73.9, 111.4, 114.7, 122.0, 124.8, 127.3 (2C), 
128.4 (2C), 129.5, 132.6, 138.6, 166.1; MS (CI) m/z 444 [M+H]+, 464 [M+NH4]+; 
HRMS (CI) m/z calculated for C23H35F3NO5 [M+NH4]+: 462.2454, found: 462.2454.  
 204 
 
 
 
(S)-5-[2-(4-Acetoxypentyl)-[1,3]dioxolan-2-yl]pent-1-ene  (99) 
 
 
 
O OO
O
 
 
 
To a solution of (R)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (270 mg, 
1.18 mmol) and triphenylphosphine (787 mg, 3.0 mmol) in PhMe (10 mL) at –15 °C 
was added acetic acid (169 µl, 3.0 mmol), followed by DIAD (503 µL, 3.0 mmol) 
dropwise. The resultant mixture was allowed to warm slowly to 23 °C and stirred for 
72 h. Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 9) to afford (S)-acetate 99 (292 mg, 91%) as a colourless oil: 
 
(S)-Acetate 99 is spectroscopically identical to (R)-acetate 99 except: [α]D +1.1 
(c 1.12, CH2Cl2)   
 
 205 
 
 
 
(2-Ethoxycarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid ethyl ester  (139)187 
 
 
 
O
O
O
OOO
 
 
 
To a solution of diethyl 1,3-acetonedicarboxylate (92) (100 g, 494 mmol) and 
ethylene glycol (55.0 mL, 989 mmol) in PhMe (1 L) was added BF3·OEt2 (3.60 mL, 
29.3 mmol). The reaction mixture was heated to 120 °C under Dean-Stark phase-
separating apparatus. After 18 h the reaction mixture was allowed to cool to 23 °C 
and quenched by addition of sat. aq. NaHCO3 (100 mL). The aqueous layer was 
extracted with Et2O (3 × 500 mL) and the combined organic extracts dried (Na2SO4). 
Concentration in vacuo afforded diester 139 (79.0 g, 65% by mass) as a colourless oil 
which was used crude without further purification: Rf  0.30 (EtOAc : hexanes, 1 : 3); 
IR (film) νmax 1736, 1372, 1185 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.28 (t, J = 7.0 
Hz, 6H, CH3CH2), 2.96 (s, 4H, CH2), 4.03 (s, 4H, O(CH2)2O), 4.17 (q, J = 7.0 Hz, 4H, 
CH2CH3); 13C NMR (75 MHz, CDCl3)  δ 14.1 (2C), 42.2 (2C), 60.6 (2C), 65.2 (2C), 
106.8, 169.4 (2C); MS (CI) m/z 247 [M+H]+, 264 [M+NH4]+; HRMS (CI) 
m/z calculated for C11H19O6 [M+H]+: 247.1182, found: 247.1174.  
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Disodium-(2-carboxymethyl-[1,3]dioxolan-2-yl)acetate  (143)95 
 
+Na-O
O
O-Na+
OOO
 
 
 
To a solution of the crude (2-ethoxycarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid 
ethyl ester (139) (72.6 g, 295 mmol) in absolute EtOH (300 mL) at 80 °C was added a 
solution of sodium hydroxide (19.5 g, 487 mmol) in hot absolute EtOH (200 mL) over 
a 2 h period. The mixture was refluxed at 80 oC for 1 h, filtered hot through a glass 
sinter funnel and the precipitate washed with hot absolute EtOH (100 mL). The crude 
white powder was recrystallised from H2O/EtOH to afford disodium salt 143 (25.0 g, 
62% over 2 steps) as colourless blades: m.p. >250 oC; IR (nujol) νmax 3431, 3385, 
1562, 1405, 1041, 920 cm-1; 1H NMR (300 MHz, D2O) δ 2.53 (s, 4H, CH2), 3.86 
(s, 4H, O(CH2)2O); 13C NMR (75 MHz, D2O) δ 46.1 (2C), 64.6 (2C), 108.3, 
177.8 (2C).  
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1,4,8-Trioxa-spiro[4.5]decane-7,9-dione  (140)95 
 
 
 
O
OO 14
7
8
9
O O
 
 
 
Following the procedure of Bruchter et al.,95 to a solution of disodium-(2-
carboxymethyl-[1,3]dioxolan-2-yl)acetate (143) (23.0 g, 100 mmol) in CH2Cl2 
(500 mL) was added a solution of oxalyl chloride (17.0 mL, 200 mmol) in CH2Cl2 
(100 mL) portionwise over 30 min. The resulting suspension was refluxed at 50 °C 
for 2 h and filtered hot through a glass sinter funnel. The filtrate was concentrated 
in vacuo to one third of its volume and the resultant bright yellow solution heated to 
boiling, followed by saturation with petroleum ether and chilling. Anhydride 140 was 
obtained upon filtration and recrystallisation from CH2Cl2/petroleum ether gave 
colourless blades (11.7 g, 68%): m.p. 111−112 °C (CH2Cl2/petroleum ether) 
[lit.,95 112−113 °C (CHCl3/petroleum ether)]; IR (nujol) νmax 1821, 1776, 1266, 1056, 
950 cm-1; 1H NMR (300 MHz, CDCl3) δ 2.99 (s, 4H, CH2), 4.05 (s, 4H, O(CH2)2O); 
13C NMR (75 MHz, CDCl3) δ 40.9 (2C), 65.6 (2C), 103.5, 163.8 (2C); MS (CI) 
m/z 190 [M+NH4]+; HRMS (CI) m/z calculated for C7H12NO5 [M+NH4]+: 190.0715, 
found: 190.0710.  
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(2-Ethoxycarbonylmethyl-[1,3]dioxolan-2-yl)-acetic acid  (141)95 
 
 
O
O
OH
OOO
 
 
Method A 
 
Following the procedure of Bruchter et al.,95 solid 1,4,8-trioxa-spiro[4.5]decane-7,9-
dione (140) (9.88 g, 57.4 mmol) and absolute EtOH (6.70 mL, 11.5 mmol) were 
heated to 80 °C at which time all solids had dissolved. The resulting solution was 
gently refluxed at that temperature for 18 h. Concentration in vacuo was followed by 
flash column chromatography  (EtOAc : hexanes, 2 : 3) to afford carboxylic acid 141 
(12.4 g, 99%) as a colourless viscous oil. 
 
Method B 
To a solution of (2-ethoxycarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid ethyl 
ester (139) (2.00 g, 8.12 mmol) in EtOH (10 mL) at 0 °C was added a solution of 
potassium hydroxide (456 mg, 8.12 mmol) in H2O (20 mL) dropwise. The resultant 
yellow solution was allowed to warm to 23 °C. After 72 h the reaction mixture was 
concentrated in vacuo to one third of its volume, diluted with H2O (50 mL) and 
extracted with Et2O (3 × 15 mL). The aqueous layer was cooled to 0 oC and carefully 
acidified to pH 4.5 with 1 M HCl, then extracted with EtOAc (3 × 15 mL). The 
combined organic extracts were washed with brine (20 mL) and dried (Na2SO4). 
Concentration in vacuo afforded carboxylic acid 141 (991 mg, 56%), which was 
spectroscopically identical to that prepared by Method A: Rf  0.40 (EtOAc : hexanes, 
1 : 1); IR (film) νmax 3472, 1734, 1373, 1190, 1034, 952 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 1.17 (t, J = 7.0 Hz, 3H, CH3CH2), 2.84 (s, 2H, CH2CO2Et), 2.88 (s, 2H, 
CH2CO2H), 3.94 (s, 4H, O(CH2)2O) 4.03 (q, J = 7.0 Hz, 2H, CH2CH3), 8.76 (br. s, 
1H, CO2H); 13C NMR (75 MHz, CDCl3) δ 14.0, 42.1, 42.2, 61.4, 65.1 (2C), 106.8, 
169.4, 173.9; MS (CI) m/z 219 [M+H]+, 236 [M+NH4]+; HRMS (CI) m/z calculated 
for C9H18NO6 [M+NH4]+: 236.1134, found: 236.1136.   
 
Note : 32% of starting diester 139 was also obtained from the hydrolysis (Method B), 
therefore the yield based on starting material recovery is 88% . 
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(2-Chlorocarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid ethyl ester  (144)95 
 
 
 
O
O
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To a solution of (2-ethoxycarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid (141) 
(1.00 g, 4.59 mmol) in PhMe (15 mL) at 0 °C was added oxalyl chloride (1.20 mL, 
13.7 mmol) dropwise. The resulting solution was allowed to warm to 23 °C over 3 h. 
Concentration in vacuo afforded acid chloride 144 (1.04 g, >100% by mass) as a pale 
yellow oil which was used crude without further purification: Rf  0.25 (EtOAc : 
hexanes, 1 : 4); IR (film) νmax 1808, 1736, 1033, 951 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 1.23 (t, J = 7.0 Hz, 3H, CH3CH2), 2.78 (s, 2H, CH2CO2Et), 3.55 (s, 2H, 
CH2CO2Cl), 4.00 (s, 4H, O(CH2)2O), 4.12 (q, J = 7.0 Hz, 2H, CH2CH3); 13C NMR 
(75 MHz, CDCl3) δ 14.1, 42.2, 42.9, 60.9, 65.4 (2C), 105.9, 168.9, 169.4; MS (CI) 
m/z 236 [M(35Cl)]+, 238 [M(37Cl)]+, 254 [M(35Cl)+NH4]+; HRMS (CI) m/z calculated 
for C9H1335ClO5 [M]+: 236.1121, found: 236.1116.   
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[2-(2-Hydroxyethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester  (145) 
 
 
 
O
O
OH
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To a solution of (2-ethoxycarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid (141) 
(1.29 g, 5.90 mmol) in THF (10 mL) at 0 °C was added BH3·THF (1.0 M in THF, 
11.8 mL, 11.8 mmol) and the resultant solution stirred at 0 °C for a further 3 h. MeOH 
(20 mL) was added and the reaction allowed to warm to 23 °C and maintained for 2 h. 
Concentration in vacuo afforded alcohol 145 (1.18 g, 98% by mass) as a colourless oil 
which was used without further purification:  Rf  0.25 (EtOAc : hexanes, 1 : 1); 
IR (film) νmax 3454, 2980, 1732, 1372, 1213, 1113, 1039, 950 cm-1; 
1H NMR (400 MHz, CDCl3) δ 1.25 (t, J = 7.0 Hz, 3H, CH3CH2), 2.05 − 2.08 (m, 2H, 
CH2CH2OH), 2.78 (s, 2H, CH2CO2Et), 3.70 − 3.80  (m, 4H, O(CH2)2O), 
4.00 − 4.03 (m, 2H, CH2CH2OH), 4.17 (q, J = 7.0 Hz, 2H, CH2CH3); 13C NMR 
(100 MHz, CDCl3) δ 14.2, 39.0, 42.7, 58.6, 60.8, 64.8 (2C), 109.6, 169.3; MS (CI) 
m/z 205 [M+H]+, 222 [M+NH4]+; HRMS (CI) m/z calculated for C9H17O5 [M+H]+: 
205.1076, found: 205.1078. 
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[2-(2-Oxoethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester  (91)95 
 
 
O
H
OOO
O  
 
Method A 
 
Following the procedure of Fleet et al.,49 to a solution of triphenylphosphine (21.6 g, 
82.4 mmol) in CH2Cl2 (150 mL) was added finely powdered copper (I) chloride 
(4.00 g, 40.4 mmol). The resulting suspension was stirred for 15 min until the copper 
had dissolved, after which time a suspension of sodium borohydride (1.52 g, 
40.4 mmol) in EtOH (15 mL) was added. After 30 min the organic layer was 
separated, washed with H2O (3 × 50 mL) and dried (Na2SO4). Saturation with Et2O 
(200 mL) afforded colourless needles which were collected by filtration to afford 
bis(triphenylphosphine)copper (I) borohydride (18.3 g, 76%) which was used crude 
without further purification: m.p. 171−173 °C (CH2Cl2/Et2O) [lit.,49  172−174 °C]. 
 
To a suspension of freshly prepared bis(triphenylphosphine)copper(I) borohydride 
(2.57 g, 4.26 mmol) and triphenylphosphine (2.23 g, 8.52 mmol) in acetone (20 mL) 
was added crude (2-chlorocarbonylmethyl-[1,3]dioxolan-2-yl)acetic acid ethyl 
ester (144) (1.00 g, 4.26 mmol) in acetone (10 mL) at 23 °C. After 30 min the reaction 
mixture was filtered through a sinter funnel and the filtrate concentrated in vacuo. The 
crude product was triturated with cold Et2O to remove Ph3PO. Concentration of the 
filtrate in vacuo was followed by flash column chromatography (Et2O : PhMe, 1 : 9) 
to afford aldehyde 91 (816 mg, 88% over two steps) as a colourless oil. 
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Method B 
 
To a solution of oxalyl chloride (131 µL, 1.5 mmol) in CH2Cl2 (3 mL) at –78 °C was 
added DMSO (250 µL, 3.5 mmol) and the reaction stirred for 15 min before addition 
of [2-(2-hydroxyethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (145) (212 mg, 
1.04 mmol) in CH2Cl2 (1 mL). After 1 h at –78 °C, Et3N (832 µL, 6.0 mmol) was 
added, the solution allowed to warm to 23 °C over 1 h and then quenched by the 
addition of H2O (3 mL) and EtOAc (5 mL). The organic layer was separated and the 
aqueous phase back-extracted with EtOAc (3 × 5 mL). The combined organic extracts 
were then washed with brine (5 mL) and dried (Na2SO4). Concentration in vacuo was 
followed immediately by flash column chromatography (Et2O : PhMe, 1 : 9) to afford 
aldehyde 91 as a colourless oil (181 mg, 84% over two steps) which was 
spectroscopically identical to that prepared by Method A: Rf  0.55 (EtOAc : hexanes, 
1 : 1); IR (film) νmax 1731, 1372, 1190, 1034, 949 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 1.24 (t, J = 7.0 Hz, 3H, CH3CH2), 2.71 (s, 2H, CH2CO2Et), 2.96 (s, 2H, CH2CHO), 
3.94 − 3.97  (m, 4H, O(CH2)2O), 4.12 (q, J = 7.0 Hz, 2H, CH2CH3), 9.72 (s, 1H, 
CHO); 13C NMR (100 MHz, CDCl3) δ 14.0, 42.1, 50.3, 60.7, 65.1 (2C), 106.8, 169.3, 
199.6; MS (CI) m/z 203 [M+H]+, 220 [M+NH4]+; HRMS (CI) m/z calculated for 
C9H15O5 [M+H]+: 203.0919, found: 203.0914.  
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[2-(3,3-Dibromoallyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester  (156) 
 
 
 
O
O OO
Br
Br
 
 
 
 
To a suspension of triphenylphosphine (1.10 g, 4.21 mmol) in CH2Cl2 (6 mL) at 0 °C 
was added carbon tetrabromide (700 mg, 2.10 mmol). The mixture was stirred for 
30 min before the dropwise addition of [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic 
acid ethyl ester (91) (210 mg, 1.05 mmol) in CH2Cl2 (2 mL) and the resulting 
suspension was stirred for a further 48 h in the dark. Concentration in vacuo was 
followed by flash column chromatography (EtOAc : hexanes, 1 : 1) to afford 
dibromide 156 (285 mg, 77%) as a colourless oil: Rf  0.55 (EtOAc : hexanes, 1 : 1); IR 
(film) νmax 1737, 1371, 1242, 1037, 950 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.24 (t, 
J = 7.0 Hz, 3H, CH3CH2), 2.61 − 2.63 (m, 2H, CH2CH=CBr2), 2.64 (s, 2H, 
CH2CO2Et), 3.96 − 3.99 (m, 4H, O(CH2)2O), 4.11 (q, J = 7.0 Hz, 2H, CH2CH3), 6.44 
(t, J = 7.0 Hz, 1H, CH=CBr2); 13C NMR (100 MHz, CDCl3) δ 14.2, 41.4,  42.7, 60.7, 
65.2 (2C), 91.4, 107.8, 133.1, 168.9; MS (CI) m/z 357 [M(79Br)(79Br)+H]+, 359 
[M(79Br)(81Br)+H]+, 361 [M(81Br)(81Br)+H]+, 374 [M(79Br)(79Br)+NH4]+, 376 
[M(79Br)(81Br)+NH4]+, 378 [M(81Br)(81Br)+NH4]+; HRMS (CI) m/z calculated for 
C10H1879Br79BrNO4 [M+NH4]+: 373.9597, found: 373.9591; calculated for 
C10H1879Br81BrNO4 [M+NH4]+: 375.9577, found: 375.9576; calculated for 
C10H1881Br81BrNO4 [M+NH4]+: 377.9555, found: 377.9557; Anal. calculated for 
C10H14BrO4: C, 33.55; H, 3.94; found: C, 33.47; H, 3.87%. 
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(2- Prop-2-ynyl-[1,3]dioxolan-2-yl)acetic acid ethyl ester  (90) 
 
 
 
 
O
O OO H
 
 
 
 
 
Method A 
To a suspension of magnesium (320 mg, 13.2 mmol) in THF (10 mL) was added 
1,2-dibromoethane (0.25 mL, 2.90 mmol) and the reaction mixture was heated to 
70 °C at which point the reaction mixture turned from brown to colourless. [2-(3,3-
dibromoallyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (156) (2.30 g, 6.42 mmol) in 
THF (15 mL) was added dropwise and the temperature maintained at 70 °C for a 
further 1 h before cooling to 23 °C and quenching by the addition of sat. aq. NH4Cl 
(5 mL) and H2O (25 mL). The aqueous layer was extracted with CH2Cl2 (3 × 10 mL) 
and the combined organic extracts dried (Na2SO4). Concentration in vacuo was 
followed by flash column chromatography (EtOAc : hexanes, 1 : 9 → 1 : 3) to afford 
alkyne 90 (826 mg, 65%) as a colourless oil: 
     
Method B  
To a solution of (1-diazo-2-oxo-propyl)phosphonic acid diethyl ester (158) (268 mg, 
1.22 mmol and [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (91) 
(100 mg, 0.49 mmol) in THF (5 mL) at –78 °C was added sodium methoxide 
(2.45 mL, 0.5 M in THF, 1.22 mmol) and the reaction mixture was allowed to warm 
slowly to 23 °C. After 2 h, the reaction mixture was quenched by the addition of sat. 
aq. NH4Cl (2 mL) and diluted with H2O (20 mL). The aqueous layer was extracted 
with EtOAc (3 × 15 mL) and the combined organic extracts dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 9) to afford alkyne 90 (38 mg, 33%) as a colourless oil which was 
spectroscopically identical to that prepared by Method A.    
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Method C  
To a solution of TMS-diazomethane (181) (345 µL, 0.69 mmol) in THF (3 mL) at  
–78 °C was added dropwise n-BuLi (239 µL, 2.5 M in hexanes, 0.60 mmol). After 
30 min, [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (91) (93 mg, 
0.46 mmol) in THF (0.5 mL) was added and the resultant solution stirred at –78 °C 
for 1 h, then 0 °C for 1 h. Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 1 : 4)  to afford alkyne 90 (36 mg, 39%) as a 
colourless oil which was spectroscopically identical to that prepared by Method A:  
Rf  0.40 (EtOAc : hexanes, 1 : 1); IR (film) νmax 3283, 1455, 1129, 1082, 911 cm-1; 
1H NMR (300 MHz, CDCl3) δ 1.28 (t, J = 7.0 Hz, 3H, CH3CH2), 2.07 (t, J = 2.5 Hz, 
1H, C≡CH), 2.79 (d, J = 2.5 Hz, 2H, CH2C≡CH), 2.85 (s, 2H, CH2CO2Et), 
4.04 − 4.10 (m, 4H, O(CH2)2O), 4.17 (q, J = 7.0 Hz, 2H, CH2CH3); 13C NMR 
(75 MHz, CDCl3) δ 14.2, 28.7, 41.8, 60.7, 65.6 (2C), 70.5, 79.5, 107.7, 169.1; 
MS (CI) m/z 199 [M+H]+, 216 [M+NH4]+; HRMS (CI) m/z calculated for C10H18NO4 
[M+NH4]+: 216.1236, found: 216.1235; Anal. calculated for C10H14O4: C, 60.59; H, 
7.12; found: C, 60.49; H, 7.12%. 
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(1-Diazo-2-oxo-propyl)phosphonic acid dimethyl ester  (158)100 
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To a suspension of NaH (60% dispersion in mineral oil, 168 mg, 4.20 mmol) in PhMe 
(8 mL) and THF (2 mL) at 0 °C was added dimethyl (2-oxopropyl)phosphonate (165) 
(552 µL, 3.99 mmol) in PhMe (4 mL). After 1 h at 0–5°C, tosyl azide (177) [freshly 
prepared from tosyl chloride (828 mg, 4.20 mmol) and sodium azide (273 mg, 4.20 
mmol]104 in PhMe (4 mL) was added dropwise and the reaction mixture allowed to 
warm slowly to 23 °C. After 2 h, the reaction mixture was filtered through celite, 
concentrated in vacuo and purified by flash column chromatography (EtOAc : 
hexanes, 3 : 1) to afford azide 158 (737 mg, 96%) as a yellow oil:  Rf  0.20 (EtOAc); 
IR (film) νmax 2123, 1659, 1273, 1180, 1024 cm-1; 1H NMR (300 MHz, CDCl3) δ 2.10 
(s, 3H, COCH3), 3.69 (d, J = 12.0 Hz, 6H, P(OCH3)2);  13C NMR (75 MHz, CDCl3) 
δ 27.0, 53.5 (2C), 189.7; MS (CI) m/z 193 [M+H]+, 210 [M+NH4]+;  HRMS (CI) 
m/z calculated for C5H13N3PO4 [M+NH4]+: 210.0641, found: 210.0641.  
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(1-Diazo-2-oxo-propyl)phosphonic acid diethyl ester  (179)188 
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To a suspension of NaH (60% dispersion in oil, 168 mg, 4.20 mmol) in PhMe (8 mL) 
and THF (2 mL) at 0 °C was added diethyl (2-oxopropyl)phosphonate (178) (781 µL, 
4.00 mmol) in PhMe (4 mL). After 1 h at 0–5 °C, tosyl azide (177) [freshly prepared 
from tosyl chloride (828 mg, 4.20 mmol) and sodium azide (273 mg, 4.20 mmol]104 in 
PhMe (4 mL) was added dropwise and the reaction mixture allowed to warm slowly 
to 23 °C. After 2 h the reaction mixture was filtered through celite, concentrated in 
vacuo and purified by flash column chromatography (EtOAc : hexanes, 3 : 1) to 
afford azide 179 (792 mg, 90%) as a yellow oil: Rf  0.25 (EtOAc); IR (film) νmax 2122, 
1659, 1268, 1171, 1018 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.33 (t, J = 7.5 Hz, 6H, 
CH2CH3), 2.22 (s, 3H, COCH3), 4.15 (q, J = 7.5 Hz, 4H, CH2CH3); 13C NMR (75 
MHz, CDCl3) δ 16.1, 27.2, 63.4 (2C), 190.2; MS (CI) m/z 221 [M+H]+, 238 
[M+NH4]+; HRMS (CI) m/z calculated for C7H17N3PO4 [M+NH4]+: 238.0957, found: 
238.0961.  
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(2-Prop-2-ynyl-[1,3]dioxolan-2-yl)acetic acid methyl ester  (180) 
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To a solution of [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (91) 
(600 mg, 2.97 mmol) and K2CO3 (1.23 g, 8.91 mmol) in MeOH (50 mL) was added 
(1-diazo-2-oxo-propyl)-phosphonic acid dimethyl ester (158) (585 mg, 3.05 mmol). 
After 18 h the reaction mixture was diluted with Et2O (50 mL), washed with sat. aq. 
NaHCO3 (2 × 10 mL) and the organic layer dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc : hexanes, 1 : 9) to afford 
alkyne 180 (311 mg, 57%) as a colourless oil: Rf  0.30 (EtOAc : hexanes, 1 : 1); 
IR (film) νmax 3279, 1737, 1436, 1208, 1034 cm-1; 1H NMR (400 MHz, CDCl3) δ 2.04 
(t, J = 2.5 Hz, 1H, C≡CH), 2.73 (d, J = 2.5 Hz, 2H, CH2C≡CH), 2.82 (s, 2H, 
CH2CO2Me), 3.67 (s, 3H, CO2CH3), 3.98 − 4.04 (m, 4H, O(CH2)2O); 13C NMR 
(100 MHz, CDCl3) δ 28.6, 41.6, 51.8, 65.6 (2C), 71.9, 79.5, 107.6, 169.5; MS (CI) 
m/z 185 [M+H]+, 202 [M+NH4]+;  HRMS (CI) m/z calculated for C9H16NO4 
[M+NH4]+: 202.1079, found: 202.1077; Anal. calculated for C19H12O4: C, 58.69; 
H, 6.57; found: C, 58.49; H, 6.48%. 
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3-Oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid methyl ester  (186) 
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To a solution of MeOAc (1.00 mL, 12.7 mmol) in THF (20 mL) at –78 °C was added 
LDA (6.33 mL, 2.0 M in THF/heptane/ethyl benzene, 12.7 mmol) dropwise and the 
resultant solution stirred for 15 min before addition of (2-prop-2-ynyl-[1,3]dioxolan-
2-yl)acetic acid methyl ester (180) (776 mg, 4.22 mmol) in THF (10 mL). The 
reaction mixture was allowed to warm slowly to 23 °C over 4 h, then quenched with 
pH 7.0 buffer (30 mL), extracted with CH2Cl2 (3 × 25 mL). The combined organic 
extracts were washed with sat. aq. NH4Cl (10 mL), then dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 2)  to afford alkyne 186 (277 mg, 29%) as a pale yellow oil: Rf  0.30 
(EtOAc : hexanes, 1 : 1); IR (film) νmax 3280, 1744, 1719, 1439, 1327, 1029 cm-1; 
1H NMR (400 MHz, CDCl3) δ 2.05 (t, J = 2.5 Hz, 1H, C≡CH), 2.65 (d, J = 2.5 Hz, 
2H, CH2C≡CH), 3.06 (s, 2H, CH2CO(CH2)2O), 3.53 (s, 2H, C(O)CH2C(O)), 3.69 
(s, 3H, CO2CH3), 3.96 − 4.03 (m, 4H, O(CH2)2O); 13C NMR (100 MHz, CDCl3) 
δ 28.8, 49.0, 50.4, 52.3, 65.4 (2C), 70.9, 79.2, 107.9, 167.4, 199.3; MS (CI) m/z 227 
[M+H]+, 244 [M+NH4]+;  HRMS (CI) m/z calculated for C11H18NO5 [M+NH4]+: 
244.1185, found: 244.1182; Anal. calculated for C11H14O5: C, 58.40; H, 6.24;  
found: C, 58.48; H, 6.24%. 
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3-Oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid ethyl ester  (89)  
 
 
 
O
OO OO
 
 
 
To a solution of  N,N-diisopropylamine (3.58 mL, 25.3 mmol) in THF (10 mL) at  
–78 °C was added n-BuLi (2.5 M in hexanes, 10.1 mL, 25.3 mmol) and the resultant 
solution warmed to 23 °C for 15 min, recooled to –78 °C and MeOAc (2.01 mL, 25.3 
mmol) added. After 30 min, (2-prop-2-ynyl-[1,3]dioxolan-2-yl)acetic acid ethyl 
ester (90) (776 mg, 4.22 mmol) was added and the reaction allowed to warm to 23 °C 
slowly over 4 h. After this time, the reaction was quenched with pH 7.0 buffer 
(10 mL), extracted with CH2Cl2 (3 × 10 mL) and the combined organic extracts 
washed with sat. aq. NH4Cl (10 mL), then dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc : hexanes, 1 : 2)  to afford 
alkyne 89 (86 mg, 86%) as a yellow oil: Rf  0.30 (EtOAc : hexanes, 1 : 1); IR (film) 
νmax 3281, 1724, 1327, 1152, 1030, 951 cm-1;  1H NMR (300 MHz, CDCl3) δ 1.25 
(t, J = 7.0 Hz, 3H, CH2CH3), 2.05 (t, J = 2.5 Hz,  1H, C≡CH), 2.62, (d, J = 2.5 Hz, 
2H, CH2C≡CH), 3.04 (s, 2H, CH2CO(CH2)2O), 3.52 (s, 2H, C(O)CH2C(O)), 
3.95 − 4.05 (m, 4H, O(CH2)2O), 4.15 (q, J = 7.0 Hz, 2H, CH2CH3); 13C NMR 
(75 MHz, CDCl3) δ 14.2, 28.8, 49.0, 50.6, 61.3, 65.4, 65.6, 70.9, 79.2, 107.9, 171.7, 
199.5; MS (CI) m/z 241 [M+H]+, 258 [M+NH4]+;  HRMS (CI) m/z calculated for 
C12H17O5 [M+H]+: 241.1076, found: 241.1074. 
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3-Oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid tert-butyl ester  (187) 
 
 
 
O
OO OO
 
 
 
 
To a solution of t-BuOAc (2.13 mL, 16.3 mmol) in THF (40 mL) at –78 °C was 
added LDA (8.15 mL, 2.0 M in THF/heptane/ethyl benzene, 16.3 mmol) dropwise 
and the resultant solution stirred for 15 min before addition of (2-prop-2-ynyl-
[1,3]dioxolan-2-yl)acetic acid ethyl ester (90) (1.00 g, 5.43 mmol) in THF (10 mL). 
The reaction mixture was allowed to warm slowly to 23 °C over 4 h, then quenched 
with pH 7.0 buffer (50 mL), extracted with CH2Cl2 (3 × 25 mL). The combined 
organics were washed with sat. aq. NH4Cl (50 mL), then dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 3)  to afford alkyne 187 (1.00 g, 69%) as an orange oil: Rf  0.30 (EtOAc : 
hexanes, 1 : 1); IR (film) νmax 3281, 1716, 1414, 1325, 1150, 1029 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 1.45 (s, 9H, C(CH3)3) 2.05 (t, J = 2.5 Hz, 1H, C≡CH), 2.65 
(d, J = 2.5 Hz, 2H, CH2C≡CH), 3.04 (s, 2H, CH2CO(CH2)2O), 3.44 (s, 2H, 
C(O)CH2C(O)), 3.99 − 4.06 (m, 4H, O(CH2)2O); 13C NMR (75 MHz, CDCl3) δ 28.0 
(3C), 28.8, 48.9, 51.9, 65.5 (2C), 70.8, 79.3, 81.9, 107.0, 166.2, 199.8; MS (CI) 
m/z 269 [M+H]+, 286 [M+NH4]+; HRMS (CI) m/z calculated for C14H24NO5 
[M+NH4]+: 286.1654, found: 286.1654. 
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3-Oxo-3-phenylpropionic acid 1-methyl-4-(2-pent-4-enyl- 
[1,3]dioxolan-2-yl)butyl ester  (193) 
 
 
O
O
O
OO
 
 
 
 
Following the procedure of Bandgar and Uppalla,111 to a solution of  (±)-5-(2-pent-4-
enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (103 mg, 0.70 mmol) and ethyl 
benzoylacetate (192) (78 µL, 0.70 mmol) in PhMe (3 mL) was added Zn dust (20 mg)  
and the resulting suspension heated to 110 °C under a distillation condenser for 72 h.  
After this time, the reaction was cooled, filtered, concentrated in vacuo and purified 
by flash column chromatography (EtOAc : hexanes, 1 : 2) to afford β-ketoester 193 
(140 mg, 64%) as a pale yellow oil: Rf  0.80 (EtOAc : hexanes, 1 : 3); IR (film) 
νmax 3070, 1736, 1687, 1634, 1451, 1266, 1021 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 1.21 (d, J = 6.5 Hz, 3H, CH3CH), 1.30 − 1.61 (m, 10H, CH2), 2.09 (app. q, 
J = 7.0 Hz, 2H, CH2CH=CH2), 3.91 (s, 4H, O(CH2)2O), 3.97 (s, 2H, C(O)CH2C(O)), 
4.93 − 5.04 (m, 3H, CH=CH2 and CH3CH), 5.80 (tdd, J = 6.5, 10.0, 17.0 Hz, 1H, 
CH=CH2), 7.48 (t, J = 8.0 Hz, 2H, m-ArH), 7.59 (t, J = 8.0 Hz, 1H, p-ArH), 7.94 (d, 
J = 8.0 Hz, 2H, o-ArH); 13C NMR (100 MHz, CDCl3) δ 19.6, 19.8, 23.1, 33.9, 35.9, 
36.6, 36.8, 46.3, 64.9 (2C), 72.2, 111.5, 114.6, 128.5 (2C), 128.7 (2C), 133.6, 136.1, 
138.7, 167.2, 192.5; MS (CI) m/z 375 [M+H]+, 392 [M+NH4]+; HRMS (CI) 
m/z calculated for C22H34NO5 [M+NH4]+: 392.2437, found: 392.2445. 
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(R)-3-Oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid 1-methyl-4- 
(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester  (88) 
 
 
O
O O
O
O O
O
 
 
 
A mixture of 3-oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid ethyl ester (89) 
(200 mg, 0.88 mmol), (±)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) 
(500 mg, 2.2 mmol) and CAL-B (140 mg, 20% w/w) were heated together neat at 
45 °C for 5 days. After this time the reaction mixture was diluted with CH2Cl2 
(10 mL) and filtered through a sinter funnel. Concentration of the filtrate in vacuo was 
followed by flash column chromatography (Et2O : CH2Cl2 : petroleum ether, 5 : 5 : 1) 
to afford (R)-enriched enyne 88 (200 mg, 54%) as a pale yellow oil: Rf  0.55 (EtOAc : 
hexanes, 1 : 1); [α]D –1.7 (c 1.25, CH2Cl2);  IR (film) νmax 3279, 2952, 2893, 1738, 
1715, 1640, 1033 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.23 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.32 − 1.70 (m, 10H, CH2), 2.02 − 2.08 (m, 2H, CH2CH=CH2), 
2.20 − 2.25 (m, 1H, C≡CH), 2.66 (d, J = 2.5 Hz, 2H, CH2C≡CH), 3.06 (s, 2H, 
CH2COR), 3.53 (s, 2H, CH2(CO)2), 3.92 (s, 4H, O(CH2)2O), 4.00 − 4.07 (m, 4H, 
O(CH2)2O), 4.93 − 5.11 (m, 3H, CH=CH2 and CH3CH), 5.67 − 5.86 (m, 1H, 
CH=CH2); 13C NMR (75 MHz, CDCl3) δ 19.4, 19.6, 23.1, 28.9, 35.1, 35.9, 36.6, 36.9, 
49.0, 50.9, 65.0 (2C), 65.6 (2C), 70.9, 72.2, 79.3, 107.9, 111.4, 114.7, 138.7, 166.7, 
199.4; MS (CI) m/z 423 [M+H]+, 440 [M+NH4]+; HRMS (CI) m/z calculated for 
C23H38NO7 [M+NH4]+: 440.2648, found: 440.2648; Anal. calculated for C23H34O7: 
C, 65.38; H, 8.11; found: C, 65.29; H, 7.99%. 
 224 
 
 
 
(S)-3-Oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid 1-methyl-4- 
(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester  (88) 
 
 
 
O
O O
O
O O
O
 
 
 
 
 
To a solution of (S)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (1.28 g, 
5.60 mmol) and 3-oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid ethyl 
ester (89) (450 mg, 1.88 mmol) in PhMe (20 mL) was added Zn dust (25 mg, 
0.38 mmol)  and the resulting suspension heated to 110 °C under a distillation 
condenser for 72 h.  After this time the reaction was cooled, filtered, concentrated 
in vacuo and purified by flash column chromatography (Et2O : CH2Cl2 : petroleum 
ether, 5 : 5 : 1) to afford (S)-enyne 88 (537 mg, 68%). 
 
(S)-Enyne 88 is spectroscopically identical to (R)-enriched enyne 88 except: 
[α]D +3.40 (c 1.00, CH2Cl2) 
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2-(6-Bromo-hexyloxy)tetrahydropyran  (225)128 
 
 
 
O BrO
 
 
 
 
Following the procedure of Morimoto et al.,128 to a solution of 6-bromo-1-
hexanol (224) (9.60 g, 53.0 mmol) and 3,4-dihydropyran (9.67 mL, 106 mmol) in 
CH2Cl2 (40 mL) was added PPTS (1.33 g, 5.29 mmol). After 18 h, the reaction 
mixture was diluted with EtOAc (100 mL), washed with H2O (3 × 50 mL) and the 
organic layer dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 3 : 97) to afford bromide 225 (13.9 g, 99%) as a 
colourless oil: Rf  0.60 (EtOAc : hexanes, 1 : 9); IR (film) νmax 1451, 1351, 1127, 
1029, 980, 868 cm-1; 1H NMR (300 MHz, CDCl3) δ  1.39 − 1.90 (m, 14H, CH2), 
3.36 − 3.45 (m, 3H, CH2), 3.46 − 3.55 (m, 1H, CH2), 3.75 (dt, J = 9.5, 6.5 Hz, 1H 
CH2), 3.84 − 3.91 (m, 1H, CH2), 4.57 − 4.60 (m, 1H, CH(OR)2); 13C NMR (75 MHz, 
CDCl3) δ 19.7, 25.4 (2C), 28.0, 29.6, 30.8, 32.8, 34.0, 62.4, 67.4, 98.9; MS (CI) m/z 
263 [M(79Br)+H]+, 265 [M(81Br)+H]+, 282 [M(79Br)+NH4]+, 284 [M(81Br)+NH4]+;  
HRMS (CI) m/z calculated for C11H2579BrNO2 [M+NH4]+: 282.1055, found: 
282.1059; calculated for C11H2581BrNO2 [M+NH4]+: 284.1035, found: 284.1036. 
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2-Oct-7-ynyloxytetrahydropyran  (226) 128 
 
 
 
OO
H
 
 
 
 
Following the procedure of Morimoto et al.,128  to a suspension of sodium iodide 
(22.3 g, 149 mmol) in DMSO (150 mL) at 23 °C was added lithium acetylide ethylene 
diamine complex (5.48 g, 59.5 mmol) portionwise. After 15 min, 2-(6-bromo-
hexyloxy)tetrahydropyran (225) (13.1 g, 49.6 mmol) in DMSO (50 mL) was added 
dropwise and the resulting dark brown suspension was stirred for a further 4 h before 
cooling to 0 °C and quenching by the addition of H2O (500 mL). The reaction was 
extracted with EtOAc : hexanes, 1 : 3 (3 × 150 mL) and the combined organic extracts 
were washed with brine (3 × 100 mL), then dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc : hexanes, 2 : 98) to afford 
alkyne 226 (8.33 g, 80%) as a colourless oil: Rf  0.70 (EtOAc : hexanes, 1 : 9); 
IR (film) νmax 3299, 1454, 1352, 1128, 1073, 1030, 868 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 1.31 − 1.85 (m, 14H, CH2), 1.96 (t, J = 2.5 Hz, 1H, C≡CH), 2.20 (td, 
J = 7.0, 2.5 Hz, 2H, CH2C≡CH), 3.36 − 3.44 (m, 1H, CH2), 3.47 − 3.55 (m, 1H, CH2), 
3.70 − 3.79 (m, 1H CH2), 3.84 − 3.93 (m, 1H, CH2), 4.57 − 4.61 (m, 1H, CH(OR)2); 
13C NMR (75 MHz, CDCl3) δ 18.3, 19.6, 25.5, 25.8, 28.4, 28.5, 29.6, 30.7, 62.2, 67.4, 
68.2, 84.5, 98.8; MS (CI) m/z 228 [M+NH4]+;  HRMS (CI) m/z calculated for 
C13H26NO2 [M+NH4]+: 228.1964, found: 228.1970.  
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Oct-7-yn-1-ol  (227)189 
 
 
 
HO
H
 
 
 
 
 
To a solution of 2-oct-7-ynyloxytetrahydropyran (226) (8.28 g, 39.4 mmol) in EtOH 
(200 mL) was added pTSA (15.0 g, 78.8 mmol) portionwise. The resulting solution 
was stirred at 23 °C for 45 min and then concentrated in vacuo. The residue was 
dissolved in sat. aq. NaHCO3 (100 mL), extracted with CH2Cl2 (3 × 50 mL) and the 
combined organic extracts dried (Na2SO4). Concentration in vacuo was followed by 
flash column chromatography (EtOAc : hexanes, 15 : 85) to afford alcohol 227 
(4.91 g, 99%) as a colourless oil: Rf 0.45  (EtOAc : hexanes, 1 : 3); IR (film) 
νmax 3300, 1462, 1433, 1055, 631 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.36 − 1.48 (m, 
5H, CH2 + OH), 1.50 − 1.65 (m, 4H, CH2), 1.97 (t, J = 2.5 Hz, 1H, C≡CH), 2.10 (td, 
J = 7.0, 2.5 Hz, 2H, CH2C≡CH),  3.67 (t, J = 7.0 Hz, 2H, CH2OH); 13C NMR 
(75 MHz, CDCl3) δ 14.1, 25.2, 28.4, 28.5, 32.4, 62.4, 68.3, 84.6; MS (CI) m/z 144 
[M+NH4]+; HRMS (CI) m/z calculated for C8H18NO [M+NH4]+: 144.1388, found: 
144.1385.  
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Hex-5-enoyl chloride  (229)190 
 
 
 
Cl
O
 
 
 
 
 
To a solution of 5-hexenoic acid (228) (7.73 g, 67.7 mmol) in CH2Cl2 (250 mL) was 
added oxalyl chloride (17.73 mL, 203 mmol) followed by DMF (1 drop). After 2 h the 
reaction mixture was concentrated in vacuo to afford acid chloride 229 (8.94 g, 100% 
by mass) as a pale yellow oil which was used crude without further purification: 
Rf  0.20 (EtOAc : hexanes, 1 : 9); IR (film) νmax 3077, 2866, 1799, 1640, 1405, 994, 
915 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.73 − 1.89 (m, 2H, CH2), 2.07 − 2.19 
(m, 2H, CH2CH=CH2), 2.85 − 2.95 (m, 2H, CH2CO), 4.97 − 5.11 (m, 2H, CH=CH2), 
5.62 − 5.84 (m, 1H, CH=CH2); MS (CI) m/z 150, 152 [M+NH4]+.  
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Hex-5-enoic acid oct-7-ynyl ester  (230) 
 
 
 
 
O
HO
 
 
 
 
 
To a solution of hex-5-enoyl chloride (229) (0.20 g, 1.51 mmol) and oct-7-yn-1-ol 
(227) (0.159 g, 1.26 mmol) in CH2Cl2 (5 mL) at 0 °C was added 
N,N-diisopropylethylamine (660 µL, 3.79 mmol) and the resulting reaction mixture 
was allowed to warm slowly to 23 °C. After 24 h, the reaction mixture was diluted 
with H2O (50 mL) and extracted with CH2Cl2 (3 × 25 mL). The combined organic 
extracts were then washed with brine (2 × 25 mL) and dried (MgSO4). Concentration 
in vacuo was followed by flash column chromatography (EtOAc, hexanes, 1 : 20) to 
afford ester 230 (305 mg, 92%) as a colourless oil: Rf  0.75 (EtOAc : hexanes, 1 : 9); 
IR (film) νmax 3299, 1732, 1457, 1169, 913 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 1.31 − 1.45 (m, 4H, CH2), 1.46 − 1.55 (m, 2H, CH2), 1.56 − 1.65 (m, 2H, CH2), 
1.65 − 1.76 (m, 2H, CH2), 1.93 (t, J = 2.5 Hz, 1H, C≡CH), 2.07 (app. q, J = 7.0 Hz, 
2H, CH2), 2.17 (td, J = 7.0, 2.5 Hz, 2H, CH2C≡CH), 2.29 (t, J = 7.5 Hz, 2H, 
CH2CO2R) 4.05 (t, J = 6.5 Hz, 2H, CH2OCOR), 4.94 − 5.05 (m, 2H, CH2=CH), 
5.69 − 5.83 (m, 1H, CH2=CH); 13C NMR (75 MHz, CDCl3) δ 18.3, 24.1, 25.5, 
28.3 (2C), 28.5, 33.1, 33.6, 64.3, 68.3, 84.4, 115.3, 137.7, 173.7; MS (CI) m/z 223 
[M+H]+, 240 [M+H]+; HRMS (CI) m/z calculated for C14H23O2 [M+H]+: 223.1698, 
found: 223.1703. 
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Hex-5-enoic acid 7-methylenenon-8-enyl ester  (231) 
 
 
 
 
O
O
 
 
 
 
 
To a solution of hex-5-enoic acid oct-7-ynyl ester (230) (35 mg, 158 µmol) in CH2Cl2 
(50 mL) with a slow stream of ethylene gas bubbled through, was added Grubbs’ 
second generation catalyst (196) (13 mg, 10 mol %). After 72 h, the reaction mixture 
was concentrated in vacuo and purified by flash column chromatography (EtOAc : 
hexanes, 2 : 98) to afford triene 231 (30 mg, 77%) as a colourless oil: Rf  0.85  (EtOAc 
: hexanes, 1 : 9); IR (film) νmax 3080, 1736, 1594, 1459, 1171 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 1.38 − 1.40 (m, 4H, (CH2)2), 1.52 (td, J = 7.5, 14.5 Hz, 2H, 
CH2), 1.62 − 1.68 (m, 2H, CH2), 1.75 (quint, J = 7.5 Hz, 2H, CH2), 2.11 (dd, J = 7.0, 
14.5 Hz, 2H, CH2), 2.23 (t, J = 6.5 Hz, 2H, CH2C(R)=CH2), 2.33 (t, J = 7.5 Hz, 2H, 
CH2CO2R), 4.09 (t, J = 7.0 Hz, 2H, CH2OCOR), 4.99 − 5.04 (m, 4H, CH2=CR2 and 
CH2=CHR), 5.07 (dd, J = 2.5, 11.0 Hz, 1H, CH2=CR-CH=CH2), 5.24 (dd, J = 2.5, 
17.5 Hz, 1H, CH2=CR-CH=CH2), 5.80 (tdd, J = 6.5, 10.0, 17.0 Hz, 1H, 
CH2CH=CH2), 6.39 (dd, J = 11.0, 17.5 Hz, 1H, CH2=CR-CH=CH2); 13C NMR 
(100 MHz, CDCl3) δ 24.1, 25.8, 28.0, 28.6, 29.2, 31.2, 33.6, 64.4, 113.1, 115.3, 
115.3, 115.6, 137.7, 139.0, 146.4, 173.7; MS (CI) m/z 251 [M+H]+, 268 [M+H]+; 
HRMS (CI) m/z calculated for C16H27O2 [M+H]+: 251.2011, found: 251.2007; 
Anal. calculated for C16H26O2: C, 76.75; H, 10.47; found: C, 76.69; H, 10.39%. 
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8-Methyleneoxacyclotetradec-6-en-2-one  (232) 
 
 
 
O O
 
 
 
 
To a solution of hex-5-enoic acid 7-methylenenon-8-enyl ester (231) (18 mg, 
81 µmol) in CH2Cl2 (50 mL) with a slow stream of argon bubbled through at 50 °C, 
was added Grubbs’ second generation catalyst (196) (6 mg, 10 mol %). After 72 h at 
this temperature, the reaction mixture was concentrated in vacuo and purified by flash 
column chromatography (EtOAc : hexanes, 2 : 98) to afford macrocycle 232 (16 mg, 
98%) as a colourless oil: Rf  0.75 (EtOAc : hexanes, 1 : 9); IR (film) νmax 2929, 1733, 
1454, 1175 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.28 − 1.35 (m, 2H, CH2), 1.38 
− 1.46 (m, 2H, CH2), 1.53 (quint, J = 7.0 Hz, 2H, CH2), 1.60 − 1.76 (m, 2H, CH2), 
1.87 − 1.94 (m, 2H, CH2), 2.20 − 2.27 (m, 4H, CH2), 2.34 − 2.39 (m, 2H, CH2), 4.16 
(t, J = 5.0 Hz, 2H, CH2OCOR), 4.87 (d, J = 2.0 Hz, 1H, C=CH2), 4.97 (d, J = 2.0 Hz, 
1H, C=CH2), 5.71 (td, J = 7.5, 15.5 Hz, 1H, C(=CH2)-CH=CHR); 6.07 (d, J = 15.5 
Hz, 1H, C(=CH2)-CH=CHR); 13C NMR (100 MHz, CDCl3) δ 22.8, 24.7, 26.4, 28.0, 
28.3, 30.5, 33.2, 63.7 (2C), 114.1, 128.3, 133.8, 146.4, 174.1; MS (CI) m/z 223 
[M+H]+, 240 [M+NH4]+; HRMS (CI) m/z calculated for C14H23O2 [M+H]+: 223.1698, 
found: 223.1700. 
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(S)-4-[2-(2-Methylenebut-3-enyl)-[1,3]dioxolan-2-yl]-3-oxobutyric acid 1-methyl-
4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester  (233) 
 
 
O
O O
O
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O
 
 
 
To a solution of (S)-3-oxo-4-(2-prop-2-ynyl-[1,3]dioxolan-2-yl)butyric acid 1-methyl-
4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester (88) (255 mg, 0.60 mmol) in CH2Cl2 
(1 L) with a slow stream of ethylene gas bubbled through, was added Grubbs’ second 
generation catalyst (51 mg, 10 mol %) in CH2Cl2 (5 mL), via syringe pump over 6 h. 
After a further 72 h the reaction was concentrated in vacuo and purified by flash 
column chromatography (EtOAc : hexanes, 1 : 9) to afford triene 233 (196 mg, 72%) 
as a colourless oil: Rf  0.65 (EtOAc : hexanes, 1 : 1); [α]D +2.9 (c 1.10, CH2Cl2); 
IR (film) νmax 3082, 1739, 1714, 1633, 1469, 1240, 1035, 908 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 1.25 (d, J = 6.0 Hz, 3H, CH3CH), 1.31 − 1.73 (m, 10H, CH2), 
2.06 (app. q, J = 6.5 Hz, 2H, CH2CH=CH2), 2.65 (s, 2H, CH2CR=CH2),  2.92 (s, 2H, 
CH2CO(CH2)2O),  3.53 (s, 2H, C(O)CH2C(O)), 3.93 (s, 4H, O(CH2)2O), 3.96 (s, 4H, 
O(CH2)2O), 4.91 − 5.12 (m, 3H, CH=CH2 and CH3CH), 5.04 − 5.13 (m, 2H, 
CH=CH2), 5.23 (d, J = 11.0 Hz, 1H, CH2=CR-CH=CH2); 5.34 (d, J = 17.5 Hz, 1H, 
CH2=CR-CH=CH2); 5.69 − 5.88 (m, 1H, CH2CH=CH2), 6.41 (dd, J = 17.5, 11.0 Hz, 
1H, CH2=CR-CH=CH2); 13C NMR (100 MHz, CDCl3) δ 19.8, 22.8, 23.1, 33.9, 36.6, 
36.9, 39.4, 41.9, 50.1, 50.9, 65.0 (2C), 65.1 (2C), 72.1, 109.4, 111.5, 114.4, 114.7, 
120.5, 138.7, 139.1, 141.0, 166.9, 200.2; MS (CI) m/z 451 [M+H]+, 468 [M+NH4]+;  
HRMS (CI) m/z calculated for C25H42NO7 [M+NH4]+: 468.2948, found: 468.2950; 
Anal. calculated for C25H38O7: C, 66.64; H, 8.50; found: C, 66.64; H, 8.44%. 
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(S)-11-Methyl-25-methylene-1,4,10,16,19-pentaoxadispiro 
[4.9.4.7]hexacos-23-ene-7,9-dione  (87) 
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To PhMe (150 mL) at 80 °C with a slow stream of argon bubbled through, were 
added both (S)-4-[2-(2-Methylenebut-3-enyl)-[1,3]dioxolan-2-yl]-3-oxobutyric acid 
1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester (233) (677 mg, 1.61 mmol) 
in PhMe (15 mL) and Grubbs’ second generation catalyst (196) (136 mg, 10 mol%) in 
PhMe (15 mL), via two separate syringe pumps over 10 h. After a  further 72 h at this 
temperature, the reaction mixture was concentrated in vacuo and purified by flash 
column chromatography (EtOAc : hexanes, 1 : 9) to afford macrocycle 87 (578 mg, 
85%) as a colourless oil: Rf  0.55 (EtOAc : hexanes, 1 : 1); [α]D +15.5 (c 1.13, 
CH2Cl2);  IR (film) νmax 2929, 1733, 1715, 1454, 1125, 1032 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 1.24 (d, J = 6.5 Hz, 3H, CH3CH), 1.28 − 1.70 (m, 10H, CH2), 
2.08 − 2.30 (m, 2H), 2.61 (AB q, J = 14.0 Hz, 1H, CH2CR=CH2), 2.74 
(AB q, J = 14.0 Hz, 1H, CH2CR=CH2), 2.80 (AB q, J = 14.0 Hz, 1H, 
CH2CO(CH2)2O), 3.14 (AB q, J = 14.0 Hz, 1H, CH2CO(CH2)2O), 3.44 (AB q, 
J = 15.5 Hz, 1H, C(O)CH2C(O)), 3.57 (AB q, J = 15.5 Hz, 1H, C(O)CH2C(O)), 
3.87 − 3.92 (m, 8H, O(CH2)2O × 2), 4.82 − 4.92 (m, 1H, CH3CH), 5.01 (d, J = 1.5 Hz, 
1H, C=CH2), 5.09 (d, J = 1.5 Hz, 1H, C=CH2), 5.71 (td, J = 7.5, 15.5 Hz, 1H, 
C(=CH2)-CH=CHR), 6.08 (d, J = 15.5 Hz, 1H, C(=CH2)-CH=CHR); 13C NMR 
(100 MHz, CDCl3) δ 20.5, 20.8, 23.1, 32.6, 34.8, 36.3, 36.6, 39.7, 50.1, 50.8, 64.6 
(2C), 65.0 (2C), 65.2, 109.3, 111.8, 118.7, 131.2, 133.2, 140.5, 167.0, 200.4; MS (CI) 
m/z 423 [M+H]+, 440 [M+NH4]+;  HRMS (CI) m/z calculated for C23H38NO7 
[M+NH4]+: 423.2383, found: 423.2387; Anal. calculated for C25H34O7: C, 65.38; 
H, 8.11; found: C, 65.41; H, 8.05%. 
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Cyclopentadec-2-enone  (240)191 
 
 
 
O
 
 
 
 
 
Method A 
To a solution of cyclopentadecanone (239) (1.0 g, 4.46 mmol) in DMSO : 
fluorobenzene, 7 : 1 (20 mL) was added IBX (2.12 g, 8.03 mmol) and the resulting 
beige suspension was heated at 60 °C for 24 h. After this time, the reaction mixture 
was cooled to 23 °C and diluted with Et2O (50 mL). The organic layer was separated 
and washed with 5% aq. NaHCO3 (3 × 50 mL), then H2O (2 × 50 mL) and dried 
(MgSO4). Concentration in vacuo was followed by flash column chromatography 
(EtOAc : hexanes, 2.5 : 97.5)  to afford enone 240 (505 mg, 51 %) as a colourless oil:  
 
 
Method B 
To a solution of 3-methylenecyclopentadecene (241) (359 mg, 1.63 mmol) in CH3CN 
(7.0 mL) was added aqueous Na2·EDTA solution (4 × 10-4 M, 5.0 mL), NaHCO3 
(685 mg, 8.16 mmol) and the resulting homogeneous solution was cooled to 0 °C and 
a –78 °C dry-ice condenser affixed. 1,1,1-Trifluoroacetone (234) (73 µL, 0.81 mmol) 
was added via precooled syringe, followed by Oxone® (500 mg, 0.81 mmol). The 
resulting solution was stirred for 1 h at 0 °C, then further 1,1,1-trifluoroacetone 
(73 µL, 0.81 mmol) and Oxone® (500 mg, 0.81 mmol) were added. After 4 h at 0 °C 
the reaction was poured into H2O (50 mL), extracted with CH2Cl2 (3 × 20 mL), dried 
(MgSO4) and concentrated in vacuo. The residue was dissolved in t-BuOH / H2O / 
THF (45 : 45 : 10, 4 mL) and NaIO4 (384 mg, 1.80 mmol) added, followed by HIO4 
(37 mg, 0.16 mmol). The resulting reaction mixture was stirred at 23 °C for 18 h, then 
H2O (10 mL) was added and the aqueous layer extracted with Et2O (3 × 5 mL). The 
combined organic extracts were washed with H2O (5 mL) and dried (MgSO4). 
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Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 2.5 : 97.5) to afford enone 240 (292 mg, 83%) as  a colourless oil which was 
spectroscopically identical to the product of Method A: Rf  0.50  (EtOAc : hexanes, 
1 : 9); IR (film) νmax 1690, 1664, 1622, 1457, 979 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 1.20 − 1.37 (m, 16H, CH2), 1.50 − 1.60 (m, 2H, CH2), 1.64 − 1.74 (m, 2H, 
CH2), 2.23 − 2.31 (m, 2H, CH2), 2.46 − 2.54 (m, 2H, CH2), 6.21 (d, J = 15.5 Hz, 1H, 
CH=CH-C=O), 6.83 (dt, J = 15.5, 7.5 Hz, 1H, CH=CH-C=O); 13C NMR (75 MHz, 
CDCl3) δ 23.4, 25.3, 26.0, 26.2, 26.5, 26.7 (2C), 26.9 (2C), 27.0, 31.7, 40.1, 130.7, 
148.2, 201.9; MS (CI) m/z 223 [M+H]+, 240 [M+NH4]+; HRMS (CI) m/z calculated 
for C15H27O [M+H]+: 223.1984, found: 223.1983.  
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3-Methylenecyclopentadecene  (241) 
 
 
H H
 
 
 
 
Following the procedure of Payack et al.,134 to a suspension of titanocene dichloride 
(10.0 g, 40.0 mmol) in PhMe (80 mL) at –5 °C was added MeLi (1.6 M in Et2O, 58 
mL, 92.4 mmol) dropwise. After 1 h, the reaction mixture was warmed to 0 °C and 
quenched carefully with ice-cold 6% aq. NH4Cl (25 mL). The organic layer was 
separated, washed with H2O (2 × 25 mL), brine (2 × 25 mL) and dried (MgSO4). The 
resulting red solution was concentrated to one third volume in vacuo. 1H NMR assay 
indicated 7.8 g (94%) of dimethyltitanocene, which was stored in the freezer and used 
as a 0.33 M solution in PhMe.  
 
To a solution of cyclopentadec-2-enone (240) (3.29 g, 14.8 mmol) in PhMe (2.0 mL) 
was added dimethyltitanocene (0.33 M in PhMe, 18.0 mL, 6.00 mmol) and the 
resulting solution was stirred at 75 °C for 24 h in the dark. After this time, the cooled 
reaction mixture was filtered through a long silica column, the filtrate concentrated 
in vacuo and purified by flash column chromatography (hexanes) to afford diene 241 
(2.41 g, 74%) as a colourless oil:  Rf  1.00  (hexanes); IR (film) νmax 3076, 1603, 1459, 
966, 833 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.26 − 1.38 (m, 16H, CH2), 1.43 − 1.52 
(m, 4H, CH2), 2.15 − 2.29 (m, 4H, CH2), 4.85 (app. d, J = 14.5 Hz, 2H, =CH2), 5.73 
(d, J = 15.5 Hz, 1H, CH=CH-C=O), 6.05 (dt, J = 15.5, 7.5 Hz, 1H, 
CH=CH-C=O); 13C NMR (75 MHz, CDCl3) δ 25.3, 26.5, 26.7, 26.8, 27.0, 27.1, 27.2, 
28.0, 29.8, 31.9, 32.2, 33.1, 113.4, 130.9, 132.2, 146.8; MS (CI) m/z 221 [M+H]+, 
238 [M+NH4]+; HRMS (CI) m/z calculated for C16H29 [M+H]+: 221.2269, 
found: 221.2271. 
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1-Oxa-spiro[2.14]heptadec-4-ene  (243) and 
1,5-dioxa-dispiro[2.1.12]octadecane  (244) 
 
 
O
O
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To a solution of 3-methylenecyclopentadecene (241) (600 mg, 2.72 mmol) in MeCN 
(19 mL) was added aqueous Na2·EDTA solution (4 × 10-4 M, 13.5 mL), NaHCO3 
(1.14 g, 13.6 mmol) and the resulting homogeneous solution was cooled to 0 °C and a 
–78 °C dry-ice condenser affixed. 1,1,1-Trifluoroacetone (127 µL, 1.42 mmol) was 
added via precooled syringe, followed by Oxone® (838 mg, 1.42 mmol). The resulting 
solution was stirred for 1 h at 0 °C, then further 1,1,1-trifluoroacetone (127 µL, 
1.42 mmol) and Oxone® (838 mg, 1.42 mmol) were added. After 4 h at 0 °C, the 
reaction was poured into H2O (100 mL), extracted with CH2Cl2 (3 × 50 mL) and dried 
(MgSO4). Concentration in vacuo was followed by flash column chromatography 
(EtOAc : hexanes, 97 : 3) to afford epoxide 243 (94 mg, 15%) and diepoxide 244 
(27 mg, 4%) as colourless oils: 
 
Monoepoxide 243: Rf  0.45  (EtOAc : hexanes, 1 : 19); IR (film) νmax 3077, 1725, 
1692, 1667, 1624, 1459, 1346, 1286, 980 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 1.15 − 1.77 (m, 20H, CH2), 2.04 − 2.17 (m, 2H, CH2), 2.17 − 2.30 (m, 2H, 
CH2), 2.57 (s, 2H, CH2OCR2), 5.23 − 5.32 (m, 1H, CH=CHCH2O), 5.53 − 5.63 
(m, 1H, CH=CHCH2O); 13C NMR (75 MHz, CDCl3) δ 25.1, 25.3, 25.7, 26.5, 
26.8 (2C), 27.0, 28.1, 28.3, 31.4, 34.9, 37.3, 55.7, 69.5, 129.3, 133.7; MS (CI) 
m/z 237 [M+H]+, 254 [M+NH4]+; HRMS (CI) m/z calculated for C16H29O [M+H]+: 
237.2218, found: 237.2212. 
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Diepoxide 244: Rf  0.30  (EtOAc : hexanes, 1 : 19); IR (film) νmax 1459, 1348, 911, 716 
cm-1; 1H NMR (300 MHz, CDCl3) δ 1.21 − 1.67 (m, 20H, CH2), 1.70 − 1.82 (m, 2H, 
CH2), 1.95 − 2.08 (m, 2H, CH2), 2.50 (d, J = 5.5 Hz, 1H, CH2OCR2), 2.58 (d, J = 5.5 
Hz, 1H, CH2OCR2), 2.84 − 2.87 (m, 1H, CH(O)CHCH(O)CH2), 2.90 − 2.97 (m, 2H, 
CH(O)CHCH(O)CH2 + CH(O)CHCH(O)CH2); 13C NMR (75 MHz, CDCl3) δ 25.3, 
25.4, 26.1, 26.2, 26.5, 26.8, 26.9, 27.2, 27.3, 31.3, 33.4, 33.6, 49.3, 50.8, 57.0, 
57.4; MS (CI) m/z 253 [M+H]+, 270 [M+NH4]+; HRMS (CI) m/z calculated for 
C16H29O2 [M+H]+: 253.2168, found: 253.2164. 
 
Note : Significant decomposition was observed by TLC analysis upon 
chromatography.  
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[2-(2-Hydroxy-but-3-enyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester  (268) 
 
 
 
O
O OHOO
 
 
 
 
To a solution of [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (91) 
(2.02 g, 1.00 mmol) in THF (100 mL) at –78 °C was added vinylmagnesium bromide 
(1.0 M in THF, 1.00 mL, 1.00 mmol) dropwise. The resultant yellow reaction mixture 
was stirred for an additional 4 h at –78 °C before quenching by the addition of sat. aq. 
NH4Cl (2 mL) and H2O (10 mL). The reaction mixture was extracted with EtOAc 
(2 × 50 mL), the combined organic extracts washed with brine (2 × 50 mL) and dried 
(Na2SO4). Concentration in vacuo was followed by flash column chromatography 
(EtOAc : hexanes, 1 : 9) to afford alcohol 268 (900 mg, 39%) as a colourless oil: 
Rf  0.40 (Et2O : CH2Cl2 : petroleum ether, 1 : 1 : 1); IR (film) νmax 3521, 1734, 1371, 
1214, 1033 cm-1; 1H NMR (300 MHz, CDCl3) δ 1.12 (t, J = 7.0 Hz, 3H, CH3CH2), 
 1.83 − 2.01 (m, 2H, CH2CHOH), 2.59 (s, 2H, CH2CO2Et), 3.35 (br. s, 1H, OH), 
3.90 − 3.92 (m, 4H, O(CH2)2O), 4.00 (q, J = 7.0 Hz, 2H, CH2CH3), 4.22 − 4.29 
(m, 1H, CHOH), 4.92 (dd, J = 1.5, 10.5 Hz, 1H, CH=CH2), 5.12 (dd, J = 1.5, 17.0 Hz, 
1H, CH=CH2), 5.70 (ddd, J = 5.5, 10.5, 17.0 Hz, 1H, CH=CH2); 13C NMR (75 MHz, 
CDCl3) δ 14.0, 42.6, 43.3, 60.5, 64.6, 65.0, 68.5, 108.9, 117.4, 140.3, 169.1; 
MS (CI) m/z 231 [M+H]+, 248 [M+NH4]+; HRMS (CI) m/z calculated for C11H22NO5 
[M+NH4]+: 248.1485, found: 248.1488. 
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(7-Hydroxy-9-vinyl-1,4,8-trioxaspiro[4,5]dec-7-yl)acetic acid ethyl ester  (269) 
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To a solution of freshly distilled EtOAc (0.88 mL, 9.04 mmol) in THF (20 mL) at  
–78 °C was added LDA (2.0 M in THF/heptane/ethyl benzene, 4.52 mL, 9.04 mmol). 
After 15 min, [2-(2-hydroxy-but-3-enyl)-[1,3]dioxolan-2-yl]acetic acid ethyl 
ester (268) (520 mg, 2.26 mmol) in THF (2 mL) was added dropwise and the reaction 
mixture was allowed to warm slowly to 0 °C. After 4 h the reaction was quenched by 
addition of H2O (2 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined 
organic extracts were washed with H2O (20 mL), then brine (20 mL) and dried 
(Na2SO4). Concentration in vacuo was followed by flash column chromatography 
(EtOAc : hexanes, 1 : 9) to afford hemi-ketal 269 (178 mg, 29%) as a 
spectroscopically indistinguishable mixture of diastereoisomers: Rf  0.45 (Et2O : 
CH2Cl2 : hexanes, 1 : 1 : 1); IR (film) νmax 3476, 2980, 2891, 1734, 1210, 1065 cm-1; 
1H NMR (300 MHz, CDCl3) major diastereoisomer (see Appendix 2a): δ 1.17 (t, J = 
7.0 Hz, 3H, CH3CH2), 1.45 (app. t, J = 13.0, Hz, 1H, CH2C(H)R), 1.64 − 1.69 (m, 1H, 
CH2C(H)R), 1.84 (AB q, J = 13.5 Hz, 1H, CH2C(OH)R), 1.99 (AB q, J =  13.5 Hz, 
1H, CH2C(OH)R), 2.51 − 2.69 (m, 2H, CH2CO2Et), 3.85 − 3.92 (m, 4H, O(CH2)2O), 
4.06 (q, J = 7.0 Hz, 2H, CH2CH3), 4.37 − 4.46 (m, 1H, CHOR), 5.00 (dd, J = 1.5, 
10.5 Hz, 1H, CH=CH2), 5.15 (dd, J = 1.5, 16.0 Hz, 1H, CH=CH2), 5.74 (ddd, J = 6.5, 
10.5, 16.0 Hz, 1H, CH=CH2); 13C NMR (75 MHz, CDCl3) both diastereoisomers: 
δ 14.1, 38.8, 39.7, 41.9, 45.8, 60.5, 64.0, 64.9, 68.6, 96.1, 105.0, 106.8, 115.1, 135.1, 
137.6, 168.8, 170.2;  MS (CI) m/z 273 [M+H]+, 290 [M+NH4]+;  HRMS (CI) m/z 
calculated for C13H24NO6 [M+NH4]+: 290.1604, found: 290.1606. 
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[2-(2-Hydroxy-pent-3-enyl)-[1,3]dioxolan-2-yl] acetic acid ethyl ester  (274) 
 
 
 
O
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To a solution of [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (91) 
(2.15 g, 10.6 mmol) in THF (100 mL) at –78 °C, was added 1-propenylmagnesium 
bromide (29.8 mL, 0.5 M in THF, 14.9 mmol) dropwise. After 4h at this temperature, 
the resultant yellow reaction mixture was quenched by the addition of sat. aq. NH4Cl 
(2 mL) and H2O (10 mL). The aqueous layer was extracted with EtOAc (3 × 50 mL), 
the combined organic extracts washed with brine (3 × 50 mL) and dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 9) to afford alcohol 274 (1.97 g, 76%) as a colourless oil: Rf  0.35 (EtOAc 
: hexanes, 2 : 3); IR (film) νmax 3518, 1734, 1371, 1033 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 1.23 (t, J = 1.5, 7.0 Hz, 3H, CH2CH3), 1.70 (dd, J = 1.5, 7.0 Hz, 3H, 
CH=CHCH3), 2.00 − 2.15 (m, 2H, CH2CHOH), 2.75 (d, J = 7.5 Hz, 2H, CH2CO2Et), 
4.06 − 4.09 (m, 4H, O(CH2)2O), 4.17 (dq,  J = 1.5, 7.0 Hz, 2H, CH2CH3), 5.41 − 5.58 
(m, 2H, CH=CHCH3 and CHOH), 5.73 (dqd, J = 1.0, 6.5, 13.0 Hz, 1H, CH=CHCH3); 
13C NMR (100 MHz, CDCl3) δ 14.2, 17.7, 42.8, 60.7, 63.9, 64.8, 65.0, 68.7, 109.3, 
126.2, 132.7, 169.2; MS (CI) m/z 245 [M+H]+, 262 [M+NH4]+; HRMS (CI) m/z 
calculated for C12H24NO5 [M+NH4]+: 262.1654, found: 262.1660. 
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{2-[2-(tert-Butyldimethylsilanyloxy)pent-3-enyl] 
-[1,3]dioxolan-2-yl}acetic acid ethyl ester  (273) 
 
 
O
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To a solution of [2-(2-hydroxy-pent-3-enyl)-[1,3]dioxolan-2-yl]acetic acid ethyl 
ester (274) (840 mg, 3.44 mmol) in DMF (20 mL) at 0 °C were added imidazole 
(937 mg, 13.8 mmol) and DMAP (84 mg, 0.69 mmol), followed after 5 min by 
TBSCl (1.56 g, 10.3 mmol). The resultant suspension was allowed to warm to 23 °C 
and maintained at that temperature for a further 18 h. After this time, the reaction 
mixture was diluted with H2O (50 mL), extracted with EtOAc (3 × 20 mL) and the 
combined organic extracts dried (Na2SO4). Concentration in vacuo was followed by 
flash column chromatography (EtOAc : hexanes, 3 : 97) to afford silyl ether 273 
(1.18 g, 96%) as a colourless oil: Rf  0.95 (EtOAc : hexanes, 2 : 3); IR (film) 
νmax 2957, 1738, 1472, 1252, 1084, 1039, 836 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 0.05 (dd, J = 4.0, 15.0 Hz, 6H, Si(CH3)2), 0.88 (s, 9H, C(CH3)3), 1.27 (t, J = 7.0 Hz, 
3H, CH3CH2), 1.67 (dd, J = 4.0, 5.5 Hz, 3H, CH3C=CH), 1.90 (ddd, J = 5.5, 14.5, 
26.0 Hz, 1H, CH2CHOH), 2.17 (ddd, J = 7.0, 10.5, 14.5 Hz, 1H, CH2CHOH), 2.79 
(dd, J = 4.5, 10.5 Hz, 2H, CH2CO2Et), 3.90 − 4.03 (m, 5H, O(CH2)2O and CHOH), 
4.15 (q, J = 7.0 Hz, 2H, CH3CH2), 5.36 − 5.60 (m, 2H, CH=CH); 13C NMR (75 MHz, 
CDCl3) δ –4.7, –3.9, 14.2, 18.1, 25.9 (3C) 43.1, 45.2, 60.3, 64.7 (2C), 70.5, 108.2, 
122.8, 125.0, 135.2, 169.6; MS (CI) m/z 359 [M+H]+, 376 [M+NH4]+; HRMS (CI) 
m/z calculated for C18H35SiO5 [M+H]+: 359.2267, found: 359.2264; Anal. calculated 
for C18H34SiO5: C, 60.30; H, 9.56; found: C, 60.40; H, 9.48%. 
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4-{2-[2-(tert-Butyldimethylsilanyloxy)pent-3-enyl] 
-[1,3]dioxolan-2-yl}-3-oxobutyric acid ethyl ester (272) 
 
 
O OTBSOO
O
O
 
 
 
 
To a solution of  N,N-diisopropylamine (2.37 mL, 16.8 mmol) in THF (20 mL) at  
–78 °C was added n-BuLi (2.5 M in hexanes, 6.70 mL, 16.8 mmol) and the resultant 
solution warmed to 0 °C for 20 min, then recooled to –78 °C for the addition of 
EtOAc (1.64 mL, 16.8 mmol). After 30 min {2-[2-(tert-butyldimethylsilanyloxy)pent-
3-enyl]-[1,3]dioxolan-2-yl}acetic acid ethyl ester (273) (1.00 g, 2.79 mmol) was 
added and the reaction allowed to warm to 23 °C slowly over 4 h. The reaction 
mixture was quenched with pH 7.0 buffer (10 mL) and extracted with CH2Cl2 
(3 × 10 mL). The combined organic extracts were washed with sat. aq. NH4Cl (5 mL) 
and dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography (EtOAc : hexanes, 3 : 97) to afford β-keto ester 272 (860 mg, 77%) 
as a pale yellow oil: Rf  0.45 (EtOAc : hexanes, 1 : 4); IR (film) νmax 2957, 1736, 1252, 
1033, 836 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.06 (s, 6H, Si(CH3)2), 0.89 (s, 9H, 
C(CH3)3), 1.29 (dt, J = 3.0, 7.0 Hz, 3H, CH3CH2), 1.66 − 1.69 (m, 3H, CH3C=CH), 
1.81 (ddd, J = 5.0, 14.5, 28.0 Hz, 1H, CH2CHOH), 2.00 (ddd, J = 7.0, 10.0, 14.5 Hz, 
1H, CH2CHOH), 2.63 (AB q, J = 15.5 Hz, 1H, CH2COR), 2.70 (AB q, J = 15.5 Hz, 
1H, CH2COR), 3.55 (s, 2H, CH2(CO)2), 3.90 − 4.00 (m, 4H, O(CH2)2O), 4.16 − 4.22 
(m, 3H, CH3CH2 and CHOH), 5.39 − 5.60 (m, 2H, CH=CH); 13C NMR (100 MHz, 
CDCl3) δ −4.6, −4.0, 14.1, 17.5, 25.9 (3C), 27.3, 44.9, 50.6, 60.4, 61.2, 64.6 (2C), 
69.7, 108.6, 125.3, 135.0, 171.9, 200.1; MS (CI) m/z 401 [M+H]+, 418 [M+NH4]+; 
HRMS (CI) m/z calculated for C20H40SiNO6 [M+NH4]+: 418.2625, found: 418.2635; 
Anal. calculated for C20H36SiO6: C, 59.97; H, 9.06; found: C, 59.90; H, 8.97%. 
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(7-Hydroxy-9-propenyl-1,4,8-trioxa-spiro 
[4.5]dec-7-yl)acetic acid ethyl ester (275) 
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To a solution of 4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-oxobutyric acid ethyl ester (272) (66 mg, 0.17 mmol) in THF (1 mL) was added 
TBAF (1.0 M in THF, 830 µL, 0.83 mmol). After 18 h, the reaction was diluted with 
brine (10 mL), extracted with CH2Cl2 (3 × 6 mL). and the combined organic extracts 
dried (Na2SO4). Concentration in vacuo was followed by flash column 
chromatography to afford hemi-ketal 275 (37 mg, 79%) as an inseparable 2 : 3 
mixture of two diastereoisomers: Rf  0.40 (EtOAc : hexanes, 2 : 3); IR (film) 
νmax 3419, 2962, 1486, 1382, 1151 cm-1; 1H NMR (400 MHz, CDCl3) see 
Appendix 2b; 13C NMR (100 MHz, CDCl3) both diastereoisomers: δ 13.5, 14.1, 17.8, 
20.8, 21.1, 22.7, 28.8, 31.6, 40.0, 40.1, 41.9, 53.6, 60.4, 60.7, 64.0, 64.3, 65.0, 68.8, 
96.1, 96.2, 106.9, 107.0, 127.7, 129.9, 130.6, 170.4, 170.5; MS (CI) m/z 287 [M+H]+, 
304 [M+NH4]+; HRMS (CI) m/z calculated for C14H26NO6 [M+NH4]+: 304.1760, 
found: 304.1765. 
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4-{2-[2-(tert-Butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-yl}-3-
oxobutyric acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester  (277) 
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To a solution of  (S)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (381 mg, 
1.67 mmol) and 4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-oxobutyric acid ethyl ester (272) (223 mg, 0.56 mmol) in PhMe (20 mL) was 
added Zn dust (8 mg, 0.12 mmol) and the resulting suspension heated to 110 °C under 
a distillation condenser for 72 h. After this time the reaction was cooled, filtered, 
concentrated in vacuo and purified by flash column chromatography (EtOAc : 
hexanes, 1 : 9) to afford ester 277 (272 mg, 84%) as a 1H NMR spectroscopically 
indistinguishable mixture of diastereoisomers: Rf  0.70 (EtOAc : hexanes, 1 : 4); 
IR (film) νmax 1735, 1641, 1251, 1032 cm-1; 1H NMR (400 MHz, CDCl3) both 
diastereoisomers (see Appendix 2c): δ 0.04 (s, 6H, Si(CH3)2), 0.87 (s, 9H, 
C(CH3)3), 1.22 (d, J = 6.0 Hz, 3H, CH3CH), 1.27 (d, J = 7.0 Hz, 3H, 
CH3CH=CH), 2.94 − 2.98 (m, 16H, CH2), 3.50 (s, 2H, C(O)CH2COR), 
3.92 (s, 4H, O(CH2)2O), 4.16 (dd, J = 7.0, 14.0 Hz, 4H, O(CH2)2O), 4.25 − 4.29 
(m, 1H, CHOTBS), 4.92 − 5.06 (m, 3H, CH2=CHR and CH3CH), 5.48 − 5.57 (m, 2H, 
CH2=CHR and CH=CHCH3), 5.78 (dd, J = 7.5, 17.0 Hz, 1H, CH=CHMe); 13C NMR 
(100 MHz, CDCl3) both diastereoisomers: δ −4.7, −4.6, −4.2, −4.0, 13.2, 14.2, 17.5, 
18.1, 19.6, 19.8, 20.0, 23.1, 25.9, 27.3, 33.9, 35.9, 36.1, 36.9, 44.9, 50.3, 50.5, 50.8, 
60.6, 64.5, 64.6, 64.9, 69.7, 70.4, 70.6, 71.9, 108.6, 109.0, 111.4, 114.6, 135.0, 138.6, 
167.0, 171.9, 200.1; MS (CI) m/z 600 [M+NH4]+; HRMS (CI) m/z calculated for 
C31H58SiNO8 [M+NH4]+: 600.3932, found: 600.3935; Anal. calculated for 
C31H54SiO8: C, 63.88; H, 9.34; found: C, 63.96; H, 9.26%. 
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25-(tert-Butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-23-ene-7,9-dione  (278) 
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To PhMe (150 mL) at 80 °C with a slow stream of argon bubbled through, were 
added both (S)-4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-oxobutyric acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)butyl ester (277) 
(128 mg, 0.22 mmol) in PhMe (15 mL) and Grubbs’ second generation catalyst (19 
mg, 10 mol %) in PhMe (15 mL), via two separate syringe pumps over 10 h. After a  
further 48 h at this temperature, the reaction mixture was concentrated in vacuo and 
purified by flash column chromatography (EtOAc : hexanes, 1 : 9) to afford 
macrocyclic diketone 278 (104 mg, 88%) as  1H NMR spectroscopically 
indistinguishable mixture of diastereoisomers:  Rf  0.65 (EtOAc : hexanes, 1 : 4); IR 
(film) νmax 1736, 1462, 1252, 1121, 1032 cm-1; 1H NMR (400 MHz, CDCl3) both 
diastereoisomers (see Appendix 2d): δ 0.03 (dd, J = 2.0, 11.0 Hz, 6H, Si(CH3)2), 
0.86 (s, 9H, C(CH3)3), 1.22 (d, J = 6.2 Hz, 3H, CH3CH),  1.16 − 1.60 (m, 10H, 
CH2), 1.98 − 2.03 (m, 4H, CH2), 2.71 (AB q, J = 13.5 Hz, 1H, C(O)CH2CO(CH2)2O), 
3.11 (AB q, J = 13.5 Hz, 1H, C(O)CH2CO(CH2)2O), 3.38 (AB q, J = 16.0 Hz, 1H, 
C(O)CH2CO2R), 3.61 (AB q, J = 16.0 Hz, 1H, C(O)CH2CO2R), 3.91 (s, 
4H, O(CH2)2O), 3.95 (s, 4H, O(CH2)2O), 4.23 − 4.28 (m, 1H, CHOTBS), 4.92 − 5.00 
(m, 1H, CH3CH), 5.44 − 5.54 (m, 2H, CH=CHR); 13C NMR (100 MHz, CDCl3) both 
diastereoisomers: δ −4.7, −4.2, 14.2, 18.2, 20.0, 20.5, 20.6, 22.3, 22.4, 25.9 (3C), 
27.3, 31.8, 31.9, 35.0, 35.8, 35.9, 36.1, 36.8, 37.0, 44.9, 45.3, 45.5, 49.9, 50.9, 50.6, 
51.2, 60.6, 64.4, 64.5, 64.6, 64.8, 69.7, 70.3, 71.9, 108.1, 108.4, 111.6, 130.5, 130.6, 
134.4, 134.6, 166.7, 167.3, 171.9, 199.9, 200.3; MS (CI) m/z 541 [M+H]+, 558 
[M+NH4]+; HRMS (CI) m/z calculated for C28H49SiO8 [M+H]+: 541.3197, found: 
541.3201; Anal. calculated for C28H48SiO8: C, 62.19; H, 8.95; found: C, 62.15; 
H, 9.03%. 
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1-Hydroxy-5-methyl-4,10,13,22,25,27-hexaoxa-bicyclo-
dispiro[7.4.5.1.4.1.1]heptacos-17-en-3-one  (280) 
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To a solution of 25-(tert-butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-23-ene-7,9-dione (278) (234 mg, 0.43 mmol) in THF (2 mL) 
was added TBAF (1.0 M in THF, 4.30 mL, 4.30 mmol). After 5 d, the resulting red 
reaction mixture was quenched by addition of brine (10 mL), extracted with CH2Cl2 
(3 × 10 mL) and the combined organic extracts dried (Na2SO4). Concentration 
in vacuo was followed by flash column chromatography (EtOAc : hexanes, 1 : 2) to 
afford hemi-ketal 280a (78 mg, 42%) as a colourless oil and hemi-ketal 280b (77 mg, 
42%) as colourless needles: 
 
Diastereoisomer 280a: 
Rf 0.30 (EtOAc : hexanes, 2 : 3); [α]D +26.5 (c = 1.00, CH2Cl2); IR (film) νmax 3474, 
1725, 1422, 1330, 1065 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.23 (d, J = 6.5 Hz, 3H, 
CH3CH), 1.28 − 1.74 (m, 12H, CH2), 1.86 (AB q, J = 13.5 Hz, 1H, 
CH2C(OH)), 2.00 − 2.13 (m, 2H, CH2CO(CH2)2O), 2.44 (AB q, J = 13.5 Hz, 1H, 
CH2C(OH)), 2.56 (AB q, J = 14.0 Hz, 1H, CH2CO2R), 2.84 (AB q, J = 14.0 Hz, 1H, 
CH2CO2R), 3.93 (s, 4H, O(CH2)2O), 3.97 − 4.08 (m, 4H, O(CH2)2O), 4.43 − 4.48 (m, 
1H, CH3CH), 5.00 (app. dq, J = 4.5, 9.0 Hz, 1H, CHOR), 5.42 − 5.49 (m, 1H, 
CH=CHCOR), 5.65 − 5.72 (m, 1H, CH=CHCOR); 13C NMR (100 MHz, CDCl3) 
δ 20.6, 21.1, 21.7, 30.3, 32.4, 36.5, 36.6, 39.5, 40.8, 46.9, 64.1, 64.3, 64.5, 64.8, 68.8, 
71.7, 96.3, 107.5, 111.9, 131.0, 131.8, 169.3; MS (CI) m/z 427 [M+H]+, 
444 [M+NH4]+;  HRMS (CI) m/z calculated for C22H38NO8 [M+NH4]+: 444.2584, 
found: 444.2588; Anal. calculated for C22H34O8: C, 61.95; H, 8.04; found: C, 62.01; 
H, 8.02%. 
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Diastereoisomer 280b: 
 Rf  0.25 (EtOAc : hexanes, 2 : 3); m.p. 137−138 °C (tBuOMe); [α]D –14.7 (c = 1.14, 
CH2Cl2); IR (film) νmax 3442, 1705, 1435, 1209, 1065 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 1.22 (d, J = 7.0 Hz, 3H, CH3CH), 1.37 − 1.56 (m, 12H, CH2), 1.59 − 2.03 
(m, 4H, CH2C(OH) + CH2CO2R), 2.08 − 2.16 (m, 2H, CH2CO(CH2)2O), 3.88 − 4.05 
(m, 8H, O(CH2)2O × 2), 4.13 (td, J = 6.0, 7.5 Hz, 1H, CHCH=CH), 4.50 − 4.55 
(m, 1H, CH3CH), 5.15 − 5.22 (m, 1H, OH), 5.43 (dd, J = 6.0, 7.5 Hz, 1H, 
CH=CHCOR), 5.63 − 5.70 (m, 1H, CH=CHCOR); 13C NMR (100 MHz, CDCl3) 
δ 21.0, 21.7 (2C), 30.8, 33.4, 37.0, 37.3, 40.3, 43.1, 45.2, 63.8, 64.6, 64.7, 65.2, 68.8, 
71.7, 96.0, 106.6, 111.7, 131.7, 132.9, 171.9; MS (CI) m/z 427 [M+H]+, 
444 [M+NH4]+;  HRMS (CI) m/z calculated for C22H38NO8 [M+NH4]+: 444.2597, 
found: 444.2597; Anal. calculated for C22H34O8: C, 61.95; H, 8.04; found: C, 61.88; 
H, 7.97%; X-ray crystal structure data: C22H34O8, M = 294.38, monoclinic, P21, 
a = 8.4675(5) Å, b =  0.1087(13) Å, c = 9.7796(8) Å, V = 1665.0(2) Å3, Z = 4, 
Dc = 1.174 gcm-3, µ(Cu-Kα) = 0.663 mm-1, T = 173(2) K, colourless blocky needles, 
reflections collected / unique: 16705 / 6009 [R(int) = 0.0840], reflections observed 
[F>4σ(F)]: 5315, full-matrix least-squares on F2, data / restraints / parameters: 
6009 / 3 / 392, final R indices [F>4σ(F)]: R1 = 0.0936, wR2 = 0.2312, R1+ = 0.0936, 
wR2+ = 0.2312, R1- = 0.0936, wR2- = 0.2313, R indices (all data): R1 = 0.0977, 
wR2 = 0.2342. 
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4-{2-[2-(tert-Butyldimethylsilanyloxy)pent-3-enyl] 
-[1,3]dioxolan-2-yl}-3-methoxybut-2-enoic acid ethyl ester  (289) 
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To a solution of 4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-oxobutyric acid ethyl ester (272) (160 mg, 0.40 mmol) in MeCN (2.7 mL) and 
MeOH (0.3 mL) was added N,N-diisopropylethylamine (77 µL, 0.44 mmol), followed 
by trimethylsilyldiazomethane (2.0 M in Et2O, 220 µL, 0.44 mmol). After 18 h, the 
yellow reaction mixture was quenched by addition of brine (10 mL), extracted with 
CH2Cl2 (3 × 10 mL) and the combined organic extracts dried (Na2SO4). Concentration 
in vacuo was followed by flash column chromatography (EtOAc : hexanes, 1 : 9) to 
afford enol ether 289 (16 mg, 10 %) as a colourless oil: Rf  0.70  (EtOAc : hexanes, 
1 : 3); IR (film) νmax 1711, 1626, 1378, 1254, 1148, 1057 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.06 (d, J = 3.0 Hz, 6H, (CH3)2), 0.89 (d, J = 3.0, 9H, C(CH3)3), 
1.29 (t, J = 7.0 Hz, 3H, CH3CH2), 1.62 − 1.69 (m, 3H, CH3C=CH), 1.95 − 2.20 (m, 
2H, CH2CHOTBS), 3.20 (AB q, J = 13.0 Hz, 1H, CH2C(OMe)=CH), 3.27 (AB q, 
J = 13.0 Hz, 1H, CH2C(OMe)=CH), 3.66 (s, 3H, OCH3), 3.83 − 4.05 (m, 4H, 
O(CH2)2O),  4.15 (q, 2H, J = 7.0, CH3CH2), 4.31 − 4.37 (m, 1H, CHOTBS), 
5.12 (s, 1H, CH=COMe), 5.37 − 5.57 (m, 2H, CH=CH); 13C NMR (100 MHz, CDCl3) 
δ −4.7, −4.1, 13.3, 14.4, 17.6, 25.9, 26.0 (2C), 39.4, 46.3, 55.4, 59.4, 64.7, 64.9, 70.0, 
93.4, 109.3, 124.2, 135.5, 167.5, 171.0; MS (CI) m/z 415 [M+H]+, 432 [M+NH4]+;  
HRMS (CI) m/z calculated for C21H42SiNO6 [M+NH4]+: 432.2782, found: 432.2782; 
Anal.  calculated for C21H38SiO6: C, 60.83; H, 9.24; found: C, 60.09; H, 9.14%. 
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7-Methoxy-25-(tert-butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-7,23-dien-9-one  (286) 
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To a solution of 25-(tert-butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-23-ene-7,9-dione (278) (105 mg, 0.19 mmol) in CH3CN (1.8 
mL) and MeOH (0.2 mL) was added N,N-diisopropylethylamine (37 µL, 0.21 mmol), 
followed by trimethylsilyldiazomethane (181) (2.0 M in Et2O, 107 µL, 0.21 mmol). 
After 18 h, the yellow reaction mixture was quenched by addition of brine (5 mL), 
extracted with CH2Cl2 (3 × 5 mL) and the combined organic extracts dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 3 : 7) to afford enol ether 286 (7 mg, 5 %) as an inseparable mixture of 
diastereoisomers:  Rf 0.75 (EtOAc: hexanes 1:2); IR (film) νmax 2955, 1710, 1623, 
1593, 1119, 1036 cm-1; 1H NMR (400 MHz, CDCl3) both diastereoisomers 
(see Appendix 2e): δ 0.07 (d, J = 10.0 Hz, 6H, (CH3)2), 0.90 (s, 9H, C(CH3)3), 
1.21 (d, J = 6.5 Hz, 3H, CH3CH), 1.29 − 1.58 (m, 10H, CH2), 1.77 − 2.22 (m, 4H, 
CH2CHOTBS + CH2CH=CH), 2.64 (AB q, J = 15.5 Hz, 1H, CH2C(OMe)=CH), 2.71 
(AB q, J = 15.5 Hz, 1H, CH2C(OMe)=CH), 3.65 (s, 3H, OCH3), 3.90 − 3.95 (m, 8H,  
O(CH2)2O × 2), 4.24 − 4.30 (m, 1H, CHOTBS), 4.03 − 4.06 (m, 1H, CH3CH), 
5.06 (s, 1H, CH=COMe), 5.27 − 5.45 (m, 2H, CH=CHR); 13C NMR (100 MHz, 
CDCl3) both diastereoisomers: δ −4.6, −4.2, 14.2, 21.1, 21.5, 26.0 (3C), 27.3, 31.7, 
34.8, 37.3, 38.2, 40.1, 44.9, 45.2, 55.3, 60.7, 64.8, 65.0, 65.2, 68.2, 70.0, 93.6, 109.5, 
111.9, 129.6, 135.5, 167.2, 170.0, 171.9; MS (CI) m/z 555 [M+H]+, 572 [M+NH4]+; 
HRMS (CI) m/z calculated for C29H51SiO8 [M+H]+: 555.3375, found: 555.3372.  
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7-Methoxy-9-propenyl-1,4,8-trioxa-spiro[4.5]dec-7-yl)acetic 
acid methyl ester (290) 
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To a solution of 4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-methoxybut-2-enoic acid ethyl ester (289) (12 mg, 0.03 mmol) in THF (0.5 mL) 
was added TBAF (1.0 M in THF, 145 µL, 0.14 mmol). After 18 h, the orange reaction 
mixture was quenched by addition of brine (5 mL), extracted with CH2Cl2 (3 × 5 mL) 
and the combined organic extracts dried (Na2SO4). Concentration in vacuo was 
followed by flash column chromatography (EtOAc : hexanes, 1 : 2) to afford 
ketal 290 (6 mg, 69%) as an inseparable 5 : 3 mixture of two diastereoisomers:  
Rf  0.15 (EtOAc : hexanes, 1 : 3); IR (film) νmax 1736, 1370, 1225, 1043, 998 cm-1; 
1H NMR (400 MHz, CDCl3) major diastereoisomer (see Appendix 2f): δ 1.28 (t, 
J = 7.0 Hz, 3H, CH3CH2), 1.55 − 1.62 (m, 3H, CH3C=CH), 1.70 − 1.80 (m, 2H, 
CH2CHC=C), 2.05 (AB q, J = 14.5 Hz, 1H, CH2C(OMe)OR), 2.22 (AB q, 
J = 14.5 Hz, 1H, CH2C(OMe)OR), 2.59 (AB q, J = 13.5 Hz, 1H, CH2CO2Et), 
2.87 (AB q, J = 13.5 Hz, 1H, CH2CO2Et), 3.64 (s, 3H, OCH3), 3.90 − 3.96 (m, 4H, 
O(CH2)2O), 4.17 (q, 2H, J = 7.0, CH3CH2), 4.22 − 4.28 (m, 1H, CHOR), 5.51  (ddd, 
J = 15.5, 7.0, 1.5 Hz, 1H, CH=CHMe), 5.74 − 5.83 (m, 1H, CH=CHMe); 13C NMR 
(100 MHz, CDCl3) both diastereoisomers: δ 13.5, 14.2, 17.9, 39.7, 39.8, 42.1, 42.2, 
42.6, 48.4, 60.6, 63.7, 64.4, 65.2, 69.3, 99.0, 99.1, 106.2, 106.3, 127.6, 128.4, 129.8, 
130.4, 169.0; MS (CI) m/z 300 [M+H]+, 318 [M+NH4]+; HRMS (CI) m/z calculated 
for C15H28NO6 [M+NH4]+: 318.1917, found: 318.1921. 
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(1R,5S,15R)-1-Hydroxy-5-methyl-4,18,21,23-tetraoxa-bicyclo-
spiro[13.1.4.1.1]tricos-13-en-3,9-dione  (293) 
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To a solution of (1R,5S,19R)-1-hydroxy-5-methyl-4,10,13,22,25,27-hexaoxa-bicyclo-
dispiro[7.4.5.1.4.1.1]heptacos-17-en-3-one (280b) (85 mg, 0.20 mmol) in acetone : 
H2O, 5 : 1 (1 mL) was added PPTS (125 mg, 0.50 mmol). After 18 h, the  reaction 
mixture was quenched by addition of brine (8 mL), extracted with CH2Cl2 (3 × 8 mL) 
and the combined organic extracts dried (Na2SO4). Concentration in vacuo was 
followed by flash column chromatography (EtOAc : hexanes, 1 : 2) to afford 
hemi-ketal 293 (72 mg, 94 %) as colourless needles: Rf 0.25 (EtOAc : hexanes, 2 : 3); 
m.p. 85−86 °C (tBuOMe); [α]D –6.7 (c = 0.87, CH2Cl2);  IR (film) νmax 3454, 1709, 
1212, 1066, 731 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.21 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.48 − 1.82 (m, 8H, CH2), 1.90 − 2.82 (m, 10H, CH2), 3.88 − 4.13 (m, 4H, 
O(CH2)2O), 4.44 − 4.57 (m, 1H, CH3CH), 5.07 − 5.13 (m, 1H, CH(OR)CH=CH), 
 5.27 − 5.36 (m, 1H, CH(OR)CH=CH), 5.45 (ddd, J = 5.5, 10.0, 13.0 Hz, 1H, 
CH(OR)CH=CH); 13C NMR (100 MHz, CDCl3) δ 20.7 (2C), 21.5, 30.1, 36.0, 38.4, 
39.6, 42.9, 43.4, 45.8, 63.8, 65.1, 69.1, 70.5, 96.0, 106.6, 131.5, 131.9, 171.5, 211.0; 
MS (CI) m/z 383 [M+H]+, 400 [M+NH4]+; HRMS (CI) m/z calculated for C20H34NO7 
[M+NH4]+: 400.2335, found: 400.2342; Anal. calculated for C20H30O7: C, 62.81; 
H, 7.91; found: C, 62.91; H, 7.81%. 
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(5S,15S)-5-Methyl-4,19-dioxa-bicyclo[13.3.1]nonadeca 
-1(18),13-diene-3,9,17-trione  (294a) 
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To a solution of (1S,5S,19S)-1-hydroxy-5-methyl-4,10,13,22,25,27-hexaoxa-bicyclo-
dispiro[7.4.5.1.4.1.1]heptacos-17-en-3-one (280a) (58 mg, 0.14 mmol) in glacial 
acetic acid (1.5 mL) was added NaClO4 (56 mg, 0.46 mmol). After 18 h, the reaction 
mixture was quenched by addition of pH 7.2 buffer (10 mL), extracted with CH2Cl2 
(3 × 8 mL) and the combined organic extracts dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc : hexanes, 1 : 2) to afford 
hemi-ketal 294a (43 mg, 97 %) as a colourless needles: Rf 0.35 (EtOAc : hexanes, 
1 : 1); [α]D +52.4 (c = 1.03, CH2Cl2);   IR (film) νmax 1732, 1710, 1669, 1612, 1392, 
1230, 978 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.27 (d, J = 6.0 Hz, 3H, CH3CH), 
1.48 − 1.94 (m, 6H, CH2), 2.20 − 2.29 (m, 2H, CH2CH=CH), 2.43 − 2.51 (m, 4H, 
CH2COCH2), 2.54 (AB q, J = 12.0 Hz, 1H, CH2CO2R), 2.58 (AB q, J = 12.0 Hz, 1H, 
CH2CO2R), 3.26 (AB q, J = 15.0 Hz, 1H, CH2COCH=CH), 3.35 (AB q, J = 15.0 Hz, 
1H, CH2C(O)CH=C), 4.85 (dt, J = 12.5, 5.0 Hz, 1H, CH(OR)CH=CH), 4.97 − 5.07 
(m, 1H, CH3CH), 5.43 (s, 1H, C(O)CH=COR), 5.54 − 5.67 (m, 2H, CH=CH); 
13C NMR (100 MHz, CDCl3) δ 20.7 (2C), 21.0, 31.3, 35.5, 39.8, 40.9, 41.7, 43.0, 
71.8, 80.2, 106.6, 128.0, 135.5, 167.6, 168.9, 192.2, 211.1;  MS (CI) m/z 321 [M+H]+, 
338 [M+NH4]+;  HRMS (CI) m/z calculated for C18H25O5 [M+H]+: 321.1702, found: 
321.1706; Anal.  calculated for C18H24O5: C, 67.48; H, 7.55; found: C, 67.58; 
H, 7.50%. 
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(5S,15R)-5-Methyl-4,19-dioxa-bicyclo[13.3.1]nonadeca 
-1(18),13-diene-3,9,17-trione  (294b) 
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To a solution of (1R,5S,19R-1-hydroxy-5-methyl-4,10,13,22,25,27-hexaoxa-bicyclo-
dispiro[7.4.5.1.4.1.1]heptacos-17-en-3-one (280b) (20 mg, 0.05 mmol) in glacial 
acetic acid (0.5 mL) was added NaClO4 (19 mg, 0.15 mmol). After 18 h, the reaction 
mixture was quenched by addition of pH 7.2 buffer (3 mL), extracted with CH2Cl2 (3 
× 5 mL) and the combined organic extracts dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc : hexanes, 1 :  2) to afford 
hemi-ketal 294b (15 mg, 99 %) as colourless needles: Rf 0.35 (EtOAc: hexanes, 1:1);  
[α]D −54.4 (c = 1.18, CH2Cl2); IR (film) νmax 1730, 1710, 1672, 1611, 1392, 1230, 
978 cm-1; 1H NMR (400 MHz, CDCl3) δ: 1.24 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.48 − 1.94 (m, 6H, CH2), 2.23 − 2.31 (m, 2H, CH2CH=CH), 
 2.40 − 2.50 (m, 4H, CH2COCH2), 2.53 (AB q, J = 12.0 Hz, 1H, CH2CO2R), 
 2.58 (AB q, J = 12.0 Hz, 1H, CH2CO2R), 3.25 (AB q, J = 15.0 Hz, 1H, 
CH2C(O)CH=C), 3.33 (AB q, J = 15.0 Hz, 1H, CH2COCH=CH), 4.85 (dt, J = 12.5, 
5.0 Hz, 1H, CH(OR)CH=CH), 4.97 − 5.05 (m, 1H, CH3CH), 5.42 (s, 1H, 
CH=C(O)R), 5.52 − 5.65 (m, 2H, CH=CH); 13C NMR (100 MHz, CDCl3) δ 20.4, 
20.7, 20.9, 31.4, 35.5, 39.7, 40.3, 41.8, 43.0, 71.4, 79.8, 106.6, 127.8, 135.2, 167.5, 
168.9, 192.4, 210.9;  MS (CI) m/z 321 [M+H]+, 338 [M+NH4]+;  HRMS (CI) 
m/z calculated for C18H25O5 [M+H]+: 321.1702, found: 321.1705; Anal. calculated for 
C18H24O5: C, 67.48; H, 7.55; found: C, 67.54; H, 7.55%. 
 
 255 
 
 
 
[2-(2-Hydroxy-hex-5-enyl)-[1,3]dioxolan-2-yl]acetic 
acid ethyl ester  (300) 
 
 
 
O
O OO OH
 
 
 
 
To a solution of [2-(2-oxo-ethyl)-[1,3]dioxolan-2-yl]acetic acid ethyl ester (91)  
(1.59 g, 7.9 mmol) in THF (25 mL) at –78 °C was added a solution of 4-pentenyl 
magnesium bromide (96) [freshly prepared from 5-bromo-1-pentane (878 µL, 
8.6 mmol) and Mg (268 mg, 11.0 mmol) in Et2O (15 mL)] via syringe pump over 
2.5 h. After a further 30 min at that temperature the reaction mixture was quenched by 
the addition of sat. aq. NH4Cl (20 mL) and H2O (20 mL). The aqueous layer was 
extracted with Et2O (3 × 20 mL) and the combined organic extracts washed with H2O 
(2 × 20 mL), then dried (Na2SO4). Concentration in vacuo afforded an inseparable 
2 : 1 mixture of starting aldehyde 91 : alcohol 300 (1.60 g, 79% by mass) as a pale 
yellow oil which was used crude without purification: Rf 0.35 (EtOAc : hexanes, 1:2); 
MS (CI) m/z 259 [M+H]+, 276 [M+NH4]+; HRMS (CI) m/z calculated for C13H23O5 
[M+H]+: 259.1545, found: 259.1545. 
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[2-(2-Oxo-hex-5-enyl)-[1,3]dioxolan-2-yl]acetic 
acid ethyl ester (299) 
 
 
 
O
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To a solution of crude [2-(2-hydroxy-hex-5-enyl)-[1,3]dioxolan-2-yl]acetic acid ethyl 
ester (300) (<33% purity, 1.35 g, 1.73 mmol) in CH2Cl2 (20 mL) at 0 °C was added 
Dess-Martin periodinane (2.23 g, 5.25 mmol). The  solution was stirred at 0 °C for 
20 min then allowed to warm to 23 °C for 30 min, before quenching by the addition 
of a 1 : 1 mixture of sat. aq. Na2S2O3 and sat. aq. NaHCO3 (10 mL). The aqueous 
layer was extracted with CH2Cl2 (3 × 10 mL) and the combined organic extracts dried 
(Na2SO4). Concentration in vacuo was followed by flash column chromatography 
(EtOAc : hexanes, 1 : 9) to afford ketone 299 (178 mg, 11 % over 2 steps) as a 
colourless oil: Rf  0.50 (EtOAc : hexanes, 1 : 2);  IR (film) νmax 3077, 1733, 1371, 
1210, 1099, 1034 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.28 (t, J = 7.0 Hz, 3H, 
CH3CH2), 2.31 − 2.37 (m, 2H, CH2CH=CH2), 2.61 (t, J = 6.5 Hz, 2H, 
CH2CH2CH2=CH2), 2.89 (s, 2H, CH2CO2R), 3.07 (s, 2H, CH2COR), 4.01 − 4.07 
(m, 4H, O(CH2)2O), 4.17 (q, J = 7.0 Hz, 2H, CH3CH2), 5.00 (dd, J = 1.5, 10.0 Hz, 1H, 
CH=CH2, cis), 5.05 (dd, J = 1.5, 17.0 Hz, 1H, CH=CH2, trans), 5.83 (tdd, J = 6.5, 
10.0, 17.0 Hz, 1H, CH=CH2); 13C NMR (100 MHz, CDCl3) δ 14.2, 27.4, 42.2, 43.5, 
49.2, 60.6, 65.0 (2C), 107.1, 115.2, 137.1, 169.5, 206.6; MS (CI) m/z 257 [M+H]+, 
274 [M+NH4]+; HRMS (CI) m/z calculated for C13H21O5 [M+H]+: 257.1389, found: 
257.1392; Anal. calculated for C13H20O5: C, 60.92; H, 7.97; found: C, 60.87; 
H, 7.91%. 
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4-{2-[2-(tert-Butyldimethylsilanyloxy)pent-3-enyl] 
-[1,3]dioxolan-2-yl}-3-hydroxy-butyric acid ethyl ester  (304) 
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To a solution of 4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-oxobutyric acid ethyl ester (272) (38 mg, 0.10 mmol) in EtOH (2 mL) at 0 °C 
was added NaBH4 (29 mg, 0.76 mmol). After 20 min at that temperature, the reaction 
mixture was quenched by addition of sat. aq. NH4Cl (2 mL), extracted with CH2Cl2 (3 
× 3 mL) and the combined organic extracts dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc : hexanes, 1 : 3) to afford 
alcohol 304 (34 mg, 89%) as an inseparable mixture of diastereoisomers: Rf  0.80 
(EtOAc : hexanes 1 : 2);  IR (film) νmax 3498, 2957, 1735, 1253, 1031, 835 cm-1; 
1H NMR (400 MHz, CDCl3) see Appendix 2g; 13C NMR (100 MHz, CDCl3) 
all diastereoisomers: δ −4.6, −4.5, −4.2, −3.9, 14.2, 17.5, 26.0 (3C), 27.3, 30.6, 42.2, 
42.3, 43.1, 43.2, 45.2, 45.4, 60.5, 60.7, 64.2, 64.3, 65.1, 65.2, 70.5, 70.6, 110.6, 110.7, 
125.1, 125.3, 135.0, 171.7, 172.0; MS (CI) m/z 403 [M+H]+, 420 [M+NH4]+; 
HRMS (CI) m/z calculated for C20H39SiO6 [M+H]+: 403.2529, found: 403.2526. 
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3-Hydroxy-4-[2-(2-hydroxy-pent-3-enyl) 
-[1,3]dioxolan-2-yl]butyric acid ethyl ester  (305) 
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To a solution of 4-{2-[2-(tert-butyldimethylsilanyloxy)pent-3-enyl]-[1,3]dioxolan-2-
yl}-3-hydroxy-butyric acid ethyl ester (304) (30 mg, 0.07 mmol) in THF (0.5 mL) 
was added TBAF (1.0 M in THF, 0.75 mL, 0.75 mmol). After 18 h, the orange 
reaction mixture was quenched by addition of brine (2 mL), extracted with CH2Cl2 
(3 × 2 mL) and the combined organic extracts dried (Na2SO4). Concentration in vacuo 
was followed by flash column chromatography (EtOAc) to afford diol 305 (10 mg, 
47%) as  1H NMR spectroscopically indistinguishable mixture of diastereoisomers:  
Rf  0.15 (EtOAc : hexanes, 1 : 1); IR (film) νmax 3454, 2922, 1728, 1283, 1028, 
820 cm-1;  1H NMR (400 MHz, CDCl3) both diastereoisomers (see Appendix 2h): 
δ 1.30 (t, J = 7.0 Hz, 3H, CH3CH2), 1.71 (d, J = 7.0 Hz, 3H, CH3CH=C), 1.88 − 2.03 
(m, 4H, CH2), 2.44 − 2.62 (m, 2H, CH2CO2Et), 3.29 (br. s, 1H, OH), 3.54 (br. s, 1H, 
OH), 4.06 − 4.10 (m, 4H, O(CH2)2O),  4.19 (q, J = 7.0 Hz, 2H, CH3CH2), 4.29 − 4.38 
(m, 2H, CHOH), 5.41 − 5.59 (m, 1H, CH=CHMe), 5.69 − 5.77 (m, 1H, CH=CHMe); 
13C NMR (100 MHz, CDCl3) both diastereoisomers: δ 14.2, 17.7, 41.9, 42.0, 42.6, 
42.8, 43.3, 43.5, 60.7, 63.9, 64.5, 64.8, 64.9, 68.8, 111.3, 111.4, 125.7, 126.4, 133.1, 
171.9; MS (CI) m/z 289 [M+H]+, 306 [M+NH4]+; HRMS (CI) m/z calculated for 
C14H28NO6 [M+NH4]+: 306.1930, found: 306.1926. 
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7-Hydroxy-25-(tert-butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-23-ene-9-one  (302)  
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To a solution of 25-(tert-butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-23-ene-7,9-dione (278) (40 mg, 0.07 mmol) in EtOH (1 mL) 
at 0 °C was added NaBH4 (14 mg, 0.37 mmol). After 20 min at that temperature, the 
reaction mixture was quenched by addition of sat. aq. NH4Cl (2 mL), extracted with 
CH2Cl2 (3 × 3 mL) and the combined organic extracts dried (Na2SO4). Concentration 
in vacuo was followed by flash column chromatography (EtOAc : hexanes, 1 : 3) to 
afford alcohol 302 (34 mg, 88 %) as a spectroscopically indistinguishable mixture of 
diastereoisomers: Rf  0.25 (EtOAc : hexanes, 1 : 2); IR (film) νmax 3500, 2952, 1728, 
1254, 1039, 836 cm-1; 1H NMR (400 MHz, CDCl3)  all diastereoisomers (see 
Appendix 2i): δ 0.06 (s,  3H, Si(CH3)2), 0.09 (s,  3H, (CH3)2), 0.90 (s 9H, 
C(CH3)3), 1.23 (d, J = 6.0 Hz, 3H, CH3CH), 1.49 − 1.64 (m, 10H, CH2), 1.75 (dd, 
J = 14.5, 9.5Hz, 1H, CH2CHOH), 1.92 − 2.01 (m, 3H, CH2), 2.05 (dd, J = 14.5, 
4.0 Hz, 1H, CH2CHOSi), 2.10 − 2.17 (m, 1H, CH2), 2.50 (app. qd, J = 15.5, 7.0 Hz, 
2H, CH2CO2R), 3.93 (app. d, J = 2.0 Hz, 4H, O(CH2)2O), 3.99 − 4.03 (m, 4H, 
O(CH2)2O), 4.20 − 4.31 (m, 2H, CH3CH + CHOTBS), 5.01 − 5.09 (m, 1H, 
CHOCOR), 5.45 − 5.56 (m, 2H, CH=CH); 13C NMR (100 MHz, CDCl3) 
all diastereoisomers: δ −4.7, −4.3, 18.2, 20.4, 20.6, 22.9, 25.9 (3C), 31.9, 35.0, 36.0,  
36.5, 42.2, 42.8, 45.8, 64.0, 64.6 (2C), 65.1 (2C), 69.8, 70.5, 110.4, 111.8, 130.5, 
134.5, 171.1; MS (CI) m/z 543 [M+H]+, 560 [M+NH4]+;  HRMS (CI) m/z calculated 
for C28H51SiO8 [M+H]+: 543.3367, found: 543.3365; Anal. calculated for C28H50SiO8: 
C, 61.96; H, 9.29; found: C, 62.04; H, 9.33%. 
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7,25-Dihydroxy-11-methyl-1,4,10,16,19-pentaoxa-dispiro 
[4.9.4.7]hexacos-23-ene-9-one  (301) 
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To a solution of 7-hydroxy-25-(tert-butyldimethylsilanyloxy)-11-methyl-
1,4,10,16,19-pentaoxa-dispiro[4.9.4.7]hexacos-23-ene-9-one (302) (163 mg, 
0.30 mmol) in THF (2 mL) was added TBAF (1.0 M in THF, 3.0 mL, 3.0 mmol). 
After 18 h, the orange reaction mixture was quenched by addition of brine (5 mL), 
extracted with CH2Cl2 (3 × 5 mL) and the combined organic extracts dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc) to 
afford diol 301 (128 mg, 99%) as an inseparable mixture of diastereoisomers: Rf  0.50 
(EtOAc); IR (film) νmax 3455, 3414, 1726, 1125, 1032, 949 cm-1;  1H NMR (400 MHz, 
CDCl3) see Appendix 2j;  13C NMR (100 MHz, CDCl3) all diastereoisomers: 
20.0, 20.1, 20.5, 20.7, 21.4, 21.7, 22.1, 31.3, 31.6, 34.3, 34.6, 36.3, 37.1, 37.7, 38.0, 
42.1, 42.5, 43.0, 43.3, 43.7, 43.8, 64.4, 64.6, 64.9, 65.1, 65.4, 65.5, 65.7, 110.9, 111.1, 
111.2, 111.5, 131.3, 131.8, 133.6, 170.6, 171.4; MS (CI) m/z 429 [M+H]+, 
446 [M+NH4]+; HRMS (CI) m/z calculated for C22H40NO8 [M+NH4]+: 446.2764, 
found: 446.2764. 
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(S)-11-Methyl-1,4,10-trioxa-spiro[4.17]docos-19-ene 
-7,9,15,21-tetraone  (306) 
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To a solution of oxalyl chloride (60 µL, 0.70 mmol) in CH2Cl2 (2.5 mL) at –78 °C 
was added DMSO (115 µL, 1.65 mmol). After 30 min, a solution of 7,25-dihydroxy-
11-methyl-1,4,10,16,19-pentaoxa-dispiro[4.9.4.7]hexacos-23-ene-9-one (301) 
(115 mg, 0.27 mmol) in CH2Cl2 (2.5 mL) was added and after a further 30 min Et3N 
(400 µL, 2.8 mmol) was added. The reaction mixture was stirred at –78 °C for 1 h 
then warmed slowly to 0 °C during 1 h. After 30 min at 0 °C, the reaction mixture 
was quenched by addition of H2O (10 mL), extracted with CH2Cl2 (3 × 10 mL) and 
the combined organic extracts dried (Na2SO4). Concentration in vacuo was followed 
by flash column chromatography (EtOAc : hexanes, 1 : 3) to afford triketone 306 
(15 mg, 15%) as a colourless oil: Rf 0.20 (EtOAc : hexanes, 1 : 2); [α]D +14.0 (c 0.95, 
CH2Cl2); IR (film) νmax 3434, 2937, 1760, 1710, 1664, 1623, 1369, 1251, 1124, 1027 
cm-1;  1H NMR (400 MHz, CDCl3) δ 1.33 (d, J = 6.5 Hz, 3H, CH3CHOR), 1.52 − 1.70 
(m, 8H, CH2), 1.83 − 1.93 (m, 2H, CH2), 2.15 − 2.56 (m, 4H, CH2C(=O)), 3.00 (AB q, 
J = 16.5 Hz, 1H, C(O)CH2CO2R), 3.48 (AB q, J = 18.0 Hz, 1H, CH2C(O)C=C), 3.52 
(AB q, J = 18.0 Hz, 1H, CH2C(O)C=C), 3.61 (AB q, J = 16. Hz, 1H, 
C(O)CH2CO2R),  3.86 − 4.10 (m, 4H, O(CH2)2O), 4.90 − 5.11 (m, 1H, CHOR), 
6.01 − 6.10 (m, 1H, C(O)CH=CH), 6.75 − 6.88 (m, 1H, C(O)CH=CH); 13C NMR 
(100 MHz, CDCl3) δ 19.7, 20.6, 21.0, 31.7, 35.1, 39.8, 41.6, 43.2, 45.6 (2C), 64.7, 
65.1, 66.4, 107.2, 132.6, 148.5, 162.5, 192.2, 197.0, 210.4; MS (CI) m/z 381 [M+H]+, 
398 [M+NH4]+; HRMS (CI) m/z calculated for C20H29O7 [M+H]+: 381.1913, found: 
381.1908. 
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(S)-11-Methyl-1,4,10,16,19-pentaoxa-dispiro 
[4.9.4.7]hexacos-23-ene-7,9,25-trione  (86) 
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To a solution of oxalyl chloride (12 µL, 138 µmol) in CH2Cl2 (0.5 mL) at –78 °C was 
added DMSO (23 µL, 330 µmol). After 30 min, a solution of 7,25-dihydroxy-11-
methyl-1,4,10,16,19-pentaoxa-dispiro[4.9.4.7]hexacos-23-ene-9-one (301) (20 mg, 
47 µmol) in CH2Cl2 (0.5 mL) was added and after a further 30 min Et3N (78 µL, 
560 µmol) was added. The reaction mixture was stirred at –78 °C for 1 h then warmed 
slowly to 0 °C during 1 h. After 30 min at 0 °C, the reaction mixture was quenched by 
addition of H2O (2 mL), extracted with CH2Cl2 (3 × 2 mL) and the combined organic 
extracts dried (Na2SO4). Concentration in vacuo was followed immediately by flash 
column chromatography (EtOAc : hexanes, 1 : 1) to afford diketone 86 (18 mg, 91 %) 
as a colourless oil: Rf 0.20 (EtOAc: hexanes, 1:2); [α]D +12.5 (c = 0.89, CH2Cl2); 
IR (film) νmax 3407, 2939, 1762, 1747, 1710, 1660, 1619, 1388, 1243, 1085 cm-1;  
1H NMR (400 MHz, CDCl3) δ 1.33 (d, J = 6.0 Hz, 3H, CH3CHOR), 1.21 − 1.39 
(m, 2H, CH2), 1.46 − 1.73 (m, 8H, CH2), 2.06 − 2.62 (m, 4H, CH2), 3.05 (AB q, 
J = 15.0 Hz, 1H, C(O)CH2CO2R), 3.40 (AB q, J = 17.0 Hz, 1H, CH2C(O)C=C), 3.44 
(AB q, J = 17.0 Hz, 1H, CH2C(O)C=C), 3.56 (AB q, J = 15.0 Hz, 1H, 
C(O)CH2CO2R), 3.94 (s, 4H, O(CH2)2O), 3.96 − 4.05 (m, 4H, O(CH2)2O), 5.04 
− 5.14 (m, 1H, CHOR), 6.10 (d, J = 16.0 Hz, 1H, C(O)CH=CH), 6.98 (td, J = 7.5, 
16.0 Hz, 1H, C(O)CH=CH); 13C NMR (100 MHz, CDCl3) δ 19.9, 20.4, 21.5, 32.2, 
34.4, 36.0, 37.2, 42.2, 45.5 (2C), 64.7 (2C), 64.8 (2C), 65.2, 107.4, 111.3, 132.9, 
150.0, 162.6, 191.4, 197.5; MS (CI) m/z 425 [M+H], 442 [M+NH4]+; HRMS (CI) 
m/z calculated for C22H33O8 [M+H]+: 425.2175, found: 425.2179. 
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(S)-17-(2-Hydroxyethoxy)-5-methyl-4,19-dioxa-bicyclo 
[13.3.1]nonadeca-1,13,15,17-tetraene-3,9-dione  (315) 
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To a solution of (S)-11-Methyl-1,4,10,16,19-pentaoxa-dispiro[4.9.4.7]hexacos-23-
ene-7,9,25-trione (86) (46 mg, 0.11 mmol) in CH2Cl2 : iPrOH, 5 : 3 (24 mL) was 
added K2CO3 (450 mg, 3.26 mmol). After 72 h, 1.2 M HCl aq. (12 mL) was added 
dropwise and the resultant reaction mixture was stirred at 23 °C for a further 4 h. 
After this time, the reaction mixture was diluted with H2O (25 mL), extracted with 
CH2Cl2 (3 × 25 mL) and the combined organic extracts dried (Na2SO4). Concentration 
in vacuo was followed by flash column chromatography (EtOAc) to afford pyrone 
derivative 315 (31 mg, 80%) as a colourless oil: Rf  0.25 (EtOAc); [α]D −2.5 
(c = 1.00, CH2Cl2); IR (film) νmax 3424, 3090, 1755, 1709, 1654, 1553, 1427, 1253 
cm-1;  1H NMR (400 MHz, CDCl3) δ 1.33 (d, J = 6.0 Hz, 3H, HA), 1.58 − 1.81 (m, 6H, 
HC, HD + HH), 2.13 (br. s, 1H, OH), 2.25 (app. q, J = 7.5 Hz, 2H, HI), 2.46 
(t, J = 7.0 Hz, 4H, HE + HG), 3.97 − 4.02 (m, 2H, HQ), 4.10 (t, J = 4.0 Hz, 2H, HP), 
4.95 − 5.06 (m, 1H, HB), 5.47 (d, J = 2.0 Hz, 1H, HR), 5.83 (d, J = 2.0 Hz, 1H, 
HM), 5.94 (s, 1H, HT), 5.98 (d, J = 15.5 Hz, 1H, HK), 6.68 (td, J = 7.0, 15.5 Hz, 1H, 
HJ); 13C NMR (100 MHz, CDCl3) δ 19.4 (CA), 19.6 (CD), 22.6 (CC), 32.1 (CH), 35.1 
(CI), 41.9 (CE), 42.3 (CG), 60.7 (CP), 64.8 (CT), 70.3 (CQ), 75.0 (CB), 89.4 (CR), 100.1 
(CM), 122.3 (CK), 139.2 (CJ), 158.8 (CL), 164.3 (CU), 164.4 (CS), 170.5 (CN), 210.0 
(CF); (See Appendix 3  for 2D NMR spectra); Anal. calculated for C20H26O6: 
C, 66.28; H, 7.23; found: C, 66.26; H, 7.31%. 
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Malonic acid monoallyl ester  (351)192 
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A solution of 2,2-dimethyl-[1,3]dioxane-4,6-dione (350) (10 g, 0.07 mol) in allylic 
alcohol (20 mL) was gently refluxed for 6 h. After this time, the reaction was 
concentrated in vacuo and the oily residue was re-dissolved in H2O (20 mL) and 
washed with hexane : Et2O, 1 : 1 (2 × 20 mL). The aqueous layer was acidified to 
~pH 4 with 1 M aq. HCl, extracted with Et2O (2 × 50 mL) and the combined organic 
extracts were dried (MgSO4). Concentration in vacuo afforded allylic ester 351 (6.2 g, 
62%) as a colourless oil which was used crude without further purification: Rf  0.10 
(EtOAc : hexanes, 1 : 3); IR (film) νmax 3545, 2951, 1738, 1154, 993 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 3.49 (s, 2H, CH2CO2H), 4.69 (d, J = 6.0 Hz, 2H, CH2CH=C), 
5.30 (dd, J = 1.0, 10.0 Hz, 1H, CH=CH2), 5.38 (dd, J = 1.0, 17.0 Hz, 1H, CH=CH2), 
5.94 (tdd, J = 6.0, 10.0, 17.0 Hz, 1H, CH=CH2), 7.09 (br. s, 1H, CO2H); 13C NMR 
(100 MHz, CDCl3) δ 40.8, 66.5, 119.2, 131.4, 166.5, 171.0; MS (CI) 
m/z 145 [M+H]+, 162 [M+NH4]+; HRMS (CI) m/z calculated for C6H12NO4 
[M+NH4]+: 162.0766, found: 162.0764. 
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3-Benzo[1,2,3]triazol-1-yl-3-oxo-propionic acid allyl ester  (348) 
 
 
 
O
O O
N
N
N
 
 
 
 
To a solution of benzo[1,2,3]triazole (20.5 g, 168 mmol) in CH2Cl2 (100 mL), was 
added thionyl chloride (3.65 ml, 84 mmol) dropwise. After 30 min, malonic acid 
monoallyl ester (351) (6.0 g, 42 mmol) was added and a solid precipitated. After a 
further 4 h, the reaction mixture was filtered, the filtrate washed with 0.5 M aq. NaOH 
(2 × 50 mL) and dried (MgSO4). Concentration in vacuo was followed by flash 
column chromatography stabilised by Et3N (EtOAc : hexanes, 3 : 7) to afford 
acyl-benzotriazole 348 (6.2 g, 60 %) as a colourless oil: Rf  0.45 (EtOAc : hexanes, 
3 : 7); IR (film) νmax 3461, 2952, 1752, 1737, 1486, 1153, 993 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 4.46 (s, 2H, CH2CO2Bt), 4.70 (d, J = 6.0 Hz, 2H, CH2CH=C), 
5.25 (dd, J = 1.0, 10.5 Hz, 1H, CH=CH2), 5.33 (dd, J = 1.0, 17.0 Hz, 1H, CH=CH2), 
5.89 (tdd, J = 6.0, 10.5, 17.0 Hz, 1H, CH=CH2), 7.57 (app. t, J = 8.5 Hz, 1H, ArH), 
7.72 (app. t, J = 8.5 Hz, 1H, ArH),  8.17 (d, J = 8.5 Hz, 1H, ArH), 8.33 (d, J = 8.5 Hz, 
1H, ArH); 13C NMR (100 MHz, CDCl3) δ 42.7, 66.6, 114.3, 119.0, 120.3, 126.6, 
130.8, 131.2, 131.5, 146.3, 164.9, 165.6; MS (CI) m/z 246 [M+H]+, 263 [M+NH4]+; 
HRMS (CI) m/z calculated for C12H12N3O3 [M+H]+: 246.0879, found: 246.0882. 
 
Note : The product is partially hydrolyzed on the column, hence at least 1% of Et3N is 
added to the eluent mixture for chromatography.  
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4-(2,2-Dimethyl-4-oxo-6H-[1,3]dioxin-6-yl)-3-oxobutyric acid allyl ester  (339) 
 
 
O O
O
O
O
1 3
6
O
 
 
 
To a solution of  HMDS ( 1.9 mL, 9.1 mmol) in THF (140 mL) at –78 ºC,  was added 
n-BuLi (2.5 M in hexanes, 3.8 mL, 9.5 mmol) and the resultant solution was stirred at 
that temperature for 30 min. After this period, 2,2,6-trimethyl-[1,3]dioxin-4-one (316) 
(1.0 ml, 7.6 mmol) was added dropwise and the solution was stirred at –78 ºC for a 
further 1.5 h. 3-Benzo[1,2,3]triazol-1-yl-3-oxo-propionic acid allyl ester (348) 
(480 mg, 1.90 mmol) was added in one portion and the reaction was allowed to warm 
to 23 °C over 18 h and then quenched by addition of sat. aq. NH4Cl (3 mL). The 
reaction was acidified to ~pH 4 with 1 M aq. HCl, extracted with EtOAc (2 × 40 mL) 
and the combined organic extracts dried (MgSO4). Concentration in vacuo was 
followed by flash column chromatography (EtOAc : hexanes, 1 : 4) to afford 
dioxinone analogue 339 (300 mg, 65%) as a pale yellow oil: Rf 0.40 
(EtOAc : hexanes, 3 : 7); IR (film) νmax 3451, 3000, 1725, 1639, 1392, 1274, 1203, 
1016 cm-1;  1H NMR (400 MHz, CDCl3) δ 1.71 (s, 6H,  3.49 (CH3)2C), 3.53 (s, 2H, 
CH2C(=O)CO2Allyl), 3.57 (s, 2H, CH2CO2Allyl), 4.68 (d, J = 6.0 Hz, 2H, 
CH2CH=C), 5.29 (dd, J = 1.0, 10.5 Hz, 1H, CH=CH2), 5.35 (dd, J = 1.0, 17.0 Hz, 1H, 
CH=CH2), 5.37 (s, 1H, C=CHC(=O)), 5.90 (tdd, J = 6.0, 10.5, 17.0 Hz, 1H, 
CH=CH2); 13C NMR (100 MHz, CDCl3) δ 25.0 (2C), 47.0, 49.0, 66.4, 97.2, 107.4, 
119.4, 131.2, 160.5, 163.4 (2C), 195.5; MS (CI) m/z 269 [M+H]+, 286 [M+NH4]+;  
HRMS (CI) m/z calculated for C13H17O6 [M+H]+: 269.1026, found: 269.1025. 
 
Note: This yield is calculated based on a 90 % purity of 3-benzo[1,2,3]triazol-2-yl-3-
oxo-propionic acid allyl ester 348 after column chromatography.  
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(±)-5-[2-(4-tert-Butyldimethylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]pent-1-ene, (110)84 
 
 
 
OTBS OO
 
 
 
 
 
To a solution of (±)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (500 mg, 
2.19 mmol) in CH2Cl2 (5 mL) was added 2,6-lutidine (508 µL, 4.37 mmol) followed 
by TBSOTf (754 µL, 3.28 mmol) and the resultant solution was stirred at 23 °C for 
20 min. After this time the reaction was diluted with brine (25 mL), the aqueous layer 
extracted with CH2Cl2 (3 × 25 mL) and the combined organic extracts washed with 
brine (2 × 25 mL), then dried (Na2SO4). Concentration in vacuo was followed by 
flash column chromatography (EtOAc : hexanes, 1 : 9) to afford (±)-silyl ether 110 
(647 mg, 86%) as a colourless oil: Rf  0.85 (EtOAc : hexanes, 1 : 4);  IR (film) 
νmax 3436, 1641, 1253, 1051 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.06 (s, 6H, 
(CH3)2Si), 0.90 (s, 9H, (CH3)3C), 1.13 (d, J = 6.0 Hz, 3H, CH3CH), 1.26 − 1.71 (m, 
10H, CH2), 2.08 (app. q, J = 7.0 Hz, 2H, CH2CH=C), 3.80 (q, J = 6.0 Hz, 1H, 
CHCH3), 3.94 (s, 4H, O(CH2)2O), 4.98 (dd, J = 1.5, 10.0 Hz, 1H, CH=CH2), 5.03 
(dd, J = 1.5, 17.0 Hz, 1H, CH=CH2),  5.82 (tdd, J = 7.0, 10.0, 17.0 Hz, 1H, CH=CH2); 
13C NMR (100 MHz, CDCl3) δ −4.7, −4.4, 14.1, 20.2, 23.2, 23.8, 25.9 (3C), 33.9, 
36.7, 37.3, 40.0, 65.0, 68.6 (2C), 111.7, 114.6, 138.7; MS (CI) m/z 343 [M+H]+, 
360 [M+NH4]+; HRMS (CI) m/z calculated for C19H39SiO3 [M+H]+: 343.2668, 
found: 343.2667. 
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6-{2-[4-(tert-Butyldimethylsilanyloxy)pentyl] 
-[1,3]dioxolan-2-yl}hex-2-enoic acid ethyl ester  (353) 
 
 
 
OTBS OO
O
O
 
 
 
 
 
To a solution of (±)-5-[2-(4-tert-butyldimethylsilanyloxypentyl)-[1,3]dioxolan-2-
yl]pent-1-ene (110) (200 mg, 0.58 mmol) and ethyl acrylate (349) (159 µL, 
1.46 mmol) in CH2Cl2 (100 mL) at 40 °C with a slow stream of argon bubbled 
through, was added Hoveyda Grubbs’ second generation catalyst (197) (37 mg, 10 
mol %) in CH2Cl2 (10 mL) via syringe pump over 2.5 h. After this time, the reaction 
was concentrated in vacuo and purified by flash column chromatography (EtOAc : 
hexanes, 1 : 9) to afford ester 353 (186 mg, 77%) as a colourless oil: Rf  0.75 (EtOAc 
: hexanes, 1 : 4);  IR (film) νmax 2952, 1722, 1583, 1255, 1047 cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.06 (s, 6H, (CH3)2Si), 0.90 (s, 9H, (CH3)3C), 1.13 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.30 (t, J = 7.0Hz, 3H, CH3CH2),1.34 − 1.67 (m, 10H, CH2), 2.22 (app. q, J 
= 7.0 Hz, 2H, CH2CH=C), 3.79 (q, J = 6.0 Hz, 1H, CHCH3), 3.94 (s, 4H, O(CH2)2O), 
4.20 (q, J = 7.0 Hz, 2H, CH3CH2), 5.84 (d, J = 15.5Hz, 1H, CH=CHCO2Et), 6.97 
(td, J = 7.0, 15.5 Hz, 1H, CH=CHCO2Et); 13C NMR (100 MHz, CDCl3) δ −4.7, −4.4, 
14.3, 18.2, 20.2, 22.3, 23.8, 25.9 (3C), 32.3, 36.7, 37.4, 39.9, 60.2, 65.0 (2C), 68.5, 
111.5, 121.5, 148.9, 166.7; MS (CI) m/z 415 [M+H]+, 432 [M+NH4]+; HRMS (CI) 
m/z calculated for C22H43SiO5 [M+H]+: 415.2880, found: 415.2876; Anal. calculated 
for C22H42SiO5: C, 63.72; H, 10.21; found: C, 63.66; H, 10.15%. 
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6-{2-[4-(tert-Butyldimethylsilanyloxy)pentyl] 
-[1,3]dioxolan-2-yl}hex-2-enoic acid  (352) 
 
 
 
OTBS OO
OH
O
 
 
 
 
To a solution of 6-{2-[4-(tert-butyldimethylsilanyloxy)pentyl]-[1,3]dioxolan-2-
yl}hex-2-enoic acid ethyl ester (353) (104 mg, 0.25 mmol) in EtOH (11 mL) at 0 °C 
was added NaOH (2 M aq, 6 mL) dropwise. After 18 h, the reaction was diluted with 
H2O (20 mL) and extracted with Et2O (3 × 20 mL). The aqueous layer was acidified 
to ~pH 4 with 1 M aq. HCl, then re-extracted with CH2Cl2 (3 × 20 mL) and the 
combined organic extracts dried (Na2SO4). Concentration in vacuo was followed by 
flash column chromatography (MeOH : CH2Cl2, 1 : 20) to afford acid 352 (76 mg, 
78%) as a colourless oil: Rf  0.40  (MeOH : CH2Cl2, 1 : 20); IR (film) νmax 3299, 
2952, 2858, 1698, 1650, 1253, 1056 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.05 (s, 6H, 
(CH3)2Si), 0.89 (s, 9H, (CH3)3C), 1.12 (d, J = 6.0 Hz, 3H, CH3CH), 1.29 − 1.66 (m, 
10H, CH2), 2.22 (app. q, J = 7.0 Hz, 2H, CH2CH=C), 3.78 (q, J = 6.0 Hz, 1H, 
CHCH3), 3.93 (s, 4H, O(CH2)2O), 5.83 (d, J = 15.5Hz, 1H, CH=CHCO2Et), 7.06 (td, 
J = 7.0, 15.5 Hz, 1H, CH=CHCO2Et), 9.12 (br. s, 1H, CO2H); 13C NMR (100 MHz, 
CDCl3) δ −4.7, −4.4, 18.1, 20.2, 22.1, 23.8, 25.9 (3C), 32.4, 36.6, 37.3, 39.9, 65.0 
(2C), 68.6, 111.5, 120.9, 151.7, 171.6; MS (CI) m/z 387 [M+H]+, 404 [M+NH4]+; 
HRMS (CI) m/z calculated for C20H39SiO5 [M+H]+: 387.2567, found: 387.2562. 
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(S)-5-[2-(4-Triisopropylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]pent-1-ene  (359) 
 
 
 
OTIPS OO
 
 
 
 
 
To a solution of (S)-5-(2-pent-4-enyl-[1,3]dioxolan-2-yl)pentan-2-ol (93) (604 mg, 
2.64 mmol) in CH2Cl2 (6 mL), was added imidazole (450 mg, 6.60 mmol), followed 
by TIPS-Cl (849 µL, 4.00 mmol. After 72 h, the reaction was diluted with brine 
(25 mL), the aqueous layer extracted with CH2Cl2 (3 × 25 mL) and the combined 
organic extracts were washed with brine (2 × 25 mL), then dried (Na2SO4). 
Concentration in vacuo was followed by flash column chromatography (EtOAc : 
hexanes, 1 : 20) to afford silyl ether 359 (1.00 g, 99%) as a colourless oil: Rf  0.85 
(EtOAc : hexanes, 1 : 4); [α]D +0.9 (c 0.97, CH2Cl2); IR (film) νmax 2944, 2867, 1461, 
1376, 1137, 1056 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.08 (s, 18H, (CH3)2C), 
1.18 (d, J = 6.0 Hz, 3H, CH3CH), 1.59 (s, 3H, (CH3)2CH), 1.41 − 1.65 (m, 10H, CH2), 
2.08 (app. q, J = 7.0 Hz, 2H, CH2CH=C), 3.95 (app. s, 5H, O(CH2)2O + CHCH3), 
4.98 (dd, J = 1.5, 10.0 Hz, 1H, CH=CH2), 5.03 (dd, J = 1.5, 17.0 Hz, 1H, CH=CH2),  
5.82 (tdd, J = 7.0, 10.0, 17.0 Hz, 1H, CH=CH2); 13C NMR (100 MHz, CDCl3) δ 12.5 
(3C), 18.1 (6C), 19.7, 23.2, 23.5, 33.9, 36.9, 37.4, 40.2, 64.9 (2C), 68.5, 111.7, 114.6, 
138.7; MS (CI) m/z 385 [M+H]+, 402 [M+NH4]+;  HRMS (CI) m/z calculated for 
C22H45SiO3 [M+H]+: 385.3138, found: 385.3138; Anal. calculated for C22H44SiO3: 
C, 68.69; H, 11.53; found: C, 68.70; H, 11.57%. 
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(S)-6-[2-(4-Triisopropylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]hex-2-enoic acid ethyl ester  (360) 
 
 
 
OTIPS OO
O
O
 
 
 
 
To a solution of (S)-5-[2-(4-triisopropylsilanyloxypentyl)-[1,3]dioxolan-2-yl]pent-
1-ene (359) (1.07 g, 2.78 mmol) and ethyl acrylate (349) (758 µL, 6.97 mmol) in 
CH2Cl2 (200 mL) at 40 °C with a slow stream of argon bubbled through, was added 
Hoveyda Grubbs’ second generation catalyst (197) (100 mg, 6 mol %) in CH2Cl2 (15 
mL) via syringe pump over 2.5 h. After this time, the reaction was concentrated in 
vacuo and purified by flash column chromatography (EtOAc : hexanes, 1 : 9) to 
afford ester 360 (926 mg, 78%) as a colourless oil: Rf  0.75 (EtOAc: hexanes, 1 : 4); 
[α]D +1.0 (c 1.74, CH2Cl2); IR (film) νmax 3517, 2944, 2867, 1722, 1654, 1463, 1047 
cm-1; 1H NMR (400 MHz, CDCl3) δ 1.06 (s, 21H, (CH3)2CH), 1.16 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.28 (t, J = 7.0Hz, 3H, CH3CH2), 1.35 − 1.65 (m, 10H, CH2), 2.20 (app. q, J 
= 7.0 Hz, 2H, CH2CH=C), 3.93 (app. s, 5H, O(CH2)2O + CHCH3), 4.18 (q, J = 7.0 
Hz, 2H, CH3CH2), 5.82 (d, J = 15.5 Hz, 1H, CH=CHCO2Et), 6.97 (td, J = 7.0, 15.5 
Hz, 1H, CH=CHCO2Et); 13C NMR (100 MHz, CDCl3) δ 12.5 (3C), 14.3, 18.2 (6C), 
19.7, 22.3, 23.5, 32.3, 36.6, 37.5, 40.1, 60.1, 65.0 (2C), 68.5, 111.5, 121.5, 148.9, 
166.7; MS (CI) m/z 457 [M+H]+, 474 [M+NH4]+;  HRMS (CI) m/z calculated for 
C25H49SiO5 [M+H]+: 457.3363, found: 457.3357; Anal. calculated for C25H48SiO5: C, 
65.74; H, 10.59; found: C, 65.82; H, 10.65%. 
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(S)-6-[2-(4-Triisopropylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]hex-2-enoic acid methyl ester  (361) 
 
 
 
OTIPS OO
O
O
 
 
 
 
To a solution of (S)-6-[2-(4-triisopropylsilanyloxypentyl)-[1,3]dioxolan-2-yl]hex-2-
enoic acid ethyl ester (360) (2.75 g, 6.0 mmol) in MeOH (55 mL) at 0 °C was added 
NaOH (2 M aq, 30 mL) dropwise. After 18 h, the reaction mixture was diluted with 
H2O (100 mL), acidified to ~pH 4 with 1 M aq. HCl, extracted with CH2Cl2 
(3 × 20 mL) and the combined organic extracts dried (Na2SO4). Concentration in 
vacuo was followed by flash column chromatography (MeOH : CH2Cl2, 1 : 99) to 
afford methyl ester 361 (1.55 g, 58%) as a colourless oil: Rf  0.70 (EtOAc : hexanes, 
1 : 4); [α]D +1.1 (c 1.11, CH2Cl2); IR (film) νmax 2942, 2865, 1727, 1656, 1463, 1380, 
1051 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.08 (s, 18H, (CH3)2C), 1.18 (d, J = 6.0 Hz, 
3H, CH3CH), 1.61 (s, 3H, (CH3)2CH), 1.30 − 1.67 (m, 10H, CH2), 2.23 (app. q, 
J = 7.0 Hz, 2H, CH2CH=C), 3.75 (s, 3H, CH3OCOR), 3.95 (app. s, 5H, O(CH2)2O + 
CHCH3), 5.85 (d, J = 15.5Hz, 1H, CH=CHCO2Et), 6.98 (td, J = 7.0, 15.5Hz, 1H, 
CH=CHCO2Et); 13C NMR (100 MHz, CDCl3) δ 12.5 (3C), 17.7 + 18.2 (6C), 19.7, 
22.3, 23.5, 32.3, 36.6, 37.5, 40.1, 51.4, 65.0 (2C), 68.5, 111.5, 121.1, 149.2, 167.1; 
MS (CI) m/z 443 [M+H]+, 460 [M+NH4]+;  HRMS (CI) m/z calculated for C24H47SiO5 
[M+H]+: 443.3206, found: 443.3202; Anal. calculated for C24H46SiO5: C, 65.11; 
H, 10.47; found: C, 65.01; H, 10.39%. 
 
Note : The transesterification product 361 was obtained because of poor starting 
material  solubility. Increasing the amount of MeOH resulted in desired hydroylsis.  
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(S)-6-[2-(4-Triisopropylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]hex-2-enoic acid  (362) 
 
 
 
 
OTIPS OO
OH
O
 
 
 
 
To a solution of (S)-6-[2-(4-triisopropylsilanyloxypentyl)-[1,3]dioxolan-2-yl]hex-2-
enoic acid ethyl ester (360) (2.00 g, 4.39 mmol) in MeOH (100 mL) at 0 °C was 
added NaOH (2 M aq, 30 mL) dropwise. After 18 h, the reaction was diluted with 
H2O (100 mL), acidified to ~pH 4 with 1 M aq. HCl, extracted with CH2Cl2 
(3 × 20 mL) and the combined organic extracts dried (Na2SO4). Concentration in 
vacuo was followed by flash column chromatography (MeOH : CH2Cl2, 1 : 99) to 
afford acid 362 (1.80 g, 96%) as a colourless oil: Rf 0.40  (MeOH : CH2Cl2, 1 : 20); 
[α]D +1.1 (c 1.00, CH2Cl2); IR (film) νmax 3691, 2944, 2867, 1698, 1650, 1463, 1056 
cm-1; 1H NMR (400 MHz, CDCl3) δ 1.04 (s, 21H, (CH3)2CH), 1.15 (d, J = 6.0 Hz, 3H, 
CH3CH), 1.36 − 1.64 (m, 10H, CH2), 2.23 (app. q, J = 6.5 Hz, 2H, CH2CH=C), 
3.92 (app. s, 5H, O(CH2)2O + CHCH3), 5.82 (d, J = 15.5 Hz, 1H, CH=CHCO2Et), 
7.05 (td, J = 6.5, 15.5 Hz, 1H, CH=CHCO2Et), 10.39 (br. s, 1H, CO2H); 13C NMR 
(100 MHz, CDCl3) δ 12.5 (3C), 18.1 (6C), 19.6, 22.1, 23.5, 32.3, 36.5, 37.4, 40.0, 
65.0 (2C), 68.5, 111.5, 121.0, 151.6, 171.7; MS (CI) m/z 429 [M+H]+, 
446 [M+NH4]+; HRMS (CI) m/z calculated for C23H45SiO5 [M+H]+: 429.3018, 
found: 429.3025. 
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(S)-6-[2-(4-Triisopropylsilanyloxypentyl)-[1,3]dioxolan-2-yl]hex-2-enoic 
2,4,6-trichlorobenzoic anhydride  (366) 
 
 
 
OTIPS OO
O
O O Cl
Cl Cl 
 
 
 
 
To a solution of (S)-6-[2-(4-triisopropylsilanyloxypentyl)-[1,3]dioxolan-2-yl]hex-2-
enoic acid (362) (137 mg, 0.32 mmol) in THF (8 mL) was added Et3N (53 µL, 
0.38 mmol) followed by 2,4,6-trichlorobenzoyl chloride (365) (50 µL, 0.32 mmol). 
After 2.5 h, the reaction was concentrated in vacuo and purified by flash column 
chromatography (EtOAc : hexanes, 2 : 3) to afford mixed anhydride 366 (215 mg, 
>100% by mass) as a colourless oil which was used crude without further 
purification: Rf  0.80 (EtOAc : hexanes, 1 : 3); IR (film) νmax 2923, 1815, 1755, 1576, 
1547, 1211, 1081, 984 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.07 (s, 21H, (CH3)2CH), 
1.17 (d, J = 6.0 Hz, 3H, CH3CH), 1.39 − 1.67 (m, 10H, CH2), 2.28 (app. q, 
J = 7.0 Hz, 2H, CH2CH=C), 3.95 (app. s, 5H, O(CH2)2O + CHCH3), 5.90 (d, J = 15.5 
Hz, 1H, CH=CHCO2Et), 7.14 (td, J = 7.0, 15.5 Hz, 1H, CH=CHCO2Et), 7.41 (s, 2H, 
ArH); 13C NMR (100 MHz, CDCl3) δ 12.5 (3C), 18.2 (6C), 19.7, 22.0, 23.5, 32.6, 
36.6, 37.5, 40.1, 65.0 (2C), 68.5, 111.4, 120.6, 130.8, 133.1, 137.4, 137.6, 153.8, 
156.0, 157.6, 162.0, 164.6; MS (ESI, Na+) m/z 635, 637 [M+H]+, 657, 659 [M+Na]+; 
HRMS (ESI, Na+) m/z calculated for C30H47(35Cl)3SiO6 [M+H]+: 635.2138, 
found: 635.2136. 
 
 
Note : The product obtained was contaminated with excess 2,4,6-trichlorobenzoyl 
chloride (365), or its acid derivative. 
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2-[2-(2,2-Dimethyl-4-oxo-6H-[1,3]dioxin-6-yl)-acetyl] 
-3-oxo-8-[2-(4-triisopropylsilanyloxypentyl) 
-[1,3]dioxolan-2-yl]oct-4-enoic acid allyl ester  (368) 
 
 
 
OTIPS OO O O
OO
O O
O
1 3
6
 
 
 
 
To a solution of 4-(2,2-dimethyl-4-oxo-6I-[1,3]dioxin-6-yl)-3-oxobutyric acid allyl 
ester (339) (54 mg, 0.20 mmol) in CH2Cl2 (0.3 mL) was added MgCl2 (21 mg, 
0.22 mmol) and the resultant suspension cooled to 0 °C for the addition of pyridine 
(34 µL, 0.42 mmol). After 30 min (S)-6-[2-(4-triisopropylsilanyloxypentyl)-
[1,3]dioxolan-2-yl]hex-2-enoic 2,4,6-trichlorobenzoic anhydride (366) (140 mg, 
0.22 mmol) in CH2Cl2 (0.3 mL) was added and the reaction was allowed to warm to 
23 °C for 2 h before quenching by the addition of sat. aq. NH4Cl (2 mL). The reaction 
was poured into pH 7.0 buffer (10 mL), extracted with CH2Cl2 (3 × 10 mL) and the 
combined organic extracts were washed with sat. aq. NH4Cl (2 × 10 mL), then dried 
(Na2SO4). Concentration in vacuo afforded the crude reaction products, which were 
analysed by MS and shown to include acyl dioxinone 368, along with starting 
materials and other unknown products (196 mg >100% by mass): MS (ESI, Na+) m/z 
679 [M+H]+, 701 [M+Na]+; HRMS (ESI, Na+) m/z calculated for C36H58NaSiO10 
[M+Na]+: 701.3697, found: 701.3699. 
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Appendix 1: Crystal Structure Data 
 
Crystal data and structure refinement for hemi-ketal 280b: 
 
 
 
Empirical formula C22 H34 O8 
Formula weight 426.49 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54248 Å 
Crystal system, space group Monoclinic, P2(1) 
Unit cell dimensions a = 5.6741(1) Å α = 90° 
 b = 10.1286(1) Å β = 93.8525(6)° 
 c = 19.5581(1) Å γ = 90° 
Volume, Z 1121.477(12) Å3, 2 
Density (calculated) 1.263 Mg/m3 
Absorption coefficient 0.790 mm-1 
F(000) 460 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.29 x 0.14 x 0.04 mm3 
θ range for data collection 2.27 to 71.65° 
Index ranges -6<=h<=6, -12<=k<=12, -23<=l<=24 
Reflns collected / unique 32188 / 4296 [R(int) = 0.0397] 
Reflns observed [F>4σ(F)] 3591 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.83092 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4296 / 46 / 294 
Goodness-of-fit on F2 0.962 
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Final R indices [F>4σ(F)] R1 = 0.0297, wR2 = 0.0719 
 R1+ = 0.0297, wR2+ = 0.0719 
 R1- = 0.0299, wR2- = 0.0724 
R indices (all data) R1 = 0.0371, wR2 = 0.0744 
Absolute structure parameter x+ =0.00(13), x- = 1.01(13) 
Largest diff. peak, hole 0.104, -0.145 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
 
Table 1: Bond Lengths [Å]: 
 
 
BOND                                BOND LENGTH 
O(1)-C(2) 1.3356(19) 
O(1)-C(18) 1.4746(17) 
C(2)-O(2) 1.2112(17) 
C(2)-C(3) 1.506(2) 
C(3)-C(4) 1.514(2) 
C(4)-O(19) 1.4153(17) 
C(4)-O(20) 1.4190(18) 
C(4)-C(5) 1.525(2) 
C(5)-C(6) 1.512(2) 
C(6)-O(24) 1.421(2) 
C(6)-O(21) 1.4454(17) 
C(6)-C(7) 1.505(2) 
C(7)-C(8) 1.528(2) 
C(8)-O(20) 1.443(2) 
C(8)-C(9) 1.493(2) 
C(9)-C(10) 1.305(2) 
C(10)-C(11) 1.499(3) 
C(11)-C(12) 1.537(2) 
C(12)-C(13) 1.525(2) 
C(13)-C(14) 1.513(2) 
C(14)-O(28) 1.434(2) 
C(14)-O(25) 1.4358(19) 
C(14)-C(15) 1.517(2) 
C(15)-C(16) 1.531(2) 
C(16)-C(17) 1.519(2) 
C(17)-C(18) 1.510(2) 
C(18)-C(29) 1.514(2) 
O(21)-C(22) 1.419(2) 
C(22)-C(23) 1.489(2) 
C(23)-O(24) 1.422(2) 
O(25)-C(26') 1.388(10) 
O(25)-C(26) 1.449(5) 
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BOND                                BOND LENGTH 
C(26)-C(27) 1.514(7) 
C(27)-O(28) 1.410(4) 
C(26')-C(27') 1.485(9) 
C(27')-O(28) 1.492(8) 
 
 
 
Table 2: Bond Angles [º]: 
  
BOND                             BOND ANGLE 
C(2)-O(1)-C(18) 117.88(11) 
O(2)-C(2)-O(1) 123.85(14) 
O(2)-C(2)-C(3) 124.02(14) 
O(1)-C(2)-C(3) 112.11(12) 
C(2)-C(3)-C(4) 113.30(12) 
O(19)-C(4)-O(20) 111.01(11) 
O(19)-C(4)-C(3) 112.14(12) 
O(20)-C(4)-C(3) 104.77(12) 
O(19)-C(4)-C(5) 107.54(12) 
O(20)-C(4)-C(5) 110.92(12) 
C(3)-C(4)-C(5) 110.50(12) 
C(6)-C(5)-C(4) 114.61(12) 
O(24)-C(6)-O(21) 105.71(12) 
O(24)-C(6)-C(7) 112.29(14) 
O(21)-C(6)-C(7) 108.81(13) 
O(24)-C(6)-C(5) 110.38(13) 
O(21)-C(6)-C(5) 108.94(12) 
C(7)-C(6)-C(5) 110.54(13) 
C(6)-C(7)-C(8) 112.07(14) 
O(20)-C(8)-C(9) 105.48(13) 
O(20)-C(8)-C(7) 109.87(13) 
C(9)-C(8)-C(7) 110.86(14) 
C(10)-C(9)-C(8) 126.03(18) 
C(9)-C(10)-C(11) 124.5(2) 
C(10)-C(11)-C(12) 111.00(15) 
C(13)-C(12)-C(11) 110.99(14) 
C(14)-C(13)-C(12) 116.21(13) 
O(28)-C(14)-O(25) 106.00(12) 
O(28)-C(14)-C(13) 110.52(15) 
O(25)-C(14)-C(13) 109.21(14) 
O(28)-C(14)-C(15) 108.85(13) 
O(25)-C(14)-C(15) 109.39(15) 
C(13)-C(14)-C(15) 112.65(13) 
C(14)-C(15)-C(16) 113.70(13) 
C(17)-C(16)-C(15) 113.23(13) 
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BOND                             BOND ANGLE 
C(18)-C(17)-C(16) 114.09(13) 
O(1)-C(18)-C(17) 108.76(12) 
O(1)-C(18)-C(29) 106.55(13) 
C(17)-C(18)-C(29) 113.24(14) 
C(4)-O(20)-C(8) 114.65(11) 
C(22)-O(21)-C(6) 108.44(11) 
O(21)-C(22)-C(23) 103.59(13) 
O(24)-C(23)-C(22) 103.10(14) 
C(6)-O(24)-C(23) 106.22(12) 
C(26')-O(25)-C(14) 111.0(4) 
C(26')-O(25)-C(26) 18.8(7) 
C(14)-O(25)-C(26) 107.2(3) 
O(25)-C(26)-C(27) 102.5(4) 
O(28)-C(27)-C(26) 102.1(4) 
O(25)-C(26')-C(27') 101.2(7) 
C(26')-C(27')-O(28) 103.6(6) 
C(27)-O(28)-C(14) 109.0(2) 
C(27)-O(28)-C(27') 28.2(3) 
C(14)-O(28)-C(27') 103.8(4) 
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Appendix 2: 1H NMR data for Diastereotopic Compounds. 
 
Appendix 2a 
 
(7-Hydroxy-9-vinyl-1,4,8-trioxaspiro[4,5]dec-7-yl)-acetic acid ethyl ester (269) 
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1H NMR Spectrum  (300 MHz, CDCl3): 
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Appendix 2b 
 
(7-Hydroxy-9-propenyl-1,4,8-trioxa- 
spiro[4.5]dec-7-yl)-acetic acid ethyl ester (275) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2c 
 
4-{2-[2-(tertButyldimethylsilanyloxy)-pent-3-enyl]-[1,3]dioxolan-2-yl}-3-
oxobutyric acid 1-methyl-4-(2-pent-4-enyl-[1,3]dioxolan-2-yl)-butyl ester (277) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2d 
 
 
25-(tert-Butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-23-ene-7,9-dione  (278) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2e 
 
7-Methoxy-25-(tert-butyldimethylsilanyloxy)-11-methyl-1,4,10,16,19-pentaoxa-
dispiro[4.9.4.7]hexacos-7,23-dien-9-one  (286) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2f 
 
7-Methoxy-9-propenyl-1,4,8-trioxa- 
spiro[4.5]dec-7-yl)-acetic acid methyl ester (290) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2g 
 
4-{2-[2-(tert-Butyldimethylsilanyloxy)-pent-3-enyl]- 
[1,3]dioxolan-2-yl}-3-hydroxy-butyric acid ethyl ester  (304) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2h 
 
3-Hydroxy-4-[2-(2-hydroxy-pent-3-enyl)- 
[1,3]dioxolan-2-yl]-butyric acid ethyl ester  (305) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2i 
 
7-Hydroxy-25-(tert-butyldimethylsilanyloxy)-11-methyl- 
1,4,10,16,19-pentaoxa-dispiro[4.9.4.7]hexacos-23-ene-9-one  (302) 
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1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 2j 
 
7,25-Dihydroxy-11-methyl-1,4,10,16,19-pentaoxa- 
dispiro[4.9.4.7]hexacos-23-ene-9-one  (301) 
 
 
O
OH O
O
O O
O
OH  
 
 
1H NMR Spectrum  (400 MHz, CDCl3): 
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Appendix 3: Further NMR Data for Unexpected Product ‘b’ (315) 
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HMQC Spectrum: 
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HMBC Spectrum: 
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